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SUMMARY
Hand hygiene is the most important measure for reducing healthcare associated 
infections. Previous in-vitro testing of alcohol hand rubs (AHR) has not reflected 
conditions found in practice; therefore little is known about their true efficacy.
This study aimed to discover how effective AHRs are when used in local intensive 
therapy Units (ITU) against Staphylococcus aureus clinical isolates and their mode 
of action.
The AHRs were unable to achieve significant bactericidal effect (> 4 log reduction) 
against S. aureus within the time healthcare workers (HCW) took to rub AHR into 
their hands, particularly when tested against bacterial cells on the surface of excised 
skin. The AHRs had no residual effect and the mechanical action of hand rubbing 
only increased bacterial cell death by approximately 1 log. The AHRs demonstrated 
varying efficacies against the isolates and variation in susceptibility to the AHRs was 
also observed among the isolates. AHR damaged the cytoplasmic membrane, but 
this was not the cause of the bactericidal effect, nor a reason for the differences in 
susceptibility observed among the strains. The cell wall and/or outer layers of the 
bacterial cell were found to most likely be the main target of AHR, most likely due to 
protein denaturation, although this study was unable to confirm this hypothesis. 
Virulence gene expression, cell surface charge and cell surface hydrophobicity was 
not affected by exposure of bacterial cells to AHR and were not responsible for 
varying AHR susceptibility among the isolates. This study determined the quality of 
AHR application amongst HCWs in the ITU and the potential cross-contamination 
resulting from failure to perform hand hygiene before and after certain activities.
It can be concluded from this study that AHRs are unlikely to kill all microbial flora 
on HCWs hands. Recommendations have been made to improve hand hygiene 
practices and the efficacy of AHRs used in ITUs.
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CHAPTER 1 GENERAL INTRODUCTION
1.1 STAPHYLOCOCCUS AUREUS IN THE HEALTHCARE 
ENVIRONMENT
1.1.1 Types of S. aureus 
1.1.1.1MSSA and MRSA
Methicillin resistant Staphylococcus aureus (MRSA) are now defined as S. aureus 
that are resistant to the antibiotic oxacillin, since methicillin has been superseded by 
oxacillin. S. aureus is defined as methicillin resistant if oxacillin has a minimum 
inhibitory concentration (MIC) breakpoint of >2 mg/L and sensitive (MSSA) if the 
value is <2 mg/L (British Society for Antimicrobial Chemotherapy (BSAC), 2006). 
MRSA are also resistant to all p-lactam antibiotics (Lowy, 2003).
Meta-analysis of mortality rates in S. aureus bacteraemia cohort studies revealed that 
MRSA mortality rates were much higher than those for MSSA (Cosgrove et al., 
2003). A retrospective study of intensive therapy unit (ITU) ventilator-associated 
pneumonia patients revealed that the median length of patient stay was significantly 
longer among those infections caused by MRSA than MSSA, despite initially 
receiving the appropriate antibiotic therapy (Shorr et al., 2006).
1.1.1.2 HA-MRSA and CA-MRSA
MRSA infection was known strictly as a healthcare-associated infection (HCAI) or 
as hospital acquired MRSA (HA-MRSA) until about 15 years ago, when the 
organism began to cause infection among healthy members of the community who 
lacked risk factors for the acquisition of a HCAI (Udo et al., 1993). Community 
associated MRSA (CA-MRSA) can cause serious illness such as severe necrotizing 
MRSA pneumonia (Francis et al., 2005) and even death (Hunt et al., 1999).
The Center for Disease Control and Prevention (CDC) Active Bacterial Core 
Surveillance sites that carry out CA-MRSA surveillance define CA-MRSA as an 
MRSA infection that does not have any of the following risk factors for HCAI: 1) a 
positive culture for MRSA obtained more than 48 hours after admission to a hospital;
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2) prior MRSA infection or colonization; 3) hospitalization, surgery, residency in a 
long-term care facility, haemodialysis, or peritoneal dialysis within the past year; or 
4) current indwelling percutaneous devices or catheters (Minnesota Department of 
Health, 2004).
CA-MRSA has found its way into hospitals and causes a significant proportion of 
HCAIs (Kourbatova et al., 2005; Gonzalez et al., 2006; Johnson et al., 2006a; 
Seybold et al., 2006), including in the ITU (Thompson et al., 2009). A meta-analysis 
of studies found the number of MRSA infections from hospitalized patients defined 
as CA-MRSA was high (a total of 30.2% in 27 retrospective studies and 37.3% in 5 
prospective studies), although most patients had at least one healthcare-associated 
risk factor and therefore exact numbers are likely to be lower (Salgado et al., 2003). 
These figures compare with those reported by the Health Protection Agency (HPA) 
in UK hospitals in 2006 and 2007, where 29% of MRSA cases were detected within 
two days of arrival; although one quarter of these had been admitted from another 
hospital or nursing home (HPA, 2008).
A recent study found 7.3% of patients were carrying MRSA in the anterior nares 
upon arrival, 30% of which were CA-MRSA (Hidron et al., 2005), indicating one 
route of its spread into the healthcare environment. A meta-analysis of studies found 
only a slightly lower prevalence of MRSA among community members (1.3%), 
although excluding those who had healthcare contacts reduced prevalence to 0.2% 
(Salgado et al., 2003).
HA-MRSA can be defined as an MRSA infection where a positive culture for MRSA 
was obtained more than 48 hours after admission to a hospital. CA-MRSA differs 
from HA-MRSA in that it affects younger people, is mostly associated with skin and 
soft tissue infection, is more likely to be sensitive to a large number of non- P-lactam 
antibiotics and more likely to carry the staphylococcal cassette chromosome mec 
(SCCmec) IV and Panton Valentine Leukocidin (PVL) toxin (Naimi et al., 2003; 
Piao et al., 2005; Wannet et al., 2005; Gonzalez et al., 2006; Johnson et al., 2006b; 
King et ah, 2006). However, the virulence of CA-MRSA was not found to be any
3
different in strains with or without PVL, indicating it is not a major virulence 
determinant of CA-MRSA (Said-Salim et al., 2005; Voyich et al., 2006).
1.1.1.3 PVL-positive S. aureus
PVL-positive strains of S. aureus can cause skin infections, tissue necrosis (Holmes 
et al., 2005) and more severe conditions such as necrotising pneumonia. PVL is a 
toxin produced by S. aureus that is made up of two sub-units, LukS-PV and LukF- 
PV. These two sub-units combine to form a pore-forming heptamer on the 
membrane of host polymorphonuclear leukocytes (PMNL), causing lysis or 
apoptosis. This process leads to necrosis of host tissue, although the exact process is 
not clear. It is thought that either reactive oxygen species from lysed PMNLs 
directly cause tissue necrosis, or granule contents from lysed PMNLs initiate an 
inflammatory response that causes tissue necrosis (Boyle-Vavra & Daum, 2007).
The PVL gene was found to be present in MSSA as well as MRSA isolates 
(Swaminathan et al., 2006; Bocchini et al., 2007), in a total of 1.6% of S. aureus 
isolates in England and Wales (Holmes et al., 2005). Its presence has been 
associated with more severe symptoms during infection, including a higher 
likelihood of bacteraemia, more severe local disease and greater systemic 
inflammatory response (Bocchini et al., 2007).
The PVL toxin is most commonly linked with CA-MRSA (present in 77% CA- 
MRSA isolates), although it is infrequently isolated in HA-MRSA isolates (present 
in 4% HA-MRSA isolates; Naimi et al., 2003). Despite this, the number of 
infections caused by PVL positive strains are increasing, meaning it is becoming 
prevalent in hospitals.
1.1.1.4EMRSA
Epidemic MRSA (EMRSA) strains are strains of MRSA that have caused outbreaks 
of infection across the UK. Seventeen epidemic types of MRSA have been 
identified, which are known as EMRSA-1 to EMRSA-17 (Johnson et al., 2005a).
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EMRSA-15 and EMRSA-16 are the most significant epidemic strains and have 
spread widely across the UK (Johnson et al., 2001).
1.1.2 Colonisation and Transmission
Studies have revealed that between 20% and 55 % of healthy adults carry S. aureus 
in the anterior nares (Kluytmans et al., 1997, Vandenbergh & Verbrugh, 1999), the 
most common site of colonisation. Studies over time, however, have shown between 
10% and 35% of healthy adults to be persistent carriers, between 20% and 75% to be 
intermittent carriers and between 5% and 70% to be non-carriers (Vandenbergh & 
Verbrugh, 1999). S. aureus nasal carriage is significant since it is a major risk factor 
for infection with the same strain (Kluytmans & Wertheim, 2005). S. aureus can 
also be found in the throat (Ringberg et al., 2006) and on various skin sites, including 
the perineal area (Vandenbergh & Verbrugh, 1999; Larson et al., 2000).
S. aureus is shed from people’s skin into the environment and has been found present 
in the air in hospital rooms (Bauer et al., 1990; Sexton et al., 2006). It then settles on 
surfaces in the surrounding area, where it is able to survive for long periods 
(Schaechter et al., 1999; Huang et al., 2006a). S. aureus can also be transferred to 
environmental surfaces via nursing staff (Boyce et al., 1997).
S. aureus transmission in the hospital environment has been demonstrated by its 
presence on surfaces and equipment near patients including beds, mattresses, linen, 
patients’ gowns, tables, chairs, window ledges, patients’ files, workstations, 
monitors, blood pressure cuffs, ledges behind beds, underneath beds, sink handles 
and computer keyboards (Boyce et al., 1997; Bures et al., 2000; Panhotra et al., 
2005; Hardy et al., 2006; Sexton et al., 2006). Oie and colleagues (2005) quantified 
S. aureus contamination in a hospital dermatological ward. They found particularly 
high levels of MSSA and MRSA on several surfaces. For example, MRSA counts as 
high as 104 CFU/900cm2 were found on an immersion bathtub and MSSA counts as 
high as 105 CFU on the entire inner surface of a foot washbowl. However, presence 
of MRSA on these surfaces does not necessarily mean they will result in patient 
infection. Wilson et al. (2007) found that of 114 ITU patients only one developed
5
MRSA infection with an isolate identical to that found in their environment or on the 
hands of healthcare workers (HCWs). They also found that five patients became 
colonized with MRSA isolates during their stay that were not found in their 
environment beforehand.
The most common mode of transmission of microorganisms in the healthcare 
environment is by the HCW (Bauer et al., 1990). Organisms are transferred to the 
HCWs either by direct contact with a patient’s skin or by contact with fomites in the 
near vicinity of the patient (Boyce et a l, 1997), onto which organisms have been 
shed. The organism is then transmitted to another patient or another area on the 
same patient when the HCW touches the patient or a fomite directly in contact with a 
patient and subsequently touches either the same or another patient (Pittet et al., 
2006). Ayliffe et al. (1988) sampled the hands of HCWs on a general hospital ward 
and found 29% were carriers of S. aureus, with counts of up to 2.4 x 107 CFU.
1.13 Staphylococcal Disease
S. aureus is the most virulent species of staphylococci (Ellner & Neu, 1992). It can 
cause a wide range of infections, depending on the area of the body it invades. S. 
aureus causes skin infections such as scalded skin syndrome, impetigo, bullous 
impetigo, folliculitis, styes, furuncles (boils), carbuncles and wound infections. 
Bacteraemia usually occurs as a result of the spread of infection from another site 
into the bloodstream. More serious infections include toxic shock syndrome, 
endocarditis, pneumonia, empyema and osteomyelitis. Ingesting food contaminated 
with S. aureus may cause food poisoning (Murray, 1998).
The ability of S. aureus to cause disease is due to its combined ability to colonize and 
invade its host and evade the host’s immune system. This ability is the result of the 
production of a number of ‘virulence’ factors and the key virulence factors are listed 
in Tables 1.1-1.3. S. aureus is able to evade the host immune system by neutralizing 
its net anionic surface charge with the addition of cationic molecules, thus reducing 
interaction with cationic antimicrobial host molecules (Fedtke et al. 2004).
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Table 1.1: Major Virulence Factors Associated with Attachment of S. aureus to Its Host
Virulence Factor Gene Function Reference
FnBP A/FnBP B fnbA/fnbB Bind fibronectin Foster & HoQk (1998); Peacock et al. (1999)
Collagen binding protein cna Binds to collagen Gillaspy et ah (1998)
Clumping factor A dfA Binds to fibrinogen McDevitt et al. (1997)
EAP aka MAP eap Binds to several host proteins Palma et al. (1999)
EAP = Extracellular adhesion protein; FnBP = Fibronectin Binding Protein; MAP = major histocompatibility complex class II analogous 
protein
Table 1.2: Major Virulence Factors Associated with Invasion of S. aureus Into Its Host
Virulence Factor Gene Function Reference
FnBP A/FnBP B fnbA/fnbB Internalization of S', aureus into host epithelial cells Peacock et al. (1999)
Panton Valentine Leukocidin, pvl/hla/hlg Destroy host cells by forming a pore in the membrane Todar (2008); Ferreras et al.
a-toxin/ y-haemolysin (1998); Lina et a l  (1999)
Hyaluronidase hysA Breaks down hyaluronic acid in connective tissue Farrell et al. (1995)
Exfoliative toxin A & B etaletb Causes separation of the epidermal and dermal layers, 
allowing spread of bacteria into the dermis
Amagai et al. (2000)
Super antigens TSST-1, tst, sea- see, Cause a massive immune response, leading to systemic Todar (2008)
enterotoxin A,B,C,D,E,G seg toxicity and host tissue damage, facilitating their spread
FnBP = Fibronectin Binding Protein; TSST = Toxic Shock Syndrome Toxin
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Table 1.3: Major Virulence Factors Associated with Evasion of Host Immune System by S. aureus
Virulence Factor Gene Function Reference
Hyaluronidase hysA May interfere with neutrophils/macrophage function Lin et al. (1994)
Capsule production cap5/ Avoid phagocytosis by binding antibodies Thakker et al. (1998)
cap8 Cunnion et al. (2003)
Intracellular adhesion icaAl Extracellular polysaccharide adhesin PNAG is produced to form a biofilm, O’Gara (2007)
icaD which protects cells from host’s immune system
Clumping factor A clfA Binds fibrinogen to the cell surface to prevent antibodies binding to it or to Higgins et al. (2006)
a PMNL, preventing phagocytosis
Protein A spa Binds IgG in the wrong orientation, preventing recognition by neutrophils Foster (2005)
CHIPS chp Binds to chemo-attractants to prevent neutrophil recognition de Hass et al. (1999)
EAP eap Competes with neutrophils for binding sites on endothelial cells, preventing Foster (2005)
neutrophil migration
SOD/Catalase sodAI Oxygen produced by phagocytes to kill bacterial cells is converted to H2O2 Clements et al. (1999)
katA by SOD, then broken down into H2O by catalase Sanz et al. (2000)
CHIPS = Chemotaxis Inhibitory Protein of Staphylococci; EAP = Extracellular Adhesion Protein; IgG = Immunoglobulin G; PMNL = 
Polymorphonuclear leukocyte; PNAG = polymeric N-acetyl-glucosamine; SOD = Superoxide dismutase
M3
1.1.4 Prevalence
Most surveillance systems used to detect prevalence of S. aureus involve counting 
the number of cases of bacteraemia. This method does not reveal the true extent of 
S. aureus morbidity, since Walker et al. (2008) found that non-bacteraemic isolation 
of MRSA occurred 8 times more frequently than bacteraemic isolation, which 
accounted for only 8% of first clinical isolations of MRSA. Surveillance of all 
infection sites of MRSA using this system would lead to faster detection of changes 
in infection rates and may be of particular use within hospitals.
Data collected by the European Antimicrobial Resistance Surveillance System 
(EARSS, 2008) showed that in 2008 the proportion of S. aureus bacteraemia due to 
MRSA in European countries ranged between <1% (Norway, Sweden and the 
Netherlands) and >50% (Portugal and Malta). The UK showed a high proportion of 
MRSA in 2008 (31%), although a steady decrease was observed from 2006. MRSA 
proportions also decreased in many other countries, although Portugal and 
Switzerland showed an increase. Countries that are grouped together according to 
their proportions of MRSA are mostly grouped together spatially. Data from EARSS 
(2007) showed that cases of MRSA bacteraemia are more frequently isolated from 
patients on an ITU ward in UK (over 60% in 2005, but reduced to <50% in 2007).
The 2007 HPA report (HPA, 2007) shows the number of reported cases of MRSA 
and MSSA S. aureus bacteraemia in England rose significantly between 1990 and 
2003, with a slight decrease between 2004 and 2006. These data are summarised in 
Figure 1.1. The report shows the proportion of S. aureus bacteraemia cases due to 
MRSA increased significantly over time: from <5% in 1990 to approximately 40% in 
2000, with a slight decrease in 2006 to approximately 37%. The report also shows 
that 77% of MRSA cases occurred in adults aged over 60 and 69% in adults over 65 
and that a significantly higher proportion of cases occur in males than in females. 
Numbers of MRSA bacteraemia cases were also shown to vary between regions, 
with the largest number of cases found in the London region and the lowest in the 
North East. The number of MRSA cases in London was considerably higher over 
the period of April 2001 to March 2007 compared to other regions, but the number of
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cases in London began to decrease significantly in 2004. All other regions have 
shown a decrease in the number of MRSA bacteraemia reports beginning between 
2003 and 2006.
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Figure 1.1: Prevalence of S. aureus Bacteraemia
Number of cases of S. aureus (MSSA and MRSA) bacteraemia reported in England 
via the voluntary and mandatory surveillance schemes between 1990 and 2006 
(extracted from HPA 2007).
Data for S. aureus bacteraemia are also available for Wales (National Public Health 
Service for Wales, 2007). These data show that 1,039 cases of S. aureus bacteraemia 
were reported in Wales in 2005, 407 (40%) of which were MRSA, but numbers had 
fallen in 2006 to 1,023 cases of S. aureus bacteraemia, 341 (33%) of which were 
MRSA. The number of S. aureus and MRSA bacteraemia cases has remained fairly 
constant in Wales between April 2001 and December 2006, with a decreasing rate of 
MRSA.
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1.1.5 Mortality
The number of deaths in England and Wales due to S. aureus rose between 1993 and 
2005, but had decreased slightly by 2007 (National Statistics, 2008; see Figure 1.2).
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Figure 1.2: Deaths Associated with S. aureus
The number of death certificates mentioning MRSA and S. aureus not specified as 
resistant to methicillin in England and Wales from 1993-2007 (extracted from 
National Statistics, 2008).
Deaths across England and Wales due to MRSA staphylococcal septicaemia 
increased from 3% to 28%, staphylococcal pneumonia increased from 13% to 44% 
and unspecified staphylococcal infection from 19% to 83% between 1993 and 1998 
(Crowcroft & Catchpole, 2002). Griffiths et al. (2004) revealed the number of death 
certificates that specifically mention MRSA also rose from 51 (12%) in 1992 to 800 
(66%) in 2002, although the actual numbers may be higher because not all cases 
where S. aureus was not specified as methicillin resistant were necessarily 
methicillin sensitive. MRSA was found to be involved in (although not necessarily
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directly responsible for) 0.07% of all deaths over the period of 1993-2002. Around 
double the rate of mortality was seen in males compared to females for both S. 
aureus and MRSA. A positive correlation between patient age and mortality rate 
was seen for both S. aureus and MRSA, where rates significantly increased for 
patients aged 65 and over.
1.1.6 Cost
The cost of hospital-acquired infections to the NHS has been estimated at around £1 
billion per annum (Plowman et al., 2001). Although the cost of infection due to S. 
aureus or MRSA alone has not been estimated for the entire NHS, University 
Hospital Lewisham NHS Trust estimated MRSA cost them £1.5 million per annum 
(Bourn, 2004). The cost of hospital-acquired infections does not result simply from 
treating the infection, but also the extra length of stay at the hospital and infectious 
complications (Haley, 1991).
Engemann et al. (2005) found the mean cost of treating S. aureus bacteraemia was 
$24,034 per episode (approximately £15,000), including re-admissions and 
outpatient costs. They also found the mean initial hospitalisation cost was 
significantly greater for patients with complicated (e.g. endocarditis, septic arthritis) 
versus uncomplicated S. aureus bacteraemia. Kanerva et al. (2007) found the total 
cost of an outbreak of MRSA was €1,821,256 (approximately £1.6 million), 
including isolation, microbial screening, medical treatment, administration, extra 
meetings, overtime, outpatient clinic for MRSA screening, screening of specimens 
obtained from staff members and closed beds.
Litigation costs are also a burden to the healthcare system. Claims of malpractice 
can be made following death or illness due to a hospital-acquired infection on the 
grounds that the hospital failed to adhere to acceptable standards of cleanliness 
and/or infection control. Guinan et al. (2005) studied claims of malpractice for 
healthcare-acquired infections in Philadelphia between 1996 and 2002 and found 
29% were due to MRSA and 9% were due to MSSA. They also found that 72% of
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claims were either settled out of court or withdrawn, but of those claims taken to 
court the success rate was 60%.
1.2 ANTIMICROBIAL ACTIVITY AND RESISTANCE
1.2.1 Antibiotics
1.2.L I Definitions
Antibiotics are defined as naturally occurring or synthetic organic substances that 
inhibit or destroy selective bacteria or other microorganisms, generally at low 
concentrations (McDonnell & Russell, 1999).
Resistance is defined as the relative insusceptibility of a microorganism to a 
particular treatment under a particular set of conditions and is usually quantified as 
the minimum concentration required to exert a definable effect (i.e. growth 
inhibition) on a population of cells (Gilbert & McBain, 2003). Antibiotic tolerance is 
defined as failure of an organism to respond to an appropriate, correctly dosed 
antibiotic in-vivo without an alternative explanation (Cunha et al., 2008). Antibiotic 
resistance in S. aureus can be either intrinsic (inherent features of the bacterial cell 
that prevent antibiotic action) or acquired (horizontal transfer from another organism 
or by mutation of chromosomal genes). Resistance is acquired from other bacteria 
by conjugation, transduction and transformation (Lyon & Skurray, 1987). 
Conjugation is the exchange of genetic material by two bacterial cells in direct 
contact by means of a sex pilus, transduction is the transfer of genetic material 
between bacteria via a virus and transformation is the acquisition of genetic material 
directly from the environment after being released from another cell. Transfer of 
genetic material between bacteria is usually via a plasmid (Todar, 2008).
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1.2.1,2 Antibiotic Use and Resistance Mechanisms
The antibiotics used to treat S. aureus infections, the mechanisms by which S. aureus 
is resistant to them and the frequency of resistance are described in Table 1.4. It is 
evident that antibiotic resistance is a major problem in the treatment of S. aureus and 
the joint working party of the BSAC, the Hospital infection Society and the Infection 
Control Nurses Association (Coia et al., 2006) recommend the avoidance of 
inappropriate or excessive antibiotic therapy and prophylaxis in all healthcare 
settings as part of the control and prevention of MRSA in healthcare facilities.
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Table 1.4: Antibiotics Available to Treat S. aureus
Antibiotic Type Mode of Activity Resistance Mode of Resistance References
Penicillin P-lactam inhibits PBP enzymes 
used in peptidoglycan 
synthesis
Widespread Penicillinase hydrolyses the 13- 
lactam ring of Penicillin
Lowy (2003)
Methicillin Modified 13- As with penicillin, but is ~40% S. aureus meek gene in SCCmec encodes Chambers et al. (1994); HPA
lactam resistant to penicillinase strains resistant modified PBPs that cannot be 
bound by (3-lactam antibiotics
(2006)
Vancomycin Glycopeptide disrupts cross-linkage of 
peptidoglycan layers 
during cell wall synthesis
Infrequent. VISA and 
increased MIC strains 
now widespread
increase in cell wall thickness 
traps vancomycin in the 
peptidoglycan layer
Murray et al. (1998); Cui et al. 
(2003); Appelbaum (2006); Tiwari 
& Sen (2006); Wang et al. (2006)
Teicoplanin Glycopeptide As for vancomycin TISA and TRSA 
infrequent
As for vancomycin Kaatz et al. (1990); HPA (2000); 
Cepeda et al. (2003); Tiwari & Sen 
(2006)
Quinupristin
-dalfopristin
Streptogramin Inhibits protein synthesis Rare Antibiotic is removed from the 
cell by efflux mechanisms
Dowzicky et al. (2000); Werner et 
al. (2001); Hershberger et al. 
(2004)
Linezolid Oxazolidinones Binds to rRNA, inhibiting 
protein translation
Rare. Monitored by 
ZAAPS
Modification of rRNA Swaney et al. (1998); Ross et al. 
(2007); Arias et al. (2008)
MIC = Minimum Inhibitory Concentration; PBP= Penicillin Binding Protein; SCCmec = Staphylococcal Cassette Chromosome mec; TISA = 
Teicoplanin-Intermediate S. aureus; TRSA = Teicoplanin-Resistant S. aureus; VISA = Vancomycin Intermediate S. aureus; ZAAPS = Zyvox 
Annual Appraisal of Potency and Spectrum
1.2.2 Antiseptics
1.2.2.1 Definitions
An antiseptic is a type of biocide that destroys or inhibits the growth of 
microorganisms in or on living tissue (McDonnell & Russell, 1999). Biocide is the 
general term for a chemical agent, usually broad spectrum, which inactivates 
microorganisms (McDonnell & Russell, 1999). Types of biocides include 
disinfectants, antiseptics and preservatives (Maillard, 2005a). Resistance to 
antiseptics often refers to the insusceptibility of microorganisms to concentrations in- 
vitro that are above MIC level, but below the in-use concentration. Since these 
results rarely reflect performance in practice, true antiseptic resistance has been 
defined as bacterial survival following challenge with an antiseptic used at the ‘in- 
use’ concentration recommended by the manufacturer (Maillard, 2007).
1.2.2.2 General Antiseptics and Their Uses
Antiseptics are used in the healthcare environment in the form of hand washes, 
surgical scrubs and alcohol-based hand rubs and for pre-operative skin disinfection 
and topical treatment of wounds (Kampf & Kramer, 2004). Their efficacy is 
dependent on factors such as the presence of organic material, contact time, 
concentration, temperature and pH (Maillard, 2005a). The joint working party of 
BSAC, the Hospital Infection Society and the Infection Control Nurses Association 
recommend that triclosan, hexachlorophene, chlorhexidine or providone iodine alone 
and in combination may be suitable antiseptic agents to use in the eradication of 
MRSA (Coia et al., 2006). The major agents used for antisepsis are described in 
Table 1.5.
17
Table 1.5: Antiseptics
Antiseptic Class Uses Mode of Action Pros/Cons
Chlorhexidine Biguanide Pre-operative skin Cationic surfactant; damages cell Broad spectrum, rapid, effective at
disinfectant, hand wall/membrane; precipitation of low concentrations
scrub/rub proteins and nucleic acids
Triclosan Bisphenol Surgical soap Damages cytoplasmic membrane; 
disrupts lipid/protein/RNA synthesis
Prolonged activity; skin irritant
Providone-iodine Iodine Pre-operative skin 
disinfection, surgical 
scrubs
Reacts with cellular constituents Broadest spectrum, including spores; 
fast-acting; skin irritation and 
staining
Benzalkonium QAC Pre-operative skin Cationic surfactant; disrupts Slower activity; activity greatly
chloride/cetrimide disinfection; instant hand 
sanitizers
cytoplasmic membrane affected by pH and organic material
Ethanol, Alcohol Instant hand sanitizer; Protein denaturation/coagulation; Broad spectrum; little residual effect
isopropanol, topical skin disinfectant lipid solubilization
n-propanol
QAC = Quaternary ammonium compounds. References: Russell & Day, 1993; McDonnell & Russell, 1999; Jones et al., 2000; Ali et al., 
2001
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1.2.2.3 Alcohol and Its Uses
Alcohol is the most common active ingredient of instant hand sanitizers, which are 
used for between-hand washing sanitization. This is due to alcohol being relatively 
inexpensive and non-toxic (to skin and the environment), easy to produce and 
colourless (Ali et al., 2001). The most effective and therefore most commonly used 
alcohols are ethanol (a primary alcohol), isopropanol (propan-2-ol; a secondary 
alcohol) and w-propanol (propan- l-ol; a primary alcohol). They have a rapid and 
broad-spectrum activity (McDonnell & Russell, 1999; Ali et al., 2001), but no 
residual effect (Ayliffe et al., 1988), which is likely because they evaporate quickly. 
Evaporation is reduced by using the alcohol in conjunction with low concentrations 
of excipients that lengthen the evaporation time of the alcohol, or other biocides such 
as chlorhexidine that do have a residual effect. The antimicrobial activity of alcohol 
is the result of its low surface tension (which enables it to spread out on surfaces) and 
its lipid solvency (which enables it to dissolve lipids in the cytoplasmic membrane; 
Ali et al., 2001). Alcohols have a polar hydroxyl group, which is thought to form a 
hydrogen bond with the ester groups of fatty acid residues in the bacterial cell 
membrane and cause disruption of membrane function (Franklin & Snow, 1989). 
Alcohol also causes denaturation and coagulation of proteins, cell lysis and 
disruption of cellular metabolism (McDonnell & Russell, 1999). It coagulates 
proteins in the cell wall and cytoplasmic membrane, where coagulation of structural 
proteins affects the integrity of these structures and coagulation of enzymatic 
proteins results in loss of cellular function (Ali et al., 2001). It is most effective at 
high concentrations between 60% and 90% (McDonnell & Russell, 1999; Kampf & 
Kramer, 2004). Higher concentrations of alcohol are less effective because protein 
denaturation does not occur as readily in the absence of water (Ali et al., 2001); 
lower concentrations are unsuitable because alcohol has a high concentration 
exponent and therefore will rapidly lose its biocidal activity when diluted (Maillard, 
2005a).
1.2.2.4 Resistance to Antiseptics
Resistance to antimicrobials may occur as the result of chromosomal mutation or 
acquisition of resistance genes by transduction, transformation and conjugation 
(Lyon & Skurray, 1987). However, unlike antibiotics, antiseptics have multiple,
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non-specific mechanisms of action on bacterial cells; therefore mutations in the 
bacterial genome are less likely to affect their activity (Jones et al., 2000) and 
antiseptic resistance is more likely to be intrinsic or by acquisition of genes. 
Acquired and intrinsic factors provide a combination of ways for the bacterial cell to 
decrease the concentration of antiseptic to below the threshold that is harmful, either 
by removal from the cell or by decreasing its uptake or penetration into the cell 
(European Commission, 2009). These factors include a change in membrane 
(Maillard & Cheeseman, 2008) and cell wall permeability, use of efflux pumps 
(Fraise, 2002), production of exopolysaccharide (Mah & O’Toole, 2001; Campanac 
et al., 2002), hydrophobicity (Jonsson & Wadstrom, 1984) and surface charge 
(Bruinsma et al., 2006). Acquired and intrinsic factors are also responsible for 
reducing the lethal interaction of the antiseptic with the cell by reducing metabolic 
activity and damage repair (Maillard & Cheeseman, 2008) and also inactivation of 
the biocide may occur by enzymatic degradation (McDonnell, 2007).
Resistance to alcohol has not been demonstrated (Wille, 1976; Narui et al., 2007). 
However, clinical isolates of S. aureus have been found that are resistant to a range 
of antiseptics. Noguchi et al. (1999) found 71% of MRSA isolates tested 
demonstrated resistance to the QAC benzethonium chloride and the biguanide 
chlorhexidine gluconate. Narui et al. (2007) found that a number of clinical MRSA 
isolates showed minimum bactericidal concentrations higher than the in-use 
concentrations of sodium hypochlorite, benzalkonium chloride, alkyl- 
diaminoethylglycine hydrochloride and chlorhexidine digluconate. Reduced 
susceptibility has been demonstrated among S. aureus isolates, where MICs are still 
below the in-use concentration for chlorhexidine (Sheng et al., 2009) and triclosan 
(Cookson et al., 1991; Al-Doori et al., 2003).
Some antiseptic resistance is mediated by efflux pumps, which are able to remove a 
range of chemically dissimilar antiseptics from the bacterial cell (Fraise, 2002). 
High level antiseptic resistance is mediated by efflux pumps encoded by the genes 
qacA and qacB. Low-level antiseptic resistance is mediated by efflux pumps 
encoded by the genes, smr and nor A. The qacA gene is usually found on the pSKl 
multi-resistant plasmid and encodes the multi-drug efflux transporter protein QacA,
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which removes antiseptics such as QACs and chlorhexidine from the cell (Tennent et 
al., 1989; Littlejohn et al., 1991). The qacB gene is closely related to qacA, and is 
usually found on heavy metal plasmids such as pSK23 (Paulsen et al., 1996). It 
encodes the multi-drug efflux transporter protein QacB. The smr gene is located on a 
plasmid and encodes the multi-drug efflux transporter protein Smr (Grinius et al., 
1992). The nor A gene is located on the S. aureus chromosome and encodes a multi­
drug efflux transporter protein called NorA (Neyfakh et al., 1993; Ng et al., 1994), 
which removes antiseptics from the bacterial cell (Noguchi et al., 2004). 
Distribution of qacA, qacB and qacC (which is identical to smr gene) genes in 
European clinical S. aureus isolates was determined by Mayer et al. (2001). They 
found qacA/B genes present in 42% of isolates (63% of MRSA isolates, 12% of 
MSSA isolates) and the qacC gene present in 5.8% of isolates (6.4% of MRSA 
isolates and 5% of MSSA isolates).
Antiseptic resistance has been linked to antibiotic resistance. Akimitsu et al. (1999) 
found that MRSA mutants resistant to benzalkonium chloride showed a higher level 
of resistance to a number of |3-lactam antibiotics, particularly oxacillin, compared to 
non-resistant parent strains. The most likely explanation for linked antibiotic and 
antiseptic resistance is that they are mediated by a common, non-specific mechanism 
such as cell impermeability or efflux pumps, or that mechanisms for antibiotic or 
antiseptic resistance are encoded in genes that are linked, such as being encoded on 
the same plasmid. Yamamoto et al. (1988) found a gentamicin-methicillin-resistant 
strain of S. aureus carrying the pSAJl plasmid, which carried the qacA gene and 
conferred resistance to several antibiotics and the antiseptics benzalkonium chloride, 
chlorhexidine and acriflavine, supporting the theory that efflux pumps may be a 
common mechanism for antibiotic and antiseptic removal from the cell. This may 
explain why Suller & Russell (1999) found that MRSA isolates showed decreased 
susceptibility to chlorhexidine, benzalkonium chloride and another QAC called 
cetylpyridinium chloride, when compared to MSSA strains.
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13 REDUCING S. AUREUS COMTAMINATION IN THE HEALTHCARE 
ENVIRONMENT
13.1 Hand Hygiene
1.3. 1.1 The Importance o f Hand Hygiene
Since the most common mode of transmission of microorganisms is HCW’s hands, 
hand hygiene is considered the most important measure for preventing their 
transmission and therefore reducing the incidence of hospital-acquired infection 
(Conly et al., 1989; Rotter, 1997). Transient flora are defined as contaminating or 
non-colonizing flora, which are isolated from the skin but are not consistently present 
in the majority of persons and resident flora are defined as colonizing flora, which 
are isolated from the skin of most persons and considered permanent residents of the 
skin (Larson, 1995). Transient bacteria are generally attached to superficial layers of 
skin, whereas resident bacteria are attached to deeper layers (Langley, 2002). 
Transient bacteria are removed by basic hand hygiene using plain soap (Langley, 
2002; Kampf & Ostermeyer, 2004), whereas resident bacteria are not (Kampf & 
Ostermeyer, 2004) and therefore require the use of antimicrobial agents in the form 
of hand washes or rubs to remove them (Kampf & Kramer, 2004; Hubner et al., 
2006).
1.3.1.2 Hand Hygiene Compliance
The use of alcohol hand Rubs (AHR) has resulted in a significant increase in hand 
hygiene compliance, mainly due to the process being much quicker and easier, 
although hand washing is still required for ‘dirty’ hands. Karabay et al. (2005) found 
hand hygiene compliance low at 15.4% among nursing staff provided only with hand 
washing facilities, but much higher at 72.5% among nursing staff provided with 
AHRs. Elsewhere, hand hygiene compliance has been found to be fairly low (42%), 
despite the introduction of AHRs (Johnson et al., 2005b).
Hand washing and AHR compliance was found to be poorer among HCWs in ITUs 
than in other hospital wards (Pittet et al., 1999; Karabay et al., 2005). Compliance
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with hand hygiene guidelines in ITUs was found to be between 28% and 51% in a 
review of studies conducted before the year 2000 (Pittet, 2001a). This fairly low 
level of hand hygiene compliance in ITUs was also observed in later studies (38.4%, 
Hugonnet et al., 2002; 51%, Creedon, 2005 and 47%, Eldridge et al., 2006), although 
compliance improved upon the introduction of interventions to improve hand 
hygiene, including the introduction of AHRs (54.5%, Hugonnet et al., 2002; 83%, 
Creedon, 2005 and 80%, Eldridge et al., 2006).
Pittet et al. (1999) found that hand hygiene compliance was higher among nurses 
than physicians, nursing assistants and other HCWs. Compliance was also found to 
be lowest at weekends, during procedures that carried a high risk of contamination 
and during high intensity of patient care.
Variation in levels of hand hygiene compliance is likely due to the difference in 
success of the intervention and differences within the hospitals in which the studies 
were conducted, such as staff-to-patient ratio. Patarakul et al. (2005) found hand 
hygiene compliance in the ITUs at one hospital to be less than 50% and 
questionnaires given to HCWs revealed the most common reason for non- 
compliance was their belief that patients’ needs came first, followed by forgetfulness 
and skin irritation by hand hygiene products. These factors were also found to be the 
most common reasons for non-compliance throughout the healthcare setting and also 
included inaccessibility of hand hygiene products, high workload and the wearing of 
gloves (Pittet, 2001b).
1.3.1.3 Alcohol Hand Rubs
AHRs consist of alcohol at a concentration of typically 60-80% using at least one 
type of alcohol. The types of alcohols used in hand rubs are normally ethanol, 
isopropanol or w-propanol; these are used at different ratios as the active ingredient, 
plus different types and concentrations of emollients to soften the skin.
Results of the efficacy of AHRs in comparison to hand washing with antimicrobial 
soap have been mixed. Larson et al. (2001) found no significant difference between 
the CFU remaining on the hands of staff using either product type. It was also found
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by Larson et al. (1995) that there was no significant difference between infection 
rates in a neonatal ITU using either product. However, Girou et al. (2002) found an 
83% reduction in bacterial contamination of the hands of ITU staff using an AHR 
compared to a 58% reduction using an antimicrobial hand wash. Karabay et al.
(2005) found bacterial contamination was reduced by 54% with the use of AHRs 
compared to only 27% with an antimicrobial soap. Rotter’s (2001) review of hand 
hygiene experiments revealed that AHR was more effective at reducing numbers of 
bacteria than medicated soaps, which were more effective than non-medicated soaps.
Alcohol-based hand rinses have been used in the healthcare environment, but in 
many hospitals have been replaced by alcohol gels, which are quicker to use and 
therefore increase compliance and also reduce drying and irritation of the skin. 
However, Kramer et al. (2002) found that no alcohol gels tested met the criteria of 
EN1500 (which are that the test product should not have a significantly smaller log 
reduction than the reference product), whereas most of the alcohol-based hand rinses 
did. They also found that isopropanol at 60% v/v was more effective than ethanol at 
70% v/v and is almost equivalent to ethanol at 80% v/v (w-propanol being the most 
efficacious) and therefore recommend that ethanol-based AHRs should be at a 
minimum concentration of 80% v/v. Rotter’s (2001) review of experiments that 
determined the efficacy of AHRs revealed that w-propanol is the most effective 
alcohol, followed by isopropanol and then ethanol, which supports the findings by 
Kramer et al. (2002).
13.2 Infection Control and Prevention Programmes
Initiatives to control and prevent HCAIs initiatives include surveillance; antibiotic 
stewardship; screening; decolonization of nose, throat and skin; management of 
MRSA colonized or infected patients through patient isolation; cleaning and 
decontamination; minimizing patient movement and topical/systemic 
decontamination or prophylactic antimicrobial therapy prior to invasive procedures; 
ensuring there are adequate nursing staff available; hand hygiene and use of personal 
protective equipment (Coia et al., 2006). Infection control programmes have been 
found to be beneficial in terms of reduction in MRSA and cost-effective, where
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treating MRSA infection was far more costly than the MRSA control programme 
(Chaix et al., 1999).
Implementation of the Health Act 2006 code of practice for the prevention of HCAIs 
(Department of Health, 2008) is a legal requirement throughout the NHS. This code 
of practice states that ‘effective prevention and control of HCAIs has to be embedded 
into everyday practice and applied consistently by everyone. It is particularly 
important to have a high awareness of the possibility of HCAIs in both patients and 
healthcare workers to ensure early and rapid diagnosis. This should result in effective 
treatment and containment of the infection. Effective action relies on an 
accumulating body of evidence that takes account of current clinical practices. This 
evidence base should be used to review and inform practice. All staff should 
demonstrate good infection control and hygiene practice.’
This code of practice can be achieved by implementing an effective infection control 
programme. These are different throughout each NHS trust and several programmes 
have been developed to reduce the incidence of HCAIs.
The Epic Project (Pratt et aL, 2001) provides detailed guidelines for hospital 
environmental hygiene, hand hygiene, patient skin antisepsis, insertion and 
maintenance of indwelling medical devices such as catheters and antibiotic 
prophylaxis that will prevent HCAIs. The guidelines were developed as a result of 
the review of scientific evidence.
The low-compliance rate of hand hygiene in the healthcare environment has led to 
the introduction of the ‘ CleanYourHandsCampaign’ (CYHC) throughout the NHS in 
2005. This involved introduction of AHR at bedsides and ward entrances along with 
promotional material and patients were encouraged to ask staff if they had sanitized 
their hands. This campaign was initially piloted in two wards in each of six acute 
NHS trusts and its effectiveness was evaluated in one of the trusts by Randle et al.
(2006). They found hand hygiene compliance rose from 32% to 63% over a six- 
month period and the volume of AHR consumed increased by 184%. A staff survey 
revealed overall positive feedback on the campaign. Similar interventions have been
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carried out in many hospitals across the globe, which have all resulted in increased 
compliance with hand hygiene guidelines (Hugonnet et al., 2002; Creedon, 2005; 
Johnson et al., 2005b; Eldridge et al., 2006). However, Gould et al. (2007) believe 
initial results may not be sustained long-term and worry this campaign is seen as a 
‘quick fix’ to solve the problem of hospital-acquired infection and that hand hygiene 
has been singled out as the solution instead of an all-round robust infection-control 
programme.
Results of the CYHC have been determined for the 6 and 12 month period after it 
was first initiated by the National Observational Study to Evaluate the CYHC 
(NOSEC; Stone et al., 2007). Results show that this campaign has resulted in a 
change in hand hygiene behaviour throughout the NHS in the UK, particularly the 
increased use of AHR without a decrease in the use of soap.
‘Saving Lives’ was launched in 2005 (Department of Health, 2007) with an aim to 
reduce infection and deliver clean and safe care and includes self-assessment, use of 
scorecards to illustrate compliance and high-impact interventions. This system was 
designed with an aim to be implemented throughout the NHS and may eventually 
replace the CYHC.
Pittet et al. (2000), McAteer et al. (2006) and Ebnother et al. (2008) found the 
implementation of infection control programmes were able to reduce the rate of 
infection, reduce transmission of MRSA and/or increased hand hygiene compliance. 
Huang et al. (2006b) found implementation of routine MRSA surveillance rather 
than introducing AHR and hand hygiene campaigns resulted in a significant 
reduction of MRSA bacteraemia. Harrington et al. (2007) found a combination of 
the introduction of AHR containing chlorhexidine gluconate throughout a hospital, 
and the introduction of a hospital-wide MRSA surveillance feedback programme 
resulted in a reduction of MRSA bacteraemia by 39% in ITU.
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1.4 AIMS AND OBJECTIVES
The aim of this project was to determine the susceptibility of S. aureus ITU isolates 
to AHRs under conditions found in practice. This was achieved with the following 
objectives:
To establish the basic characteristics of the isolates used in this study, including 
their identity, susceptibility to antibiotics, virulence and genotype.
To determine the hand sanitizing practices used in the ITU and the susceptibility 
of S. aureus isolates to AHR, including the effect of mechanical rubbing and residual 
activity on their antibacterial properties.
- To design the susceptibility tests to mimic conditions found in practice as far as 
possible and to extrapolate the results to in-situ use of AHR.
- To determine the effect of AHR on S. aureus by investigating their effect on the 
cytoplasmic membrane, cell wall, cell structural appearance, proteins and gene 
expression.
To determine the properties of S. aureus that are linked to its susceptibility to 
AHR by comparing hydrophobicity, surface charge, cell size, cell aggregation and 
total protein content of the most- and least-susceptible isolates to AHR.
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CHAPTER 2 GENERAL MATERIALS AND METHODS
2.1 GENERAL MATERIALS
All media, chemicals, materials and equipment listed in this study were purchased 
from Fisher Scientific (Loughborough, UK) or Sigma-Aldrich (Poole, UK), unless 
otherwise stated. Tryptone soya agar (TSA), tryptone soya broth (TSB) and blood 
agar base no. 2 were all purchased from Oxoid (Basingstoke, UK). Blood plates and 
slopes were prepared using blood agar base no. 2 with sheep blood defibrinated 
liquid (Oxoid). Tryptone sodium chloride (TSC) buffer was prepared with 0.4 g 
tryptone (Oxoid) and 3.4 g sodium chloride in 400 ml deionised water. All media 
and buffers were prepared using deionised water and autoclaved at 121 °C for 15 min 
according to British Pharmacopoeia 2007 recommendation (British Pharmacopoeia 
Commission, 2006). All plates were dried in a laminar airflow cabinet with their lids 
open for 5 min prior to use.
2.2 ANTISEPTICS
The antiseptics used for testing were Soft Care Med H5 alcohol gel (Johnson 
Diversey, Northampton, UK), Cutan gel hand sanitizer (Deb Ltd. Belper, UK) and 
Guest Medical AHR (Guest Medical, Edenbridge, UK). Soft Care Med H5 contains 
isopropyl alcohol (isopropanol) and propyl alcohol (w-propanol) at a total 
concentration of 70% w/w as the active ingredient. It also contains the emollient 
glycerol and is the current antiseptic used in University Hospital of Wales (UHW), 
Cardiff. Cutan contains ethyl alcohol (ethanol) and propyl alcohol at a total 
concentration of 70% w/w as the active ingredient. It also contains the emollients 
glycerine and panthenol and is the current antiseptic used at the bedside and by the 
sinks of Morriston Hospital (MH), Swansea. Guest Medical contains ethyl alcohol at 
a concentration of 70% v/v as the active ingredient. It also contains the 
emollients/skin care additives carbomer, glycerine, and vitamin E, plus isopropyl 
myristate to increase penetration into the skin and monopropylene glycol as a 
surfactant, to ease spreading of the product on the surface of the skin. It is the 
current antiseptic ITU nurses in MH carry around on their person. All AHRs were 
stored at room temperature.
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23  BACTERIAL ISOLATES
Fifty nine hospital isolates of S. aureus (32 MRSA and 27 MSSA) were supplied by 
UHW and Singleton Hospital (SH), Swansea (see Table 2.1). These isolates 
originated from blood cultures taken from bacteraemia patients in the hospitals’ 
ITUs. S. aureus NCIMB 9518/ATCC 6538 (National Collections of Industrial 
Marine and Food Bacteria; American Type Culture Collection), ATCC 49775, 
NCTC (National Collection of Type Cultures) 8325, NCTC 8530 and NCTC 8178 
are MSSA strains. Reference strains were purchased from LGC Standards 
(Teddington, UK), except for ATCC 49775 and NCTC 8530, which were kindly 
provided by P. Lambert (Aston Universtiy) and NCTC 8178, which was kindly 
provided by C. Emanuel (Cardiff University).
Table 2.1: List of Hospital Isolates
Information shown is that provided by the hospital from which the samples came. 
UHW = University Hospital of Wales, Cardiff, SH = Singleton Hospital, Swansea. 
MRSA = Methicillin Resistant S. aureus, MSSA = Methicillin Sensitive S. aureus. 
*Found to be MSSA.
Isolate Date
Isolated
Hospital Methicillin 
Resistance Profile
3,5,9,11,15,17,18,19,20,25,26,27,31, Feb 2004- UHW MRSA
32,37,41,42,43,45,46,48,49,50,52,55 Jun 2006
4,6,10,13,14,16,21,24,28,30,34,38,39, Mar 2004- UHW MSSA
44,47,51 Nov 2005
N10, K17, Q49, T4, H9 2006 UHW MSSA
P59, 043 2006 UHW MRSA
SI, S2, S7, S8, S10, SI 1, Feb 2006- SH MSSA
Oct 2006
S3, S4, S5*, S6, S12 Mar 2006- SH MRSA
Nov 2006
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2.4 PREPARATION OF CULTURES
2.4.1 Frozen Cultures
Upon arrival, frozen stocks of all hospital isolates of S. aureus were prepared in 
duplicate. Plastic cryovials (1.2 ml) were filled with 200 pi glycerol and autoclaved 
at 121 °C for 15 min. Overnight cultures were prepared according to 2.4.4 and 800 
pi of each culture was added to a cryovial and stored at -80 °C.
2.4.2 Working Cultures
Each hospital isolate was inoculated onto a blood agar plate from frozen culture 
using a sterile swab and inoculation loop and incubated at 37 °C for 24 hours. The 
agar plate was checked for purity and several well-isolated colonies were inoculated 
onto a blood agar slope. The slope was incubated at 37 °C for 24 hours then 
refrigerated. Slopes were replaced every 3 months.
2.43 TSA Slope Culture
A loop-full of working culture was used to inoculate the surface of a TSA slope and 
TSA plate. These were incubated at 37 °C for 16-24 h. The TSA plate was 
examined for purity of the culture.
2.4.4 Overnight Broth Cultures
A loop-full of working culture (or original culture) was used to inoculate 10 ml TSB 
and a TSA plate. The broth was placed in a shaker incubator (Fisher Scientific) at 70 
rpm, 37 °C overnight (16-18 h, unless otherwise specified) and the TSA plate 
incubated at 37 °C and examined for purity of culture.
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2.5 PREPARATION OF A BACTERIAL SUSPENSION
2.5.1 Preparation of Bacterial Suspension from TSA slope
A TSA slope was prepared according to section 2.4.3. Slopes were washed with 5 
ml TSC buffer and the suspension was centrifuged in a Mistral 1000 centrifuge 
(MSE, London, UK) at 2600 g  for 15 min. The supernatant was discarded and 5 ml 
TSC was added to re-suspend the pellet by vortex mixing. The suspension was 
adjusted to the appropriate concentration according to section 2.5.3.
2.5.2 Preparation of Bacterial Suspension from TSB
An overnight broth culture was performed according to section 2.4.4 and centrifuged 
at 940 g for 10 min. The supernatant was discarded and 5 ml TSC was added to re- 
suspend the pellet by vortex mixing. If required, cells were washed in TSC buffer 
unless otherwise stated and centrifuged at 2,600 g  for 15 min. The suspension was 
adjusted to the appropriate concentration according to section 2.5.3.
2.5.3 Adjusting the Concentration of a Bacterial Suspension
The optical density (OD) range at 500 nm required to achieve the desired bacterial 
concentration was calculated using the linear equation produced from the fitted line 
plot in Figure 2.1 in Section 2.7. The O D 5 0 0  of the re-suspended pellet prepared 
above was measured using a spectrophotometer (Helios a spectrophotometer, 
Unicam, Cambridge, UK) and adjusted to within the acceptable OD range using TSC 
buffer. A viable count was performed according to Section 2.6 and the results of the 
OD and viable count were added to the fitted line plot in Figure 2.1.
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2.6 PERFORMING A VIABLE COUNT OF A SUSPENSION
2.6.1 Drop Count Method 
2.6,1.! Method
Viable counts were performed to determine the concentration of a bacterial 
suspension and were performed using an adaptation of the Miles & Misra (1938) 
drop count method. A suspension was prepared according to either Section 2.5.1 or
2.5.2 and serially diluted by transferring 100 pi neat suspension into a sterile 
centrifuge tube containing 900 pi TSC buffer, creating a 10'1 dilution. After vortex 
mixing, 100 pi of the 10’1 dilution was transferred to another sterile centrifuge tube 
containing 900 pi TSC buffer to make a 10'2 dilution, with further serial dilutions to 
the required level. Ten pi of the appropriate dilutions were dropped in triplicate onto 
a TSA plate. The dilutions were then mixed using a vortex mixer and the 10 pi 
triplicate drops repeated on a separate TSA plate. Plates were incubated at 37°C for 
24 hours and the dilutions yielding counts between 3 and 30 CFU were recorded.
2.6.1.2 Validation Method
A bacterial suspension of S. aureus NCIMB 9518 was prepared according to section
2.5.1 and from this ten dilution series were prepared and plated out using the drop 
count method in section 2.6.1.1, but on triplicate plates instead of duplicate. 
Statistical analysis was performed on the log data values according to section 2.8.1 to 
determine whether there was a significant difference between viable counts of each 
dilution series.
2.6.1.3 Validation Results
Statistical analysis of viable count data revealed there was no significant difference 
between the means of each dilution series (P >0.05), data not shown. The drop count 
method was therefore demonstrated to provide reproducible results and was 
successfully validated.
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2.6.2 Pour Plate Method
2.6.2.1 Method
The pour plate method was used to determine the concentration of a bacterial 
suspension. A suspension was prepared according to Section 2.5.1 or 2.5.2 and 
serially diluted by transferring 1 ml of neat suspension into a sterile glass bottle 
containing 9 ml TSC buffer, creating a 10'1 dilution. After vortex mixing, 1 ml of the 
10'1 dilution was transferred to a fresh glass bottle containing 9 ml TSC buffer to 
make a 10‘ dilution, and so on down to the appropriate dilution. One ml of each 
appropriate dilution was transferred to duplicate Petri dishes, vortex mixing them in 
between the duplicate transfers. Around 20 ml molten TSA agar cooled to 45 °C was 
poured onto each plate and gently rotated to mix. Plates were left to set on the bench 
at room temperature for approximately 1 h until solidified, then inverted and 
incubated at 37 °C for 24 hours. The dilutions yielding counts between 30 and 300 
CFU were recorded.
2.6.2.2 Validation Method
A bacterial suspension of S. aureus NCIMB 9518 was prepared according to section
2.5.1 and the pour plate method was performed with eight replicates according to 
section 2.6.2.1, except 1 in 10 serial dilutions were made by adding 350 pi bacterial 
solution to 3.15 ml TSC buffer and dilutions were plated out in triplicate. Statistical 
analysis was performed on the log data values according to section 2.8.1 to determine 
whether there was a significant difference between viable counts of each dilution 
series.
2.6.23 Validation Results
Statistical analysis of viable count data revealed there was no significant difference 
between the means of each dilution series (P >0.05), data not shown. The pour plate 
method was therefore demonstrated to provide reproducible results and was 
successfully validated.
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2.7 STANDARDISING THE CONCENTRATION OF A BACTERIAL 
SUSPENSION
A bacterial suspension of S. aureus NCIMB 9518 was prepared according to section 
2.5.1; 1 in 2, 1 in 4, 1 in 5, 1 in 10, 1 in 20, 1 in 40 and 1 in 100 dilutions of the 
suspension were made in TSC buffer. The OD500 of each dilution was measured and 
a viable count was performed for each dilution according to 2.6.1.1. The OD500 of 
each dilution was plotted against the results of the viable count in a Fitted Line Plot 
graph, using Minitab (release 14 software, Minitab inc., PA, USA) and is shown in 
Figure 2.1. This created a linear equation that allows the optical density required to 
achieve the desired bacterial concentration to be determined. Subsequent 
ODsoo/viable count results of each bacterial suspension performed according to 2.5 
were added to Figure 2.1, data not shown.
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Figure 2.1: Relationship between Bacterial Count and Optical Density
Fitted Line Plot showing the relationship between bacterial count and optical density 
of S. aureus NCIMB 9518.
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2.8 STATISTICAL ANALYSIS
2.8.1 One-Way ANOVA
One-way analysis of variance (ANOVA) was used at the 95% level of significance to 
test differences between the means of data sets. Minitab software (release 14/15 
software, Minitab inc., PA, USA) was used to perform the calculations and to test the 
normality of distribution of the residuals and homogeneity of variances of the data. 
Where the assumptions of ANOVA were not met the Kruskal-Wallis test was used.
2.8.2 Paired T-Test
The paired t-test in Minitab software was performed, using a confidence level of 95.0 
and a test mean of 0.00 to determine whether the mean difference was significantly 
less (<0) or more (>0) than 0.
2.9 VALIDATION OF EQUIPMENT
Pipettes were calibrated weekly. The pH meter and Bioscreen Microbial Growth 
Analyser was calibrated prior to each use according to in-house standard operating 
procedures.
2.10 EXTRACTION OF NUCLEIC ACID
2.10.1 Materials
All buffers required for DNA extraction were made in 50 ml volumes. The required 
volume of deionised water was autoclaved in a glass bottle and other materials were 
later added (see Table 2.2). Buffers could be kept for several weeks and were stored 
at room temperature. Ultrapure™ 1 M Tris-HCl pH 8.0, Ultrapure™ 0.5 M 
ethylenediaminetetraacetic acid (EDTA) pH 8.0 and Ultrapure™ 10% SDS were 
purchased from Invitrogen (Paisley, UK). RNase A in powder form was made into a 
5 mg/ml working concentration in Tris-HCl EDTA (TE) buffer and boiled for 10 min
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to destroy any DNase. Pronase was purchased in powder form from Roche Applied 
Science (Burgess Hill, UK) and prepared as a 20 mg/ml stock in DNase and RNase- 
free distilled water (Invitrogen). RNaseA and pronase were stored at -20 °C. 
Ethanol solutions were prepared in deionised water. Ethanol at 100% and 70% v/v 
were stored at -20 °C ready for use and ethanol at 75% v/v was stored at room 
temperature. Lyophilized, powdered lysozyme containing >40,000 units/mg protein 
was prepared as 3mg/ml in TE buffer that was prepared according to Table 2.2 and 
stored at -20 °C. Isopropyl alcohol was stored at room temperature.
Table Z2: DNA Extraction Buffers
Buffer Vol. Deionised 
Water 
(ml)
Vol. 1 M 
Tris-HCl 
(ml)
Vol. 0.5 M 
EDTA 
(ml)
Vol. 10% 
SDS 
(ml)
Other
(Id)
TE buffer 48.5 0.5 1.0 0 0
Lysis buffer 41.5 2.5 1.0 5.0 ♦
Low EDTA 49.5 0.5 0.01 0 5 pi
buffer RNase
* A 25 pi volume of pronase was added to the lysis buffer immediately prior to use. 
EDTA = Ethylenediaminetetraacetic acid; RNase = Ribonuclease; TE = Tris-HCl 
EDTA
2.10.2 DNA Extraction
This method was kindly provided by E. Mahenthiralingam, Cardiff University and is 
now published by Cheeseman et al. (2007). DNA was extracted from all hospital 
isolates and S. aureus NCIMB 9518 in preparation for DNA analysis. An overnight 
broth culture was prepared according to 2.4.4. The culture was centrifuged at 940 g 
for 10 min and the pellet was re-suspended in 100 pi TE buffer. A 2 ml screw cap 
plastic tube was filled 1/3 full with 0.1 mm zirconia/silica beads (BioSpec Products,
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Inc., Bartlesville, OK, USA) and 500 pi of lysis buffer and 100 pi of pellet 
suspension were added. The tube was placed in a mini-bead beater (BioSpec 
Products) for 10 s at 2,500 rpm, incubated for 1-3 hours at 37°C and centrifuged in a 
Heraeus Biofiige Pico mini-centrifuge (DJBLabcare, Newport Pagnell, UK) at 
13,000 g  for 1 min to remove bubbles. A 200 pi volume of saturated ammonium 
acetate was added to the tube, which was then placed in a mini-bead beater at 2,500 
rpm for 5 s and centrifuged at 13,000 g  for 1 min. Chloroform (600 pi) was then 
added to the tube and placed in a mini-bead beater at 2 500 rpm for 5 s. 
Centrifugation at 13,000 g  for 3 min revealed three phases. A 400 pi volume of the 
clear top phase was transferred to a 1.5 ml no-stick microtube (Alpha Laboratories 
Ltd., Eastleigh, UK) containing 1ml 100% ethanol and refrigerated for 15 min. The 
tube was inverted to precipitate the DNA and centrifuged at 13,000 g  for 5 min. The 
ethanol was discarded and 500 pi 70% ethanol was added. The tube was centrifuged 
at 13,000 g for 1 min and the ethanol was removed with a pipette. The tube was 
placed for 10 min in a vacuum dryer to remove excess liquid. A 30 pi volume of 
Low EDTA buffer was added to the tube, which was then incubated at 37 °C for 1 h 
then left at room temperature overnight. Electrophoresis was performed on the 
extracted DNA according to 2.11 to check DNA was present and to estimate 
concentration. DNA was diluted 1 in 10 with DNase and RNase-free distilled water 
(Invitrogen) and transferred into 0.5 ml PCR tubes (Eppendorf, Cambridge, UK) and 
refrigerated.
2.10.3 RNA Extraction
The method was provided by Invitrogen (TRIzol LS Reagent manual). Between 4 
and 6 broth cultures were prepared according to section 2.4.4, but cells were grown 
to the exponential growth phase (for 6 hours). Suspensions of the bacteria were 
adjusted to a concentration of approximately 1 x 107 CFU/ml in TSB according to 
section 2.5.3. One ml of each adjusted suspension was transferred to a plastic 
microcentrifuge tube flash-frozen in liquid nitrogen and centrifuged in a Heraeus 
Biofuge Pico mini-centrifuge at 12,000 g. The supernatant was discarded and the 
pellet was re-suspended in 1 ml TRIzol®. The mixtures were transferred to 2 ml 
plastic screw cap tubes containing 0.1 mm zirconia/silica beads and vortex mixed
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using a horizontal vortex adaptor (Ambion, Warrington, UK) for 10 min. After 5 min 
0.2 ml chloroform was added and the tubes were shaken vigorously by hand for 15 s 
to mix. After 3 min the tube was centrifuged at 12,000 g for 15 min and the top 
aqueous phase was transferred to a fresh tube. A 0.5 ml volume of isopropanol was 
added to the aqueous phase and after 10 min the mixture was centrifuged at 12,000 g 
for 10 min. The supernatant was removed and the pellet was washed with 1ml of 
75% ethanol by vortex mixing and centrifugation at 7,000 g  for 5 min. After 
removing the supernatant the pellets were air-dried for 10 min and one pellet was re- 
suspended in 20 pi HyPure™ molecular biology grade distilled water. The pellet 
was re-suspended and added to the second pellet, and so on until all RNA was 
pooled. After incubating for 10 min at 60 °C the RNA was quantified. Two pi of 
RNA mixture was transferred to a plastic UVette® (Eppendorf, Hamburg, Germany) 
containing 68 pi TE buffer prepared according to Section 2.10.1. A negative control 
was also set up containing 70 pi TE buffer. The concentration of RNA was 
measured using a BioPhotometer (Eppendorf). RNA extraction was also performed 
post-exposure to AHR as above, except after adjusting the concentration of the broth 
cultures 900 pi of each were transferred to separate microcentrifuge tubes. A volume 
of 100 pi AHR was added to each tube, mixed, and after a contact time of 1 h were 
flash frozen.
2.11 ELECTROPHORESIS OF NUCLEIC ACID
2.11.1 Materials
One sachet of Tris-Borate-EDTA (TBE) 10 x powder was dissolved in 1 L deionised 
water using a magnetic stirring plate (Fisher stirring hotplate, Fisher Scientific). This 
provided a 10 x TBE solution. One x TBE solution was prepared by adding 100 ml 
10 x TBE to 900 ml deionised water. One Kb Plus DNA Ladder was purchased from 
Invitrogen and prepared as a 0.05 pg/ml stock for DNA analysis (50 pi ladder, 200 pi 
gel loading solution and 750 pi 1 x TBE) and 0.1 pg/ml stock for RNA analysis (100 
pi ladder, 200 pi gel loading solution and 700 pi 1 x TBE). Stock solutions were 
stored in a refrigerator.
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2.11.2 Preparation of Gel without Ethidium Bromide
Gels for DNA extraction were prepared using 1% agarose for routine use with 1 x 
TBE. Gels used for all other tests were prepared using 1.5% high resolution agarose 
with 1 x TBE. The appropriate volume of agarose and 1 x TBE was added to a 
conical flask and heat dissolved in a microwave at 950 W or on a magnetic stirring 
plate at 250 °C until melted and poured into a gel casting tray (Bio-Rad Laboratories 
Ltd., Hemel Hempstead, UK). Trays were left to set at room temperature and 
refrigerated until needed.
2.113 Preparation of Gel with Ethidium Bromide
Gels were prepared as in section 2.11.2, except 0.005% v/v ethidium bromide was 
added to the molten agarose prior to pouring into the gel casting tray. Gels used for 
analysis of RT-PCR product were prepared with 0.001% ethidium bromide.
2.11.4 Electophoresis
Small gel casting trays were loaded into a Mini-Sub® Cell GT electrophoresis 
chamber (Bio-Rad Laboratories Ltd) and large gels were loaded into a Sub-Cell® GT 
electrophoresis chamber (Bio-Rad Laboratories Ltd), along with 1 x TBE buffer 
prepared according to section 2.10.1. Ten pi 1Kb Plus Ladder (prepared according 
to section 2.10.1) was added to the first well for a small gel and the first and last well 
of a large gel, plus in an additional well in the middle for large gels for random 
amplification of polymorphic DNA (RAPD) testing. A mixture of 2 pi gel loading 
solution and 5 pi of gently vortex mixed DNA sample was added to the remaining 
wells. Electrophoresis was performed at 90 V for routine use gels and 80V for high 
resolution gels using a PowerPac™ Basic power supply (Bio-Rad Laboratories Ltd). 
Gels performed according to section 2.11.2 were then stained with ethidium bromide 
by immersing in 1 x TBE containing 0.007% ethidium bromide and placing on a 
Grant Bio POS 300 rotating platform for 45 min at 50 rpm. Gels performed 
according to 2.11.3 did not require this step. Gels were then viewed under UV light 
using Bio-Rad Gel Doc 1000 and Bio-Rad Molecular Analyst software (Bio-Rad 
Laboratories Ltd.
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CHAPTER 3 DETERMINING THE BASIC 
CHARACTERISTICS OF STAPHYLOCOCCUS AUREUS 
INTENSIVE THERAPY UNIT ISOLATES
3.1 INTRODUCTION
3.1.1 Genotypic Characterization of Isolates
The hospital isolates involved in this study (see Chapter 2, Table 2.1) were isolated 
from two hospitals over a period of two years. Genotyping isolates enables them to 
be grouped together into strains according to their genetic profile, revealing which 
isolates are genetically similar and allowing comparison of isolates within each 
hospital and between the two hospitals. Genotyping can be performed using Pulsed 
Field Gel Electrophoresis (PFGE), Multi Locus Sequence Typing (MLST), spa 
typing and SCCmec typing. PFGE uses alternating electric currents to pass through 
the gel, which separates the bacterial DNA into its component parts (Schwartz & 
Cantor, 1984). MLST categorises bacterial isolates according to the variations in 
sequence of gene fragments from seven housekeeping loci (Maiden et al., 1998). 
Differences in sequence are seen among different strains and a central database 
stores this sequence information and allows global characterisation of isolates. Spa 
typing is used specifically in the typing of S. aureus and involves sequencing the 
short sequence repeat region of the protein A gene {spa; Shopsin et al., 1999). 
SCCmec contains the mec gene complex, which includes the mecA gene, and the ccr 
gene complex, which includes ccr genes. A number of mec and ccr allotypes have 
been found within SCCmec among S. aureus isolates, leading to the classification of 
isolates according to the meet ccr profile within the S CCmec (Chongtrakool et al.,
2006). This is known as SCCmec typing, although SCCmec classification has also 
been performed based on a number of loci of other regions of the complex (Oliveira 
& de Lencastre, 2002). Genotyping can also be performed using a technique called 
RAPD, which uses one or more random primers to generate banding pattern profiles 
(Williams et al., 1990). The sequences/banding patterns in question are unique 
among different strains and therefore strains can be identified using these techniques.
However, factors such as time, expense, accuracy and inter-laboratory comparison 
need to be considered. RAPD testing often compromises between these factors 
because although it is not the most accurate test (Faria et al., 2008) it is fast, 
relatively inexpensive and was found to be more discriminatory than PFGE using
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one primer only and able to type all isolates tested, whereas PFGE was not (Casey et 
al., 2007). RAPD is therefore an ideal candidate for typing the large number of 
isolates in this study due to the relative simplicity of testing and interpretation, 
although using only one primer may not be discriminatory enough.
3.1.2 Identification of Isolates
The isolates used in this study had already been identified as S. aureus at UHW and 
MH but confirmation was necessary in the event of errors during transcription of 
isolate information or subculture. Identification was not performed until after 
genotypic analysis; therefore only one isolate from each RAPD profile was tested, 
since isolates with the same RAPD profile were assumed to be the same strain and 
therefore be the same species.
3.13 Antibiotic Susceptibility Testing
Antibiotic resistance is a vast problem when it comes to treating hospital infections. 
S. aureus is well documented for its resistance to a wide range of antibiotics (see 
Table 1.4) and therefore the antibiotic susceptibility profile of the isolates is a very 
important piece of information, especially since antibiotic and biocide resistance is 
linked by common mechanisms (European Commission, 2009). Fusidic acid, 
erythromycin, mupirocin, gentamicin, penicillin G, vancomycin, ciprofloxacin and 
oxacillin are antibiotics that are currently used to screen S. aureus isolates in the 
hospital (Williams, 2006, personal communication).
3.1.4 Determining the Virulence of Isolates
Virulence is traditionally defined as the degree of pathogenicity of a microorganism, 
where pathogenicity refers to the ability of a microorganism to produce disease in a 
host organism (Todar, 2008). Virulence factors (or determinants) are products 
produced by microorganisms that cause disease (Smith, 1977). However, Wassenaar 
& Gaastra (2001) highlight the problems associated with labelling every gene 
involved in pathogenicity as a virulence gene, regardless of its function in the 
virulence process. They instead propose categories of ‘true virulence genes’ (which
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include only genes whose products are involved in the interactions between the 
bacteria and host, are responsible for pathogenic damage and absent in non- 
pathogenic microorganisms) and ‘virulence life-style genes’ (genes whose products 
enable a microorganism to colonize the host, evade its immune system and 
intracellular survival). However, for the purpose of this study the term ‘virulence 
gene/factor’ will encompass Wassenaar & Gaastra’s (2001) definitions of both true 
virulence genes and virulence life-style genes.
The ‘virulence’ factors chosen in this study were chosen for their role in infection, 
which is discussed in chapter 1 and in more detail below.
Hyaluronidase is an enzyme produced by S. aureus that is able to degrade hyaluronic 
acid in host tissue and is known to have a role in early subcutaneous infection 
(Makris et al., 2004). Genes cna (encoding collagen binding protein), hlg (encoding 
y- haemolysin), eta (encoding exfoliative toxin) and fiibA (encoding fibronectin 
binding protein A), plus the ica locus (encoding intracellular adhesion factors) were 
found to be significantly more common in invasive S. aureus isolates than isolates 
from healthy individuals (Peacock et al., 2002). Invasive S. aureus isolates are more 
likely to contain both fiibA and fiibB (encoding fibronectin binding protein B) genes 
(Peacock et al., 2000). Gamma haemolysin is similar to PVL, but is present in a 
much larger number (99%) of clinical isolates (Prevost et al., 1995), and are able to 
lyse erythrocytes as well as phagocytes, indicating they are more significant in 
infection. Cap5 and cap8 are encoded by capS and cap8 gene clusters, which contain 
genes cap5A-? and cap8A-?, respectively and are involved in capsule production 
(O’Riordan & Lee, 2004). The genes encoding PNAG production, which is involved 
in biofilm formation, are located in the ica operon and only co-expression of ica A  
and icaD genes located in the operon were found to produce full activity (Gerke et 
al., 1998). S. aureus grown in a biofilm are more resistant to antibiotics (Amorena et 
al., 1999), biocides (Ueda & Kuwabara, 2007) and the actions of the immune system 
(Kropec et al., 2005), thus allowing persistence of infection and survival. Exfoliative 
toxin A (ETA) causes bullous impetigo (localised blistering at the site of infection) 
and exfoliative toxin B (ETB) causes staphylococcal scalded skin syndrome (SSSS - 
widespread blistering) (Yamasaki et al., 2005). These toxins mediate the separation
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of extended areas of the epidermis below the epidermal barrier, causing blistering 
and allowing spread of bacteria beneath the barrier (Amagai et al., 2000).
3.1.5 Aims and Objectives
The aim of this chapter was to determine the basic characteristics of the isolates used 
in this study, including their identification, their susceptibility to antibiotics, their 
virulence and also genotypic characterization.
3.2 MATERIALS AND METHODS 
3.2.1 RAPD
3.2.1.1 Primers
All primers (see Tables 3.1 and 3.2) were arbitrary sequences of 10 bases in length 
that were chosen at random from a list provided by The University of British 
Columbia (Vancouver, British Columbia) with the exception of primers A to E, 
which were chosen because they were previously shown to produce good banding for 
RAPD testing using staphylococcal isolates (Marsou et al., 2001, primer A and Naffa 
et al., 2006, primers B-E). All primers were purchased from Invitrogen freeze-dried 
in tubes with a desalted purity and a scale of synthesis of 50 nmol. They were re­
suspended in TE buffer that was prepared according to section 2.10.1, to produce a 
10 pM solution and stored at -20 °C.
3.2.1.2 RAPD Method
PCR mixtures were prepared in 0.5 ml PCR tubes as shown in Table 3.3. A PCR 
tube was set up for each DNA sample containing 23 pi of PCR mixture and 2 pi of 
diluted DNA prepared according to section 2.10.2. A negative control was also set 
up for each run with 23 pi of PCR mixture only. The PCR tubes were transferred to 
a Techgene Thermal Cycler PCR machine (Techne, Stone, UK) and run on the 
following cycle: 4 cycles of 5 min at 36 °C, 5 min at 72 °C and 5 min at 94 °C; 30
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cycles of 1 min at 94 °C, 1 min at 36 °C and 2 min at 72 °C; 10 min at 72 °C. 
Electrophoresis was performed according to section 2.11.
3.2.1.3 Screening o f Primers
Primers 208 and 272 had been previously demonstrated to show good discriminatory 
banding (G. Williams, personal communication) and would therefore be used for 
RAPD testing to test the isolates. However, it was necessary to use three primers to 
increase the discrimination between strains. It was therefore necessary to screen a 
selection of random primers (shown in Table 3.1) to find one that was able to 
produce good discriminatory banding for use in RAPD testing. Screening of primers 
was performed for isolate 30 and 45, using the RAPD method in section 3.2.1.2.
3.2.1.4 RAPD Testing o f Isolates
RAPD method in section 3.2.1.2 was performed on all hospital isolates plus S. 
aureus NCIMB 9518 DNA that was extracted and diluted according to section 
2.10.2. All samples were tested using primers 208, 272 and 268 (shown in bold in 
Tables 3.1 and 3.2). Primers 208 and 272 were used since they had previously 
demonstrated good discriminatory banding for S. aureus clinical isolates (G. 
Williams, personal communication) and primer 268 was found to produce the best 
discriminatory banding of all primers screened in section 3.2.1.3.
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Table 3.1: List of RAPD Primers Part 1 of 2
Shows the 5’ to 3’ sequence for each primer used during RAPD testing. UBC = 
University of British Columbia
Primer 5’ to 3’ Sequence Reference
208 ACGGCCGACC UBC
232 CGGTGACATC UBC
234 TCCACGGACG UBC
235 CTGAGGCAAA UBC
236 ATCGTACGTG UBC
237 CGACCAGAGC UBC
238 CTGTCCAGCA UBC
239 CTGAAGCGGA UBC
240 ATGTTCCAGG UBC
241 GCCCGACGCG UBC
242 CACTCTTTGC UBC
243 GGGTGAACCG UBC
244 CAGCCAACCG UBC
245 CGCGTGCCAG UBC
246 TATGGTCCGG UBC
247 TACCGACGGA UBC
248 GAGTAAGCGG UBC
249 GCATCTACCG UBC
250 CGACAGTCCC UBC
251 CTTGACGGGG UBC
252 CTGGTGATGT UBC
253 CCGTGCAGTA UBC
254 CGCCCCCATT UBC
255 TTCCTCCGGA UBC
256 TGCAGTCGAA UBC
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Table 3.2: List of RAPD Primers Part 2 of 2
Shows the 5’ to 3’ sequence for each primer used during RAPD testing. UBC = 
University of British Columbia
Primer 5* to 3’ Sequence Reference
257 CGTCACCGTT UBC
258 CAGGATACCA UBC
259 GGTACGTACT UBC
260 TCTCAGCTAC UBC
261 CTGGCGTGAC UBC
262 CGCCCCCAGT UBC
263 TTAGAGACGG UBC
264 TCCACCGAGC UBC
265 CAGCTGTTCA UBC
266 CCACTCACCG UBC
267 CCATCTTGTG UBC
268 AGGCCGCTTA UBC
270 TGCGCGCGGG UBC
271 GCCATCAAGA UBC
272 AGCGGGCCAA UBC
273 AATGTCGCCA UBC
274 GTTCCCGAGT UBC
A TCACGATGCA Marsou et al. (2001)
B AGGGAACGAG Naffa et al. (2006)
C CAGCACCCAC Naffa et al. (2006)
D GGGT AACGCC Naffa et al. (2006)
E GTGAATCCCCA- Naffa et al. (2006)
GGAGCTTACAT
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Table 33: PCR Mixture
Solution Volume/p.l*
DNase and RNase-free Water 122.4
lOx buffer (Qiagen Ltd., Crawley, UK) 30
Q buffer (Qiagen Ltd.) 60
10 mM dNTPs (Qiagen Ltd.) 6
MgCh (Qiagen Ltd.) 18.8
Primer (as prepared in 3.2.1.1) 48
Taq Polymerase (Qiagen Ltd.) 2.4
dNTPs = Deoxynucleotide triphosphates; DNase = Deoxyribonuclease; RNase = 
Ribonuclease; * Volumes shown are for 12 samples
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3.2.2 Identification of Isolates
One isolate belonging to each RAPD banding pattern profile after testing with all 
three primers (see Table 3.7) were speciated using a BBL™ Crystal™ Gram positive 
kit (Becton, Dickinson & Co., Oxford, UK) according to manufacturer’s instructions. 
Identification was performed after initial genotyping, due to one of the cultures 
provided by MH being morphologically dissimilar to the other isolates and upon 
Gram staining was found not to be Gram positive cocci. It was necessary to confirm 
that all other isolates were S. aureus, but since RAPD had already separated them 
into strains only one of each RAPD profile needed to be identified. Results were 
entered into BBL™ Crystal™ MIND software (Becton, Dickinson & Co.), which 
compared the BBL profile results to bacteria in the database and therefore assigned a 
positive species identification.
3.23 Antibiotic Susceptibility Testing 
3.2.3.1 Materials
Iso-sensitest agar (ISA) was purchased from Oxoid and Columbia agar base was 
purchased from Becton Dickinson & Co. Antibiotic disks (fusidic acid, 10 pg/disc; 
erythromycin, 5 pg/disc; mupirocin, 5 pg/disc; gentamicin, 10 pg/disc; penicillin G, 
1 unit/disc; vancomycin, 5 pg/disc; ciprofloxacin, 1 pg/disc and oxacillin, 1 pg/disc) 
were purchased from Oxoid and stored in a sealed container with a desiccant at -20 
°C. Disks were removed from the freezer 15 min before use to prevent condensation.
3.2.3.2 Method
Testing was performed in duplicate for all 59 hospital isolates, including reference 
isolate S. aureus NCIMB 9518, for each antibiotic according to the BSAC method 
(BSAC, 2006). A bacterial suspension was prepared to a concentration of 8.14 ± 
0.243 logio CFU/ml according to section 2.5.1. The suspension was diluted 1 in 100 
in TSC buffer and spread in 3 directions across each of two ISA plates and one 
Columbia agar plate with 2% NaCl using a sterile swab. Antibiotic disks were 
placed on the surface of the agar plate using sterile forceps. The oxacillin disk was 
placed on the Columbia agar plate with 2% NaCl and the remaining 7 disks (fusidic
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acid, erythromycin, mupirocin, gentamicin, penicillin G, vancomycin and 
ciprofloxacin) were placed on two ISA plates (a maximum of 6 disks can be placed 
on 1 plate). ISA plates were incubated at 37 °C for 18-20 hours and Columbia agar 
plates with 2% NaCl were incubated at 30 °C for 24 hours. The zones of inhibition 
were measured for each disk and interpreted as sensitive or resistant according to the 
zone diameter breakpoints reported in the BSAC method (BSAC, 2006).
3.2.4 Determining the Presence/Absence of Virulence Genes among S, aureus 
Isolates
3.2.4.1 Primers
Forward and reverse primers for each virulence gene were purchased from Invitrogen 
freeze-dried in tubes with a desalted purity and a scale of synthesis of 50 nmol. They 
were re-suspended in TE buffer prepared according to section 2.10.1 at 10 pM and 
stored at -20 °C. Sequences were 18 to 34 bases in length and were taken from 
previous studies, except for the cna gene primer, which was self-designed (see 
Tables 3.4-3.5). The cna gene sequence from the National Center for Biotechnology 
Information (NCBI) CoreNucleotide Search software was entered into Primer3 
software (Rozen & Skaletsky, 2000), which designed several primers. A primer was 
chosen from these that met the following criteria: 1) primer length was 20-25 bases 
in length, 2) GC content was 40-50%, 3) melting temperature was 55-75 °C. These 
criteria, along with a suitable primer sequence avoid formation of dimer, hairpin or 
secondary priming sites and mispriming.
3.2.4.2 PCR
The presence/absence of the genes described in Tables 3.4 and 3.5 was determined 
for all hospital isolates, plus S. aureus NCIMB 9518 in duplicate. This was also 
performed for isolates known to be positive for a specific gene(s), which served as 
positive controls. Positive control isolates were: S. aureus NCTC 8530 for the cna 
gene, S. aureus ATCC 49775 for the hlgCB gene, S. aureus NCTC 8325 for genes 
fiibA, fnbB  and hysA and S. aureus NCTC 8175 for genes hlgA, icaA, icaD and clfA. 
No positive control isolates could be obtained for genes cap8, eta or etb. Where a
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positive and negative result was obtained for a sample the negative result was 
assumed to be a test failure and this was repeated.
PCR mixtures were prepared in 0.5 ml PCR tubes as shown in Table 3.6, containing 
23 pi of PCR mixture and 2 pi of diluted DNA prepared according to section 2.10.2. 
A negative control was performed with 23 pi of PCR mixture only. PCR was 
performed in a Techgene Thermal Cycler PCR machine and run on the following 
cycle: 92°C for 2 min; 35 cycles of: 92 °C for 2 min, 50°C for 1 min, 72 °C for 2 min; 
72 °C for 3 min. Electrophoresis was performed according to section 2.11.
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Table 3.4: List of Virulence Gene Primers Part 1 of 2
Forward (F) and reverse (R) primer sequences for each virulence gene primer, their PCR product’s length and their origin. BP = length of 
PCR product in base pairs.
Gene 5’ to 3’ Sequence Product length (bp) Reference
hysA F-CTTCTCATATGACTCGTACCTATCG
R-TAGGTGTTCCAATTTCATAATCCCA
242 Makris et al. (2004)
cna F-AAAGCGTTGCCTAGTGGAGA
R-TTTTGAGTGCCTTCCCAAAC
196 Accession No. M81736
fnbA F- CATAAATTGGGAGCAGCATCA 
R- ATCAGCAGCTGAATTCCCATT
127 Otsuka et al. (2006)
fnbB F- GTAACAGCTAATGGTCGAATTGATACT 
R- CAAGTTCGATAGGAGTACTATGTTC
524 Otsuka et al. (2006)
hlgA F-ATGATTAAAAATAAAATATTAACAGCAACT
R-ATCAACATTAGAGTCTTTTCGTTTT
350 Bronner et al. (2000)
Hlg
CB
F- AGCTCTCGAACAACATATTATA 
R- CTGCAGCTTTAAGCACTAAAG
940 Bronner et al. (2000)
u>
Table 3.5: List of Virulence Gene Primers Part 2 of 2
Forward (F) and reverse (R) primer sequences for each virulence gene primer, their PCR product’s length and their origin. BP = length of 
PCR product in base pairs.
Gene 5’ to 3’ Sequence Product length (bp) Reference
cap5 F-GTCAAAGATTATGTGATGCTACTGAG 
R-ACTT CG AAT AT AA ACTT G AAT C A AT GTT AT AC AG
361 Verdier et al. (2007)
cap8 F-GCCTTATGTTAGGTGATAAACC
R-GGAAAAACACTATCATAGCAGG
173 Verdier et al. (2007)
icaA F-ACACTTGCTGGCGCAGTCAA 
R-TCT GG A ACC A AC ATCC AAC A
187 Grinholc et al. (2007)
icaD F -AT GGT C AAGCCC AG AC AG AG 
R-AGTATTTT C AAT GTTT A AAGC AA
197 Grinholc et al. (2007)
clfA F-GGCTTCAGTGCTTGTAGG 
R-TTTT C AGGGT C A AT AT AAGC
1042 Kalorey et al. (2007)
eta F- GCAGGTGTTGATTTAGCATT 
R - AGATGTCCCTATTTTTGCTG
93 Mehrotra et al. (2000)
etb F- ACAAGCAAAAGAATACAGCG 
R - GTTTTTGGCTGCTTCTCTTG
226 Mehrotra et al. (2000)
Table 3.6: PCR Mixture
Solution Volume/jil*
DNase and RNase-free Water 122.4
lOx buffer (Qiagen Ltd., Crawley, UK) 30
Q buffer (Qiagen Ltd.) 60
10 mM dNTPs (Qiagen Ltd.) 6
MgCl2 (Qiagen Ltd.) 18.8
Forward Primer (as prepared in 3.2.4.1) 24
Reverse Primer (as prepared in 3.2.4.1) 24
Taq Polymerase (Qiagen Ltd.) 2.4
dNTPs = Deoxynucleotide Triphosphates; DNase = Deoxyribonuclease; RNase = 
Ribonuclease; * Volumes shown are for 12 samples
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3 3  RESULTS
33.1 RAPD
3.3.1.1 Screening o f Primers
Most of the primers screened showed either no banding or poor discriminatory 
banding. Primers 261, 265 and particularly 268 showed good discriminatory banding 
(see Figure 3.1). Primer 268 was therefore used for RAPD testing of isolates in 
Section 3.2.1.2.
3.3.1.2 RAPD Testing o f Isolates
Primers 208 (Figure 3.2) and 272 (Figure 3.3) produced good discriminatory 
banding. Primer 268 showed good discriminatory banding when used to test all 
samples (Figure 3.4). Banding was found on the negative control of some RAPD 
tests although it was faint and did not correspond to any banding found for any of the 
isolates in the same run. This banding was therefore ignored.
Banding patterns for each isolate were cross-referenced against each other and 
isolates were grouped together according to their banding pattern profile for each 
primer individually. Isolates with an identical banding profile for primers 208, 272 
and 268 collectively were then grouped together in Table 3.7. Each profile pattern 
was numbered, the first identified was named number one and subsequent profiles 
identified were assigned consecutive numbers.
Twenty four distinct banding pattern profiles were seen among the isolates using 
primer 208, 18 using primer 272 and 20 using primer 268. Thirty nine overall 
distinct banding pattern profiles, and therefore 39 different genotypes, were seen 
among the isolates (see Table 3.7). MRSA isolates fell into 17 groups, whereas 
MSSA isolates fell into 25 groups, meaning there are 17 MRSA and 25 MSSA 
strains among all isolates. Three of the groups had both MSSA and MRSA isolates 
in them.
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Figure 3.1: Example of Screening of Primers
RAPD testing of isolates 30 and 45 using primers 260, 261, 264-268, 270 and 271. BP = length in base pairs
Well Contents
1 1Kb Plus ladder
2 Isolate 30, primer 260
3 Isolate 45, primer 260
4 Isolate 30, primer 261
5 Isolate 45, primer 261
6 Isolate 30, primer 264
7 Isolate 45, primer 264
8 Isolate 30, primer 265
9 Isolate 45, primer 265
10 IKb Plus Ladder
11 Isolate 30, primer 266
12 Isolate 45, primer 266
13 Isolate 30, primer 267
14 Isolate 45, primer 267
15 Isolate 30, primer 268
16 Isolate 45, primer 268
17 Isolate 30, primer 270
18 Isolate 45, primer 270
19 Isolate 30, primer 271
20 IKb Plus Ladder
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Figure 3.2: Example of RAPD Testing Using Primer 208
RAPD testing of multiple isolates using primer 208. BP = length in base pairs
V/l
00
Well Contents
19 20 Bp
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1Kb Plus ladder 
Isolate 3, primer 208 
Isolate 4, primer 208 
Isolate 5, primer 208 
Isolate 6, primer 208 
Isolate 9, primer 208 
Isolate 10, primer 208 
Isolate 11, primer 208 
Isolate 13, primer 208 
IKb Plus Ladder 
Isolate 15, primer 208 
Isolate 16, primer 208 
Isolate 17, primer 208 
Isolate 18, primer 208 
Isolate 20, primer 208 
Isolate 21, primer 208 
Negative control 
No sample 
No sample 
1 Kb Plus Ladder
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Figure 3.3: Example of RAPD Testing Using Primer 272
RAPD testing of multiple isolates using primer 272. BP = length in base pairs
1 1Kb Plus ladder
2 Isolate 41, primer 272
3 Isolate42, primer 272
4 Isolate 43, primer 272
5 Isolate 45, primer 272
6 Isolate 46, primer 272
7 Isolate 48, primer 272
8 Isolate 49, primer 272
9 Isolate 50, primer 272
10 IKb Plus Ladder
11 Isolate 52, primer 272
12 Isolate 55, primer 272
13 Isolate 4, primer 272
14 Isolate 6, primer 272
15 Isolate 10, primer 272
16 Isolate 13, primer 272
17 Isolate 14, primer 272
18 Isolate 16, primer 272
19 Negative control
20 1 Kb Plus Ladder
1 1 J 4  5 6 ? * » 10 U  12 1) II 15 lti 17 IS 19 20
Figure 3.4: Example of RAPD Testing Using Primer 268
RAPD testing of multiple isolates using primer 268. BP = length in base pairs
Well
Bp 1
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4 660 8
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Contents
1Kb Plus ladder 
Isolate 14, primer 268 
Isolate 19, primer 268 
Isolate 26, primer 268 
Isolate 27, primer 268 
Isolate 28, primer 268 
Isolate 30, primer 268 
Isolate 31, primer 268 
Isolate 32, primer 268 
IKb Plus Ladder 
Isolate 34, primer 268 
Isolate 37, primer 268 
Isolate 38, primer 268 
Isolate 39, primer 268 
Isolate 41, primer 268 
Isolate 42, primer 268 
Isolate 43, primer 268 
Isolate 44, primer 268 
Negative control 
1 Kb Plus Ladder
Table 3.7: RAPD Banding Pattern Profiles Obtained for Primers 208, 272 &
268 combined
Isolates are grouped together according to their banding pattern profiles, as 
determined during RAPD testing for primers 208, 272 and 268 combined. Each 
group is given a strain number. Isolates shown in bold are MRSA, all other samples 
are MSSA.
Banding Pattern 
Profile/Strain
Isolate Banding Pattern 
Profile/Strain 
(Continued)
Isolate
1 5,18,20, 28, 41, 21 S12
2 26,31,37,42,43 22 45
3 19,32, 23 51
4 27,46,50 24 38
5 S8, H9 25 44
6 S7, S10 26 24
7 11,17 27 14
8 13,15 28 Q49
9 30, 34 29 K17
10 S3, S4, S6 30 S ll
11 48,49 31 6
12 T4, N10 32 4
13 9, 10 33 39
14 NCIMB 9518 34 16
15 043 35 25
16 SI 36 21
17 55 37 47
18 P59 38 S2
19 3 39 52
20 S5
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3.3.2 Identification of Isolates
All 39 RAPD strains plus S. aureus NCIMB 9518 were identified as S. aureus using 
the BBL™ Crystal™ system. Therefore the identity of all 59 hospital strains were 
confirmed as S. aureus.
3 3 3  Antibiotic Susceptibility Testing
Antibiotic resistance profiles for isolates are shown in Table 3.8. Identical resistance 
profiles were found for duplicate tests of each isolate. There were 10 different 
patterns of resistance profiles among the isolates. Susceptibility testing for all 
isolates agreed with the MRSA/MSSA profile provided by the hospital, except for 
S5. Isolate S5 is documented as MRS A, but was found to be susceptible to 
methicillin, which may be a documentation error from the hospital. Isolate S5 was 
therefore treated as MSSA. Five hospital isolates had an identical antibiotic 
susceptibility profile to the reference isolate S. aureus NCIMB 9518.
The percentage of isolates from this study showing resistance to each antibiotic was 
calculated and is shown in Table 3.9. No isolates showed resistance to vancomycin, 
whereas isolates were most commonly resistant to penicillin G. More MRSA 
isolates were found to be resistant to the antibiotics than MSSA isolates. MRSA 
isolates showed resistance to a wider range of antibiotics, with at least 1 MRSA 
isolate showing resistance to each antibiotic tested, with the exception of 
vancomycin. MSSA isolates, however, only showed resistance to fusidic acid, 
penicillin G and ciprofloxacin. All MRSA isolates were also found to be resistant to 
penicillin G and ciprofloxacin, whereas a lower percentage of MSSA isolates showed 
resistance to them, particularly to ciprofloxacin. The percentage of isolates from this 
study showing resistance to each antibiotic was compared to those found by Hope et 
al. (2008; Table 3.9), who screened S. aureus isolates from bacteraemia patients in 
the UK and Ireland between 2001 and 2006. The findings of their study can be 
compared to those from this study, despite their use of a different method (the BSAC 
agar dilution method) to determine the antibiotic susceptibility. Table 3.9 reveals 
data from this study to be similar to those found by Hope and colleagues, indicating 
that isolates from UHW and MH are fairly representative of those found throughout
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the UK in terms of antibiotic susceptibility and therefore subsequent results from this 
study can be more confidently extrapolated to the whole of the UK. Rates of MRSA 
found in isolates used in this study were much higher (53%) than in isolates reported 
to the HPA in England during the same period of isolation (37-38%; HP A, 2007). 
This is likely to be due to the fact that the isolates used in this study originated from 
ITUs, in which the EARSS surveillance found MRSA rates to be as high as 60% 
during the same period of isolation (EARSS, 2007).
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Table 3.8: Antibiotic Susceptibility Profile of S. aureus Isolates
FD = fusidic acid, E = Erythromycin, MUP — Mupirocin, CN = Gentamicin, P = 
Penicillin G, VA = Vancomycin, CIP = Ciprofloxacin, OX = Oxacillin. S = 
sensitive, R = resistant, according to BSAC interpretation. MRSA isolates are shown 
in bold
Isolate Antibiotic susceptibility profile
FD E MUP CN P VA CIP OX
6 ,  1 0 ,  1 3 ,  1 6 , 2 1 , 2 8 ,  3 0 ,  4 4 , N 1 0 , S s s s R S s s
K 1 7 ,  Q 4 9 ,  T 4 ,  S I ,  S 2 ,  S 7 ,  S 1 0 ,  S I  1
1 4 R s s s R s s s
3,15,17,19,25,26,31,43,45,46, S R s s R s R R
50,55, P59, S6, S12
5,18 S R R R R s R R
9,11,27,32,37,42,52,043, S3, S4 s s s s R s R R
20 R R R R R s R R
4 s S S S S s R S
3 8 ,  5 1 ,  H 9 ,  S 5 s s s s R s R s
41,48,49 s R R s R s R R
2 4 ,  3 4 ,  3 9 , 4 7 ,  N C I M B  9 5 1 8 ,  S 8 s S S s S s S S
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Table 3.9 Percentage of S. aureus Isolates Resistant to Antibiotics
Comparison of Antibiotic Susceptibility in S . aureus Isolates from Hope et al. 
2008 and this Study
The % MRSA and MSSA isolates resistant to a number of antibiotics found in this 
study and by Hope et al. (2008).
Antibiotic % MRSA resistant isolates % MSSA resistant isolates
This study 
n = 31
Hope^at 
(2008) 
n = 163
This study 
n = 29
Hope et aL 
(2008) 
n = 835
Fusidic Acid 3.23 9.3 3.45 8.6
Erythromycin 67.74 81.7 0 28
Mupirocin 19.35 Not tested 0 Not tested
Gentamicin 9.68 9.0 0 2.5
Penicillin G 100 99.8 75.86 82.4
Vancomycin 0 0 0 0
Ciprofloxacin 100 95.9 17.24 9.1
Oxacillin 100 99.8 0 0
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33.4 Determining the Presence/Absence of Virulence Genes among S. aureus 
Isolates
Results of the screening isolates for presence of virulence genes are shown in Table 
3.10. All isolates showed bands of identical size for each virulence gene and bands 
were confirmed as being the correct gene by checking the size of the band against 
that described in the literature (provided in Tables 3.4 and 3.5) or in the case of cna 
using CoreNucleotide Search software. Ten virulence gene profiles were seen 
among the isolates. All positive control isolates tested positive for the appropriate 
virulence gene.
The percentage of isolates carrying each virulence gene is shown in Table 3.11. No 
isolates possessed the eta or etb gene, whereas all isolates possessed genes hysA, 
HlgCB, icaA, icaD and clfA. All other genes were present in a varying high 
percentage of isolates.
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Table 3.10: Virulence Gene Profiles of S. aureus Isolates
+ = gene present, - = gene absent
Isolates hysA cna fnbA fnbB big A hlgCB capS capS icaA icflZ) cl/A eta etb
3 + + - + + + + - + + + - -
4,5,6,9,10,11,13,14,15,16,17, + + + + + + + + + + + - -
18,19,20,21,24,25,26,27,37,47
28,30,34,41,48,49 + + + + + + - + + + + - -
38 + - + + - + + - + + + - -
39 + - + + + + + - + + + - -
44 + - + + + + - + + + + - -
31,32,42,43,45,46,50,51,52 + + + + + + + - + + + - -
55,P59,043,H9,S2,S3,S4, + + + - + + + + + + + - -
S5,S6,S8,S10,S11,S12
N10,K17,Q49,NCIMB 9518 + - + + + + + + + + + - -
T4,S1,S7 + - + - + + + + + + + - -
Table 3.11: Percentage of S. aureus Isolates Carrying Virulence Genes
Percentage of hospital isolates plus S. aureus NCIMB 9518 positive for each 
virulence gene.
Virulence Gene %  Isolates Carrying Gene 
(n=60)
HysA 100
cna 83
fribA 98
jhbB 72
hlgA 98
hlgCB 100
cap5 88
cap8 80
icaA 100
icaD 100
clfA 100
eta 0
etb 0
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3.4 DISCUSSION
3.4.1 RAPD
RAPD was able to group S. aureus isolates that were indistinguishable following 
typing with three primers as a single strain. The observation that MSSA isolates 
could be divided into more RAPD types than MRSA isolates (section 3.3.1.2) 
indicates that there was more variability within MSSA isolates and reflects the fact 
that MSSA has a much broader lineage compared to MRSA, since MRSA has 
evolved more recently (Deurenberg & Stobberingh, 2008). The observation that 
three of the RAPD groups consisted of both MRSA and MSSA isolates indicates that 
the three primers used did not complement part of the sequence of the gene that 
encodes methicillin resistance (mecA gene).
The observation that three primers provided better discrimination between isolates’ 
genotypic profiles led to the formation of a larger number of RAPD types (strains) 
than either one or two primers. Greater discrimination using multiple primers was 
also found by Madadgar et al. (2008). Multiple primers may be more beneficial, 
since being able to distinguish between isolates more accurately may then enable 
better tracking of S. aureus isolates in the hospital environment.
The primers used for the RAPD method are random and therefore arbitrary and 
therefore not suitable for inter-laboratory comparison of strains. RAPD is relatively 
quick and easy to perform in comparison to other genotypic methods and therefore 
may be useful for in-house reference only.
3.4.2 Antibiotic Susceptibility Testing
Data showing the percentage of S. aureus isolates resistant to the antibiotics are 
shown in Table 3.9. These data reveal that a low percentage of the isolates were 
resistance to mupirocin, fusidic acid and gentamicin and none were resistant to 
vancomycin indicating that current ITU isolates can be treated easily with a number 
of therapy options. This means that teicoplanin and new antibiotics such as linezolid 
and quinupristin-dalfopristin may not be required for regular use for some time and
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the predicted explosion of unbeatable S. aureus infections appears to be further in 
the future.
3.4.3 Determining the Presence/Absence of Virulence Genes among S. aureus 
Isolates
Data showing the percentage of S. aureus isolates carrying each virulence gene are 
shown in Table 3.11. No isolates possessed the eta or etb gene, which means none 
are capable of causing SSSS or bullous impetigo. All isolates possessed genes hysA, 
hlgCB, icaA, icaD and clfA; all other genes were present in a high percentage of 
isolates.
Mehrotra et al. (2000) also found no eta or etb genes among isolates from nasal 
swabs of healthy individuals, clinical isolates and surveillance cultures. The 
percentage of isolates positive for clfA is very similar to those found in S. aureus 
clinical isolates by Tristan et al. (2003); however, a much higher percentage of 
isolates were positive for cna, jhbA and fnbB  than those found by Tristan and 
colleagues. This could be explained by the fact that the clinical isolates tested by 
Tristan and colleagues were from a mixture of nasal swabs from asymptomatic 
carriers and specimens from patients with endocarditis and osteomyelitis/arthritis. 
They found a significant difference in the percentage of isolates positive for these 
genes depending on which sample type the isolates originated, which may explain 
the differences seen between this study and those by Tristan and colleagues. 
Wisniewska et al. (2008), however, found a similar percentage of S. aureus clinical 
isolates positive for genes fnbA, JhbB and clfA, although they found a much lower 
percentage positive for the cna gene. The isolates they tested were from a wide 
range of different infection sites, including bloodstream, but they found no 
correlation between origin of specimen and presence of the genes. Peacock et al. 
(2002) found a similar percentage of S. aureus invasive clinical isolates positive for 
fnbA, hlgCB, clfA, icaA and etb; however, they found a much lower percentage of 
isolates positive for the cna gene and a much higher percentage of isolates positive 
for the eta gene. Verdier et al. (2007) found a much lower percentage of S. aureus 
bacteraemia isolates contained cap5 and especially cap8 genes than was found in this
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study. They also found cap5 and cap8 genes present in a much lower percentage of 
S. aureus isolates from other infection sites. The reason for such large differences in 
the presence of the cap5 and cap8 genes between these studies is not clear. Although 
isolates studied by Verdier and colleagues were not from the UK, neither were the 
isolates studied by Wisniewska et al. (2008) and Tristan et al. (2003) that were 
shown to have virulence genes in similar numbers.
No positive control isolate could be obtained for genes eta, etb and cap8, therefore 
they could not be used in this study to confirm the accuracy of the primers under the 
conditions of this study. However, the primers used in this study for genes eta and 
etb were previously validated with a positive control in Mehrotra et al. (2000) and 
primers for cap8 gene were used previously by Verdier et al. (2007).
3.4.4 Summary
The RAPD, antibiotic susceptibility and virulence gene profiles of the isolates 
provides important information for characterisation and tracking of these isolates and 
provides important information regarding their potential ability to cause disease. 
Possible relationships between genotypic and phenotypic characteristics studied in 
this chapter are discussed in Chapter 7, with RAPD and antibiotic susceptibility 
profiles directly compared in Table 7.1. The genetic profile of isolates in this study 
cannot be compared to those of other isolates in the UK or worldwide due to 
characterization of most isolates being carried out using PFGE or MLST. The 
antibiotic susceptibility and virulence gene profiles of the isolates in this study are 
comparable to those of other S. aureus isolates in the UK and worldwide and are 
similar to those found in other studies, particular with regards to antibiotic 
susceptibility. Knowledge of the characteristics of these isolates is important, since 
these characteristics may provide insight as to how they are able to infect, how they 
spread throughout the hospital and how they can be treated. Differences found 
between the isolates in future testing, such as antiseptic susceptibility may also be 
explained by differences in their genotypic, antibiotic and virulence gene profiles.
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CHAPTER 4 DETERMINING THE EFFICACY OF 
ALCOHOL HAND RUBS AGAINST STAPHYLOCOCCUS
AUREUS ISOLATES
4.1 INTRODUCTION
4.1.1 Hand Sanitizing Practices in Intensive Therapy Units
It is important to determine whether the current hand sanitizing practices are 
effective, or whether they lead to potential spread of S. aureus, particularly to the 
patient, thus increasing the risk of nosocomial infection. It is also important to 
discover the mechanisms of potential spread of S. aureus in the ITU. Developing an 
understanding of how and when AHRs are used in practice will enable the 
development of a method for testing AHRs against conditions found in practice. 
Antiseptic susceptibility testing can therefore be designed and interpreted according 
to the results of the ITU observations with respect to those contact times used in 
practice.
Studies have shown increased compliance of HCWs with hand hygiene using AHRs 
compared to hand washing (Girou et al., 2002; Karabay et al., 2005) and after 
hygiene compliance interventions (Hugonnet et al., 2002). The effect of the use of 
AHRs has also been well studied with regards to the subsequent reduction in HCAIs 
such as MRSA (Johnson et al., 2005b; Harrington et al., 2007). These studies either 
observe compliance rates based on the number of applications of AHR compared to 
the total number of hand hygiene opportunities (Girou et al., 2002; Hugonnet et al., 
2002; Karabay et al., 2005; Johnson et al., 2005b; Patarakul et al., 2005), and/or the 
volume of AHR depleted from stocks (Johnson et al., 2005b; Harrington et al.,
2007).
The quality of hand hygiene has been less well studied. Studies by Larson et al. 
(2001) and Girou et al. (2002) included observation of the length of time taken by 
HCWs from ITUs to rub AHR into their hands, although the HCWs were volunteers 
and were aware of the nature of observations and provided with instructions on how 
to use the AHR. Larson et al. (2001) also studied whether AHR was rubbed in 
correctly, although these observations were not recorded individually, but grouped as 
failure to perform the hygiene procedure correctly along with re-contamination of 
hands. The use of gloves has also been previously studied by Girou et al. (2002).
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4.1.2 Methods Currently Used for Testing the Efficacy of Alcohol Hand Rubs
The AHRs used in UHW and MH are assumed by hospital staff, patients and 
relatives to be effective at killing organisms likely to be found on the hands of HCWs 
(such as S. aureus). However, since manufacturers have not tested the AHRs against 
clinical isolates it is not clear whether they are effective in practice. Furthermore, 
some isolates may be less susceptible to AHRs than others due to differences in cell 
structure or composition. It is therefore important to establish the antiseptic 
susceptibility profile of a large number of ITU isolates to the AHRs to which they are 
exposed, thus determining the efficacy of the AHR in-situ.
The main test used by manufacturers to test AHRs is the hygienic hand disinfection 
test EN1500 (European Standard EN1500, 1997), which involves inoculating hands 
with the non-pathogenic strain Escherichia coli K17. Fingertips are sampled before 
and after application of the test product according to manufacturer’s instructions. 
The method is repeated with a standard reference product, 60% w/v propan-2-ol, and 
logio reduction of bacterial cells must not be significantly less for the test AHR than 
that found by the standard reference product. AHRs may alternatively be tested 
using European Standard EN12791 (2005), which uses a similar method as EN1500, 
except the reference product is 60% propan-l-ol. These standard methods all test the 
AHR under more or less practical conditions, but for ethical reasons cannot 
incorporate use of pathogenic species that can be found on the hands of HCWs.
Some manufacturers also test their AHRs using a standard suspension test such as 
(European Standard EN1276, 1997) or EN 12054 (European Standard prEN12054, 
1995), which measure the logio reduction of a small number of standard bacterial 
strains, including S. aureus, in a suspension. EN1276 is designed to test the 
bactericidal activity of chemical disinfectants and antiseptics used in food, domestic 
and industrial areas and a logio reduction of >5 must be achieved within 5 min. 
EN 12054 is designed to test the bactericidal activity of hygienic and surgical 
handrub and handwash products and a logio reduction of >4.52 for a hygienic hand 
rub is required within 1 min. Bacterial cells are significantly less susceptible to 
biocide treatment when they are attached to a surface, compared to a suspension 
(Lindsay and von Holy, 1999); therefore results obtained using suspension tests
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cannot predict whether the product is effective at killing bacteria on the surface of 
hands. Thus although suspension tests provide additional efficacy results to those 
provided by EN1500, they are unable to demonstrate the product’s efficacy under 
conditions found in practice.
4.13 Alternative Tests for Testing the Efficacy of Alcohol Hand Rubs
Carrier tests are not used by AHR manufacturers to test their products, but they most 
accurately replicate conditions of AHR use found in practice. This is because carrier 
testing determines the efficacy of antibacterial products against bacteria dried on a 
surface. The stainless steel disk carrier test EN 13697 (European Standard EN 13697, 
2001) is an appropriate carrier test method for the screening of a large number of 
isolates. The criteria for this test is to achieve a > 4 log reduction within 5 min.
The efficacy of AHRs has been tested in-vivo on hands against resident flora 
(Marchetti et al., 2003; Kampf & Kapella, 2003; Suchomel et al., 2009a; Suchomel 
et al., 2009b) and non-pathogenic organisms (Kampf et al., 2003; Kampf, 2008). 
The efficacy of AHRs has been tested on standard strains of pathogenic organisms 
(Kampf et al., 2003; Marchetti et al., 2003) and also against clinical isolates, 
including a small number of S. aureus isolates (Kampf & Hollingsworth, 2003; 
Kampf & Hollingsworth, 2008; Hall et al., 2009) using a suspension test method. 
The efficacy of AHR against clinical isolates has not previously been tested using a 
carrier test, nor has the difference been tested between the susceptibility of a large 
number of S. aureus isolates to AHRs.
The stainless steel disk carrier test EN13697 (European Standard EN13697, 2001) 
was chosen as the basis for testing the efficacy of AHRs against S. aureus isolates 
and a range of contact times were chosen to incorporate the contact times used in 
practice, as shown in Table 4.1. Dirty conditions only were chosen to reflect the 
high level of organic material likely to be found on the hands of HCWs. The 
presence of organic material decreases the efficacy of a biocide by inhibiting the 
interaction between the biocide and bacteria either by quenching the biocide or 
protecting the bacteria (Maillard, 2005b). It is important to use clinical strains of
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bacteria, rather than one standard strain, in order to give a more accurate prediction 
as to how effective the AHR is against isolates found in practice, especially since it 
has been previously demonstrated that clinical and reference strains have varied 
susceptibilities (Kampf & Hollingsworth, 2008).
The Bioscreen method is a high throughput method suitable for enumeration of 
surviving cells from the carrier test. It is particularly relevant to this study, which 
required testing all fifty nine hospital isolates against three AHRs and with three 
replicates. However, Lambert & van der Ouderaa (1999) found a discrepancy 
between logio reductions using the Bioscreen and plate count methods after exposure 
to biocide, where the Bioscreen logio reductions were higher. This is almost 
certainly due to the fact that cells which have undergone sub-lethal damage by a 
biocide require time to repair themselves before they can grow. Sub-lethally 
damaged bacteria will have a longer lag phase than healthy cells and will therefore 
take longer to achieve the OD required for analysis, so it will appear as if fewer cells 
had survived AHR exposure than actually had, resulting in an overestimation of logio 
reduction. The plate count method, however, allows for delays in growth due to cell 
damage because the incubation time is longer and colony size is not taken into 
account when counting. Therefore, if the logio reduction in bacterial number 
following exposure to AHR when using the Bioscreen method is significantly higher 
than using the plate count method this will imply that the AHR has sub-lethally 
damaged the cells. A comparison of these two methods of enumeration will 
determine firstly whether the Bioscreen estimates comparable logio reduction values 
and secondly whether bacterial cells that survived exposure to AHRs are sub-lethally 
damaged.
In-vitro tests such as the stainless steel carrier test, particularly using the Bioscreen to 
enumerate recovery, are appropriate for large-scale screening of isolates, but they are 
not truly representative of conditions of AHR exposure in practice. This is because 
they do not take into consideration the effect the surface of skin will have on the test 
organism or the AHR. In-vivo tests are not appropriate for testing of pathogens such 
as S. aureus due to ethical reasons, and therefore an ex -vivo skin test is needed. Ex- 
vivo testing involves using excised skin as a surface. Skin is not readily available in
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large quantities and therefore inappropriate for large-scale screening of isolates, but 
is crucial to validate the logio reduction values obtained for stainless steel carrier 
testing using a small number of isolates. Human skin is difficult to obtain due to the 
necessity of ethical approval and therefore animal skin can be used as an alternative. 
Pig skin is the most appropriate animal skin to use, due to the similarities in structure 
(Montagna & Yun, 1964), lipid composition (Gray & Yardley, 1975) and 
permeability (Bhatti et al., 1988; Dick & Scott, 1992) to human skin. The fact that 
pigs are commercially reared and slaughtered provides a readily available source of 
skin. The use of pig skin as a model surface for testing antiseptic hand washes has 
been successful and logio reductions have been similar to those found in-vivo 
(McDonnell et al., 1999). An ex-vivo method for testing the antimicrobial efficacy 
of antiseptic agents on skin surfaces was developed by Maillard et al. (1998).
4.1.4 Alms and Objectives
The aim of this chapter was to determine the hand sanitizing practices used in the 
ITU and the susceptibility of S. aureus isolates to AHRs, as well as to determine the 
antibacterial behaviour of AHR in practice, such as the effect of mechanical rubbing 
and residual activity. The aim was to design susceptibility tests to simulate 
conditions found in practice and to extrapolate the results to in-situ use of AHRs.
4.2 MATERIALS AND METHODS
4.2.1 Observation of Hand Sanitizing Practices in ITU
Hand sanitizing practices were observed on the ITU ward on two separate occasions 
at UHW and on one occasion at MH, with the full approval of the senior nurse in 
charge. This involved standing at several locations in the ward and observing 
doctors, nursing staff and visitors as they sanitized their hands and touched objects, 
materials and patients. Observations included whether or not staff washed their 
hands or used AHRs, the quality of hand sanitization with AHRs, whether or not 
gloves were worn and the incidences of potential cross-contamination that occurred 
as a result of the failure of staff to perform hand sanitizing between touching a
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patient/object. A healthcare observation period began upon the approach of a HCW 
to the vicinity of the patient, or if a HCW was already present when observations 
were due to commence then observation would not start until the current healthcare 
procedure taking place had ended. A healthcare observation period ended when a 
healthcare procedure ended.
4.2.2 Stainless Steel Carrier Testing
4.2.2.1 Materials
Stainless steel disks used were 2 cm diameter, with a grade 2B finish and were 
purchased from Goodfellows Cambridge Ltd. (Huntingdon, UK). Between each use 
the disks were autoclaved, rinsed in water and placed in 5% (v/v) Decon®90 (Decon 
Laboratories Limited, Hove, UK) in deionised water for 60 min, rinsed with 
deionised water, dried in a glass drier and autoclaved to sterilize.
Bovine serum albumin (BSA) was prepared weekly from powder purchased from 
Acros Organics (Geel, Belgium) and dissolved in the appropriate volume of 
deionised water. BSA was stored under refrigerated conditions and the required 
volume was filter sterilized using a 0.45 pm syringe filter (Fisher Scientific) daily 
prior to use. Dirty conditions are represented by the presence of 3 g/L BSA 
(European Standard EN 13697, 2001) and is therefore required at a concentration of 6 
g/L BSA to achieve dirty conditions with a 1:1 ratio of BSA and bacterial 
suspension.
4.2.2.2 Validation o f Neutralizer
This test was performed under dirty conditions for Soft Care Med H5, Cutan and 
Guest Medical AHRs and was a modified version of the neutralization validation in 
EN 13697 (European Standard EN13697, 2001). A bacterial suspension of S. aureus 
NCIMB 9518 was prepared to a concentration of 8.29 ± 0.34 logio CFU/ml according 
to section 2.5.1. One ml 6 g/L sterile BSA prepared according to section 4.2.2.1 and 
1 ml bacterial suspension was mixed together and 20 pi was inoculated onto each of 
two stainless steel disks. Disks were incubated at 37 °C in a Petri dish with the lid
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partially opened for approximately 1 h until visibly dry. A 6-well culture plate 
(Coming, NY, USA) was set up with two wells filled with 9.9 ml TSC buffer. One 
hundred pi TSC buffer was added to the first well, which served as a control and 100 
pi AHR was added to the other, which served as a test. After 5 min neutralization 
time, one disk was placed in each of the two wells, inocula-side up. Bacteria were 
removed from the surface of each disk by flushing 5 ml TSC buffer from the well 
across the surface of the disk with a pipette 15 times. A viable count was performed 
according to section 2.6.2.1. This procedure was performed 5 times for each AHR, 
using a fresh inoculum for each replicate.
The recovery of cells (neutralizer toxicity) and the logio reduction in number of cells 
(neutralizer efficacy) was calculated using the following equations, respectively :
1 )N -N C  and 2 )N C -N T
Where N = logio number of CFU/20 pi in original BSA/suspension, NC = logio 
number of CFU recovered per disk for the control, NT = logio number of CFU 
recovered per disk for the test. Results were interpreted according to European 
Standard (EN 13697, 2001) guidelines.
4.2.2.3 Carrier Testing o f Standard Strain Using the Plate Count Method
This test was performed under dirty conditions for Soft Care Med H5, Cutan and 
Guest Medical AHRs and was based on the method in EN 13697 (European Standard 
EN 13697, 2001). This test was performed on reference NCIMB 9518 only in order 
to perform a comparison between the plate count method of recovery and Bioscreen 
method of recovery. A bacterial suspension was prepared to a concentration of 8.60 
± 0.08 logio CFU/ml and inoculated onto stainless steel disks according to 4.2.2.2. A 
100 pi volume of AHR was added to the surface of the first disk, entirely covering 
the inoculum spot. After a contact time of 10 s the disk was transferred inoculum- 
side down in a flat-bottomed 100 ml glass bottle 4-5 cm in diameter (Fisher 
Scientific) containing 10 ml TSC buffer and 5 g 3 mm glass beads (Sigma Aldrich). 
After 5 min neutralization time the bottle was placed on a Grant Bio POS 300
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rotating platform (Patterson Scientific, Luton, UK) at 150 rpm for 1 min to remove 
cells and a viable count was performed according to 2.6.2.1. A control was 
performed on the remaining disk as described above, using 100 pi TSC buffer. The 
procedure was repeated with contact times of 30 s, 1 min, 2 min and 5 min and the 
entire procedure for all contact times was repeated a further four times using a fresh 
inoculum.
The % recovery was calculated using the following equation, where the inocula was 
divided by 2 to account for subsequent dilution of the inocula with BSA and divided 
by 50 to account for only 20 pi being inoculated onto the disk:
% Recovery = _________ 100_________  x CFU/disk
(CFU/ml inocula 2 50)
Logio reductions were calculated for each time point for each AHR using the 
following equation, where Nc is the logio number of CFU recovered per disk for the 
control and Nd is the logio number of CFU recovered per disk for the test:
Logio reduction = Nc -  Nd
An Nc-Nd value of >4 logio order demonstrates a target bactericidal effect. Due to 
the limit of detection of this method, which is 1 cfu/ml, if a value of 0 cfu was 
obtained on duplicate counts it was recorded as (<) 0.5 cfu. Statistical analysis was 
performed on the percentage recovery values to validate the recovery method, and to 
compare the logio reduction values at each time point for each AHR. Statistical 
analysis was performed according to section 2.8.1.
4.2.2.4 Determining the Viable Count of Bioscreen Growth from Optical Density 
Value
A bacterial suspension of S. aureus NCIMB 9518 was prepared to a concentration of
Q ftapproximately 10 cfu/ml according to section 2.5.1. This was serially diluted to 10*
A
and a viable count of the undiluted to 10' dilutions was performed according to 
section 2.6.2.1. The dilutions were also enumerated using the Bioscreen method,
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where 50 pi of each dilution was placed in 5 wells each of a 100-well honeycomb 
plate (Thermo Electron Corporation, Basingstoke, UK) containing 350 pi TSB. A 
negative control (blank) was performed by adding 50 pi TSC buffer in 5 wells of the 
honeycomb containing 350 pi TSB. The honeycomb plate was incubated in a 
Bioscreen C Microbial Growth Analyser (Oy Growth Curves Ab Ltd., Helsinki, 
Finland) at 37°C for 14 hours with O D  readings taken automatically every 15 min 
using a wideband filter with a wavelength of 420-580 nm. The plate was shaken for 
10 s before each OD420-5 8 0 reading. This process was repeated a further nine times, 
using a fresh culture for each replicate to produce CFU/ml and O D 420-580 readings for 
ten dilution series. The logio CFU/ml of each dilution in each dilution series was 
plotted against the time taken to reach an O D 420-580 of 0.2 in a fitted line plot, using 
Minitab. This created a linear equation that allows the logio CFU/ml to be calculated 
of any suspension according to the time taken to reach an O D 420-580 of 0.2. An O D 420-  
58o  of 0.2 was chosen because the growth curves revealed that this O D  showed the 
best discrimination between each dilution.
4,2,2.5 Carrier Testing o f Standard Strain Using the Bioscreen Method
A direct comparison with the plate count method of recovery was performed to 
ensure the Bioscreen method was able to accurately predict the true bactericidal 
effect of AHR. This test was performed on a reference strain NCIMB 9518 under 
dirty conditions for Soft Care Med H5, Cutan and Guest Medical AHRs and was 
based on the method in 4.2.2.3. A bacterial suspension of S. aureus NCIMB 9518 
was prepared according to section 2.5.1 and 4 ml of 6 g/1 sterile BSA prepared 
according to section 4.2.2.1 was mixed with 4 ml bacterial suspension to achieve a 
final concentration of 8.34 ± 0.07 logio CFU/ml. Bacterial suspensions were tested 
according to section 4.2.2.3, except that after cells were removed from the rotating 
platform a viable count of each test and control solution was performed according to 
the Bioscreen method of enumeration described in section 4.2.2.4. The mean of each 
test/control O D 420-580 reading was calculated at each 15 min reading interval and the 
overall mean OD value of the blank was subtracted from each mean test and control 
mean value to provide mean minus blank values. Testing was performed in 
triplicate.
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Logio CFU/ml values were calculated from mean minus blank OD values using the 
linear equation from the Fitted Line Plot (Figure 4.4) produced according to section
4.2.2.4. These logio values were converted to inverse logio values and multiplied by
10.1 to obtain cfu/disk values. Due to the limit of detection being 4 CFU/ml for this 
method, if a value of 0 CFU was obtained in each of the 5 wells they were recorded 
as (<) 4 CFU/ml. The test logio CFU/disk values were subtracted from control logio 
CFU/disk values to obtain logio reduction values/disk. Statistical analysis was 
performed on logio reduction values according to section 2.8.1 to compare the logio 
reduction values at each time point for each AHR.
4.2.2.6 Comparison of the Carrier Test plate Count and Bioscreen Methods for the 
Standard Strain
Logio reduction values from the carrier test Bioscreen method performed in section
4.2.2.5 at each time point for Soft Care Med H5, Cutan and Guest Medical AHRs 
were statistically compared against the respective carrier test plate count values 
performed in section 4.2.2.3, according to section 2.8.1 to determine whether there 
was a significant difference between them.
4.2.2.7 Carrier Testing o f Isolates Using the Bioscreen Method
All 59 hospital isolates were tested against Soft Care, Cutan and Guest Medical 
AHRs in triplicate according to section 4.2.2.5. However, data were not adjusted to 
compensate for the limit of detection, the reasons for which are discussed in section
4.3.2.5. Bacterial suspensions used were prepared to a concentration of 8.55 ± 0.14 
logio CFU/ml.
4.2.2.8 Determining the Logio Reduction of Isolates 44 and SI Using Guest 
Medical AHR with the Carrier Test Plate Count Method
Carrier testing using the plate count method was performed in triplicate for isolates 
44 and SI using Guest Medical AHR only, according to section 4.2.2.3. This was 
performed in order to determine the true logio reduction values of these two isolates, 
since they were used in further testing.
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4.23 Ex- Vivo Carrier Testing
4.2.3.1 Materials
Pig ears were kindly provided by Dr Charles Heard (Cardiff University) following 
collection from a local slaughterhouse. Ears were frozen on the day of collection and 
thawed on the day of preparation of skin samples. Glass diffusion cells were 
purchased from J.B. & D.W Jones (Loughborough, UK).
4.2.3.2 Preparation of Skin
Ears were thawed under a laminar air flow cabinet, during which time they were 
placed in a container to prevent drying. After thawing they were washed thoroughly 
in sterile deionised water (SDW) to remove residues of blood and dirt. The ears 
were shaved using an electric razor and rinsed in fresh SDW, after which the skin 
was separated from the ear using a scalpel blade, taking care to remove excess 
subcutaneous fat and cartilage. The skin was cut into approximately 2 cm2 pieces 
using a scalpel blade and was frozen in sterile Petri dishes until needed. Prior to 
testing, skin was removed from frozen storage and left to thaw in a closed Petri dish 
for a few minutes. The skin pieces were decontaminated by immersion in 85% v/v 
ethanol for 30 s and were transferred to a sterile Petri dish. The top surface of the 
skin was gently rubbed using alcohol-coated gloved fingertips to physically dislodge 
resident flora and finally the skin was immersed in 85% ethanol for a further 10 s. 
Immediately after removal from ethanol the skin was immersed in SDW for 5 min to 
neutralize the effect of the alcohol and was finally transferred to a sterile Petri dish.
4.2.3.3 Assembly of the Diffusion Cell
The lips of the donor and receptor compartments of the diffusion cells were coated 
with a thin layer of high vacuum grease and autoclaved to sterilise. The set-up of 
diffusion cells for testing was carried out aseptically in a laminar air flow cabinet and 
is shown in Figure 4.1. The recipient compartment of each sterile diffusion cell was 
fixed to the surface of a tray and 1 ml TSC buffer was added to keep the dermis of 
the skin moist. A piece of skin that had been prepared according to section 4.2.3.2 
was placed face up on top of each recipient compartment and left for the surface to 
dry in the laminar air flow cabinet for 20 min. The donor compartment of each
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diffusion cell was then placed on top of each piece of skin and fixed in place using a 
pinch clamp. To evaluate the decontamination process existing bacterial flora were 
removed from the surface by adding 1 ml TSC buffer to the donor compartment and 
flushed across the surface 15 times using a pipette. This was enumerated according 
to section 2.6.1.1. This piece of skin was also used for testing, but the TSC buffer 
was discarded and the skin dried in the laminar air flow cabinet for 10 min prior to 
inoculation.
4.2.3.4 Determining the Contact Time Required by an AHR to Achieve a 
Bactericidal Effect against S. aureus Isolates Using the Ex-Vivo Carrier Test
This test was based on that described by Maillard et al. (1998). Testing was carried 
out in a laminar air flow cabinet and was performed under dirty conditions with Soft 
Care Med H5, Cutan and Guest Medical AHR for isolates 44, S. aureus NCIMB 
9518 and SI in triplicate. Skin pieces were prepared according to section 4.2.3.2 and 
skin was set up in diffusion cells according to section 4.2.3.3. An equal volume of 
bacterial suspension (prepared according to section 2.5.1) and 6 g/L sterile BSA 
(prepared according to 4.2.2.1) was mixed to achieve a final concentration of 9.24 ± 
0.11 logio CFU/ml. A 20pl volume was added to the skin surface via the donor 
compartment. This was left to dry for approximately 20 min, until the inoculum spot 
was visibly dry. A volume of 100 pi AHR was added to the skin surface via the 
donor compartment, entirely covering the inoculum spot.
After the appropriate contact time 900 pi TSC buffer was added to the donor 
compartment and was flushed across the skin surface 15 times using a pipette to 
remove bacteria from the surface of the skin. Surviving bacteria were enumerated 
according to section 2.6.1.1. A control was also performed for each time point, 
adding 100 pi TSC buffer to the skin surface.
The % recovery was calculated using the following equation:
% Recovery = _____100_____ x CFU/skin surface
(Inocula 50)
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Figure 4.1: An Assembled Diffusion Cell for Ex-Vivo Testing
Statistical analysis was performed on percentage recovery values to validate the 
recovery method and on logio reduction values to compare the logio reduction values 
at each time point for each AHR and for each time point for each isolate. Statistical 
analysis was performed according to section 2.8.1.
4.23.5 Determining the Effect o f Mechanical Rubbing Using the Ex-Vivo Test
This test was adapted from the method described by Messager et al. (2004). Testing 
was carried out in a laminar air flow cabinet and was performed under dirty 
conditions only for Soft Care Med H5, Cutan and Guest Medical AHR for S. aureus 
NCIMB 9518 in triplicate. Skin pieces were prepared according to section 4.2.3.2 
and left to dry for 10 min on each side. Each piece was mounted on the surface of a 
decontaminated plastic 40 mm Petri dish lid (Fisher) with superglue (see Figure 
4.2A). The surface of each Petri dish was decontaminated by spraying with 70 % v/v 
ethanol and leaving to dry. Two pieces of mounted skin were required for each run 
and one piece for evaluating the decontamination procedure. An equal volume of 
bacterial suspension (prepared according to section 2.5.1) and 6 g/L sterile BSA 
(prepared according to 4.2.2.1) was mixed to achieve a final concentration of 9.19 ± 
0.07 logio CFU/ml. A 20pl volume of each suspension was added to the surface of 
two pieces of skin and left to dry for approximately 20 min. One of the two Petri 
dishes was fixed to a steel rod with a 3.5 cm attachment using superglue and the 
other Petri dish was fixed to a polystyrene block. The block was placed on a balance 
and the rod was attached to a drill (IKA Labortechnik, Staufen, Germany) and 
adjusted so the two pieces of skin were aligned and were pressed together with a 
weight of 100 ± 8 g (see Figure 4.2 B & C). The drill scaffold was lifted and 100 pi 
AHR was added to the surface of the bottom piece of skin. Immediately the scaffold 
was lowered to achieve the previously adjusted weight and the rod was rotated at 150 
rpm for 10 s, after which both Petri dishes were de-mounted and placed skin-side 
down in one 90 mm sterile Petri dish containing 5 ml TSC buffer. After 5 min 
neutralization time each 40 mm Petri dish was held at a 90 degree angle over the 90 
mm Petri dish and the surface of the skin was flushed 30 times with TSC buffer 
using a pipette to remove bacteria from the surface of the skin. A control was 
performed using 100 pi TSC buffer. One mounted piece of skin was also added to a 
Petri dish containing 5 ml TSC buffer and the surface was flushed. This served to
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evaluate the efficiency of the decontamination procedure. The contents of each Petri 
dish were enumerated according to section 2.6.1.1.
The % recovery was calculated using the following equation:
% Recovery = _________ 100__________  x CFU/pair of skin surfaces
(CFU/ml of inocula + 25)
Statistical analysis was performed on percentage recovery values to validate the 
recovery method and on logio reduction values to compare the logio reduction values 
for each AHR. Statistical analysis was performed according to section 2.8.1.
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Figure 4.2: Ex-Vivo Test Using Mechanical Rubbing
Picture A shows a piece of skin mounted on a Petri dish. Picture B shows a close-up 
of the two pieces of skin pressed together. Picture C shows the ex-vivo test using 
mechanical rubbing.
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4.2.3.6 Determining the Residual Activity o f  AHR Using the Ex-vivo Test 
This test was carried out in a laminar air flow cabinet and was performed under dirty 
conditions only for Soft Care Med H5, Cutan and Guest Medical AHR for S. aureus 
NCIMB 9518 in triplicate. An equal volume of bacterial suspension (prepared 
according to section 2.5.1) and 6 g/L sterile BSA (prepared according to 4.2.2.1) was 
mixed to achieve a final concentration of 8.30 ±0.13 logio CFU/ml. Skin pieces were 
prepared according to section 4.2.3.2 and skin was set-up in diffusion cells according 
to section 4.2.3.3 but without the donor compartment. The surface of one piece of 
skin was inoculated with 20 pi AHR and this was massaged into the entire surface 
for 15 s using a glass rod, by which time the AHR appeared thoroughly absorbed into 
the skin. The donor cell was immediately placed on top of the skin and held together 
using a pinch clamp. After a period of 1 min after inoculation with AHR, the surface 
of the skin was inoculated with 20 pi of bacterial suspension. After a 20 min contact 
time, 480 pi TSC buffer was added to the donor compartment and flushed across the 
skin surface 15 times using a pipette to remove bacteria from the skin surface. 
Surviving bacteria were enumerated according to section 2.6.1.1. A control was also 
performed, for which 20 pi suspension was added to the surface of the skin for 20 
min, but no AHR was added prior to this step.
4.2.4 Comparison of the Efficacy of AHRs Using Stainless Steel and Skin 
Surface Carrier Tests and Ex-Vivo with Mechanical Rubbing
The ex-vivo carrier test was performed under dirty conditions for Soft Care Med H5, 
Cutan and Guest Medical AHR for S. aureus NCIMB 9518 in triplicate and using a 
contact time of 10 s, according to section 4.2.3.4. The results of this test, plus the 
results of stainless steel plate count carrier testing from section 4.2.2.3 and ex-vivo 
with mechanical rubbing from section 4.2.3.5 for S. aureus NCIMB 9518 with 10 s 
contact time were compared statistically according to section 2.8.1.
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43  RESULTS
43.1 Observation of Hand Sanitizing Practices in ITU
Hand sanitizing observations were made of 54 separate healthcare observation 
periods in UHW ITU during two visits and of 56 separate healthcare observation 
periods in MH ITU during one visit. A summary of these observations is shown in 
Table 4.1. Results of these observations are also published (Cheeseman et al., 2009).
Only one visitor was observed during the visits, all other observations were of 
HCWs. No patient-to-patient contact via staff hands was observed in either hospital. 
Potential staff-to-object and staff-to-patient cross-contamination usually occurred 
when a member of staff touched an object/patient without gloves or without first 
sanitizing their hands, but also when a member of staff touched their own skin/hair 
after hand sanitizing or putting on gloves then touched an object/patient, thereby 
potentially transferring any microorganisms that they may have picked up from their 
skin/hair to the object/patient. Potential object-to-object cross-contamination 
occurred when a member of staff touched an object and then touched another object, 
thereby potentially transferring any microorganisms that may have been picked up 
from the first object to the second object. Potential object-to-patient cross­
contamination occurred when a member of staff touched an object then touched a 
patient, thereby potentially transferring any microorganisms that may have been 
picked up from the object to the patient. Potential patient-to-object cross­
contamination occurred when a member of staff touched a patient then touched an 
object, thereby potentially transferring any microorganisms that may have been 
picked up from the patient to the object. These incidences of potential cross­
contamination could be avoided either by sanitizing hands or by applying/changing 
gloves either prior to, or in-between, these actions.
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Table 4.1: Hand Sanitizing Observations
UHW = University Hospital of Wales, MH = Morriston Hospital.
Observation UHW MH
% healthcare observations during which staff washed hands 28 20
% healthcare observations during which staff used AHR 30 9
Mean number of pumps of AHR used 1.3 1.0
Mean time taken (s) to rub in AHR 11 15
% of AHR uses where the required areas of hands were cleaned 75 80
% healthcare observations during which staff wore gloves 40 34
Of those observations where HCWs wore no gloves, % 41 14
observations where HCWs used AHR
% observations where HCWs wore no gloves and used no AHR, 17 19
but washed hands
% observations where HCWs used no hand protection/sanitization 19 46
% healthcare observations resulting in potential staff-to-object 30 59
cross-contamination
% healthcare observations resulting in potential staff to patient 4 0
cross-contamination
% healthcare observations resulting in potential object-to-object 70 88
cross-contamination
% healthcare observations resulting in potential object-to-patient 20 9
cross-contamination
% healthcare observations resulting in potential patient-to-object 17 9
cross-contamination
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43.2 Stainless Steel Carrier Testing
4.3,2.1 Validation o f Neutralizer
The mean recovery rate and logio reduction values of S. aureus NCIMB 9518 after 
contact with Soft Care Med H5, Cutan and Guest Medical AHRs for the carrier test 
neutralizer validation are shown in Table 4.2. According to European Standard 
EN13697 (2001), the neutralizer is valid if N-NC is not greater than 2 logio orders 
and if NC-NT is not greater than ± 0.30. Data in Table 4.2 therefore demonstrate 
that the neutralizer was effective at neutralizing the bactericidal activity of Soft Care 
Med H5, Cutan and Guest Medical AHRs under dirty conditions, but was not toxic, 
at a 1 in 100 dilution.
4.3.Z2 Carrier Testing of Standard Strain Using the Plate Count Method
Percentage recovery of S. aureus NCIMB 9518 using the carrier test plate count 
method was 52.01± 14.04 and the differences in recovery were not found to be 
significant (P >0.05). Logio reduction values of S. aureus NCIMB 9518 for the 
carrier test plate count method using Soft Care Med H5, Cutan and Guest Medical 
AHRs are shown in Figure 4.3. Exposure to Soft Care Med H5 resulted in a >4 logio 
reduction average, and therefore bactericidal effect, within 10 s. Exposure to Cutan 
and Guest Medical, however, only showed a >4 logio reduction average, and 
therefore bactericidal effect, following a contact time of 5 min.
Soft Care Med H5 had a higher logio reduction at contact times of 10 s, 30 s, 1 min 
and 2 min compared to Cutan and Guest Medical AHRs (P <0.05); therefore it was 
significantly more efficacious against S. aureus NCIMB 9518 than Cutan and Guest 
Medical AHRs.
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Table 4.2: Carrier Test Neutralizer Validation Results
Shows the mean recovery rate (N-NC) and lo g io  reduction (NC-NT) ± standard 
deviation (SD) of 5. aureus NCIMB 9518 after exposure to Soft Care Med H5, Cutan 
and Guest Medical AHRs for the validation of neutralizer test. N = lo g io  number of 
CFU/20 pi in original BSA/suspension; NC — lo g io  number of CFU recovered per 
disk for the control; NT = lo g io  number of CFU recovered per disk for the test
AHR N-NC NC-NT
Soft Care Med H5 0.08 ±0.15 0.06 ±0.08
Cutan 0.58 ± 0.06 -0.05 ± 0.03
Guest Medical 0.34 ± 0.05 0.02 ±0.04
■ Sottcare Med H5
■  Cutan
■ Guest Medical
10 30 60 120 300
C o n ta c t T im e /se c o n d s
Figure 43: Results of Carrier Testing of S. aureus NCIMB 9518 Using Plate
Count Method
Mean logio reduction ± SD of S. aureus NCIMB 9518 after exposure to Soft Care 
Med H5, Cutan and Guest Medical AHRs for the carrier test plate count method.
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4.3.2.3 Determining Viable Count of Bioscreen Growth from Optical Density 
Value
The fitted line plot of viable count versus OD is shown in Figure 4.4.
4.3.2.4 Carrier Testing o f Standard Strain Using the Bioscreen Method
Logio reduction values of S. aureus NCIMB 9518 for the carrier test Bioscreen 
method using Soft Care Med H5, Cutan and Guest Medical AHRs are shown in 
Figure 4.5. After exposure to Soft Care Med H5 and Guest Medical AHR a >4 logio 
reduction average, and therefore a bactericidal effect, was observed within 30 s. 
Exposure to Cutan, however, resulted in a >4 logio reduction average being observed 
by a contact time of 5 min.
Soft Care Med H5 and Guest Medical had a higher logio reduction at contact times 
10 s, 30 s, 1 min and 2 min compared to Cutan (P <0.05). Therefore, similarly to 
plate count enumeration results (Figure 4.3), Bioscreen enumeration resulted in Soft 
Care Med H5 AHR appearing more efficacious than Cutan AHR, although contrary 
to plate count enumeration results, Guest Medical appeared to be more efficacious 
than Cutan.
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Figure 4.4: Relationship between Bacterial Count and Optical Density of
Bioscreen Readings
Fitted line plot showing the relationship between logio bacterial count/ml of S. 
aureus NCIMB 9518 and OD of Bioscreen readings. The linear equation is shown.
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Figure 4.5: Results of Carrier Testing of S. aureus NCIMB 9518 Using
Bioscreen Method
Mean logio reduction ± SD of S. aureus NCIMB 9518 after contact with Soft Care 
Med H5, Cutan and Guest Medical AHRs for the carrier test Bioscreen method of 
enumeration.
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4.3.2.5 Comparison of Carrier Testing of Standard Strain Using Plate Count and 
Bioscreen Methods
Logio reductions of the carrier test plate count and Bioscreen test methods that were 
performed in sections 4.2.2.3 and 4.2.2.4, respectively are shown in Figure 4.6, 
which provides a comparison between values from both methods of enumeration for 
Soft Care Med H5, Cutan and Guest Medical AHRs. A comparison of these methods 
is published in Cheeseman et al. (2009).
A significant difference between plate count and Bioscreen logio reduction values 
was only observed at contact times of 1 min, 2 min and 5 min for Soft Care Med H5 
AHR and 10 s, 30 s and 1 min for Guest Medical (P <0.05). Bioscreen results were 
not adjusted to compensate for the limit of detection because this caused the logio 
cfu/ml of the controls to fall below 4 and therefore a logio reduction of 4 would not 
have been observed.
The observation that Bioscreen logio reduction values were significantly higher at 
contact times 10 s, 30 s and 1 min for Guest Medical compared to the plate count 
method revealed that Guest Medical AHR was reversibly damaging bacterial cells up 
to, and including, a 1 min contact time. The observation that there was no significant 
difference between logio reduction values of Bioscreen and plate count methods for 
Guest Medical AHR at contact times 2 min and 5 min revealed that bacterial cells 
were not irreversibly damaged until a contact time of 2 min. Therefore Bioscreen 
results for Guest Medical AHR should be interpreted with caution and plate count 
results for NCIMB 9518 in Figure 4.6 indicate logio reduction values found during 
subsequent Bioscreen testing using Guest Medical may more closely reflect those 
seen for Cutan AHR.
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Figure 4.6: Comparison of Carrier Testing of S. aureus NCIMB 9518 Using
Plate Count and Bioscreen
Mean logio reduction ± SD of S. aureus NCIMB 9518 after contact with Soft Care 
Med H5, Cutan and Guest Medical AHRs for the carrier test using Bioscreen and 
plate count methods of enumeration.
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4.3.2.6 Carrier Testing of Isolates Using the Bioscreen
The mean contact time by which each AHR had a bactericidal effect (>4 log io  
reduction) for each hospital isolate plus S. aureus NCIMB 9518 is shown in Table
4.3 and is published in Cheeseman et al. (2009). Isolates 16 and 20, however, did 
not grow sufficiently for control wells to demonstrate a 4 logio growth during 
Bioscreen testing, meaning a 4 logio reduction could not be detected and therefore 
antiseptic susceptibility data was unavailable for these isolates. Bioscreen data is 
also summarised in Figures 4.7-4.11. Figures 4.7, 4.8 and 4.9 compare the logio 
reduction of each isolate following exposure to Soft Care Med H5, Cutan and Guest 
Medical AHRs, respectively. Figures 4.10 and 4.11 compare the logio reduction of 
each isolate after exposure to AHR following 10 s and 30 s contact time, 
respectively.
Table 4.3 shows that a bactericidal effect was achieved fastest on the hospital isolates 
using Soft Care Med H5 AHR, followed by Guest Medical AHR, then Cutan AHR. 
These differences in efficacy between the AHRs are further highlighted in Figures 
4.10 and 4.11. Variability in the time point by which a bactericidal effect was 
achieved among the isolates tested was observed for all the AHRs. Variability was 
mostly widely observed for Guest Medical AHR, for which bactericidal effects were 
observed by contact times of between 10 s and >5 min. Variability was observed for 
Soft Care Med H5 AHR, with bactericidal effects observed by contact times of 
between 10 s and 1 min, although this was achieved by a contact time of 30 s for the 
majority of isolates. There was very little variability for Cutan AHR, which achieved 
a bactericidal effect against most isolates by a contact time of 5 min, with the 
exception of 8 isolates by 2 min and one isolate by >5 min. Variability between 
strains at contact times of 10 and 30 s, which are contact times closest to those found 
in practice, is further illustrated in Figures 4.7-4.9, which also illustrate the change in 
logio reduction between these time points.
By a 10 s contact time Soft Care Med H5 and Guest Medical AHRs were only able to 
exert a bactericidal effect on one isolate (<2% total isolates) and Cutan AHR was not 
able to exert a bactericidal effect on any isolates. Within a 30 s contact time Soft 
Care Med H5 and Guest Medical AHRs were able to exert a bactericidal effect on 50
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(86%) and 25 (42%) isolates, respectively, whereas Cutan AHR was still unable to 
exert a bactericidal effect on any isolates.
The mean logio reduction among isolates after 10 s exposure to Soft Care Med H5, 
Cutan and Guest Medical AHRs is 2.67±0.68, 0.696±1.74 and 1.96±3.59, 
respectively. The mean logio reduction among isolates after 30 s exposure to Soft 
Care Med H5, Cutan and Guest Medical AHRs is 4.58±0.52, 1.74±0.53 and 
3.60±1.11, respectively.
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Table 43: Results of Carrier Testing of Isolates Using Bioscreen
Time point by which a bactericidal effect is observed for Soft Care Med H5, Cutan 
and Guest Medical AHRs against each isolate using the carrier test Bioscreen 
method. MRSA isolates are shown in bold. “Isolates 16 and 20 are not included.
Isolate* Time Point by which a bactericidal effect 
was observed (mean >4 logio reduction)
Soft Care Med 
H5
Cutan Guest
Medical
44 10 s 5 min 30 s
27 30 s 5 min 10s
37, 41, 42, 43,46,49, 50, S4, S6 30 s 2 min 30 s
3, 5, 10, 13,17,19,25,26,31, 30 s 5 min 30 s
32, 39, 45, SI 1, NCIMB 9518
11, 14,15,18,21,24,38, 47, 48, 30 s 5 min 1 min
52, 043, P59, N10, S3
34, 55, T4, Q49, K17, H9, S8 30 s 5 min 2 min
9, 30, S7, S12 30 s 5 min 5 min
S5 30 s >5 min 2 min
4,6 1 min 5 min 1 min
51 1 min 5min 2 min
28, S2, S10 1 min 5 min 5 min
SI 1 min 5 min >5 min
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Figure 4.7: Mean Logio Reduction of S. aureus Isolates With Soft Care Med H5 AHR at 10 s and 30 s Contact Times Using the
Bioscreen
•a r>Q> °
O)O
■ Cutan 30 s 
a  Cutan 10 s
f O ^ - i n t D O O T - C O T r i O N O O C n ^ - T M O C D N C O O r - C M ^ N O O O r - N C O T M f i O S C O O O T - C N J i n N ^ C O Q Q O C O T - C N J C O T f i n ^ N O O O T - C M
T - T - T - T - T - T - r - T - C N C N C \ i C M C M C N C O C O C O C O C O O O C O ,,^ - ' ^ - T r ^ l - ^ J - T j - T t ' ^ - ' ^ - L O l O m i r > ' ^ ^ ^ l - L O ^ t ' « - - C  to (O to to to to to t O r - T - r -^ o a c r e  to to to
Iso la te
ou> Figure 4.8: Mean Logio Reduction of 5. aureus Isolates With Cutan AHR at 10s and 30 s Contact Times Using the Bioscreen
6 ■ Guest Medical 30 s 
«  Guest Medical 10 s
P :
CO ^  IT) ( O O O r - C O ' t i n S C O O T - ^ i n t O N O O O ' c - C M T f N C O r o T - C M C O T M O C D N O O O O T - C M i n N ^ C O O O O O T - C N J C O ^ i n t O S C O  
T - T - ' r - T - T - r - T - T - C N J C N J C N J C N i C N J C N I C O C O C O C O C O C O C O ' ^ ' ^ - ' ^ - T j - T l - T i - ’^ - ' ^ T j - i n L n L n L O ’r - ' ^ ' ^ - L n ' ^ - ' r - X ;  to to CO (0 to to to too  a c r e
O  T -  OJ 
T—  T — T—
to to to
2
Iso la te
Figure 4.9: Mean Logio Reduction of S. aureus Isolates With Guest Medical AHR at 10s and 30 s Contact Times Using the
Bioscreen
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4.3.2.7Determining the Logio Reduction of Isolates 44 and SI Using Guest 
Medical AHR with the Carrier Test Plate Count Method
Logio reduction data for isolates 44 and SI for Guest Medical using the carrier test 
plate count method are shown, along with those using the Bioscreen method, in 
Figures 4.12 and 4.13, respectively. Logio reduction values for isolate 44 were 
significantly higher using the Bioscreen than the plate count method for contact 
times of 10 s, 30 s, 1 min and 2 min, (P <0.05), which indicates that Guest Medical 
reversibly damaged bacterial cells up to contact times of 2 min, but by 5 min cells 
were irreversibly damaged. Logio reduction values were significantly higher for 
isolate SI using the Bioscreen than the plate count method following a contact time 
of 30 s (P <0.05), which indicates that Guest Medical reversibly damaged cells up to 
a contact time of 30 s, but by 1 min cells were irreversibly damaged.
A bactericidal effect was not observed for the most-susceptible isolate (44) using 
Guest Medical until 5 min, which is the same contact time required by Cutan AHR. 
A bactericidal effect was not observed for the least-susceptible isolate (SI) until >5 
min, which was longer than required by Cutan AHR. Since all three isolates (most- 
and least-susceptible and standard strain) require contact times with Guest Medical 
of 5 min or greater to achieve a bactericidal effect, this indicates that all other 
hospital isolates are also likely to require a 5 min contact time or greater. Guest 
Medical is therefore less efficacious than Soft Care and, contrary to results obtained 
during Bioscreen testing, is no more efficacious than Cutan AHR (and in the case of 
isolate SI Guest Medical is less efficacious).
107
10
v Guest Medical Plate Count 
■ Guest Medical Bioscreen
ii3
30 60 120
Contact T im e/seconds
300
Figure 4.12: Logio Reduction of Isolate 44 Using Guest Medical AHR with the 
Carrier Test Plate Count Method
Mean logio reduction ± SD of isolate 44 after contact with Guest Medical AHR for 
the carrier test using the plate count method of enumeration.
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Figure 4.13: Log10 Reduction of Isolate SI Using Guest Medical with the 
Carrier Test Plate Count Method
Mean logio reduction ± SD of isolate SI after contact with Guest Medical AHR for 
the carrier test using the plate count method of enumeration.
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4.33 Ex- Vivo Carrier Testing
4.3.3.1 Determining the Bactericidal Contact Time of Isolates Using the Ex-Vivo 
Carrier Test
Percentage recovery of S. aureus isolates 44, NCIMB 9518 and SI using the ex-vivo 
carrier test was 99.60± 19.53 and the differences in recovery were not found to be 
significant (P >0.05). Ex-vivo carrier test data are shown in Figures 4.14-4.16 and 
results are summarised in Table 4.4. Logio reduction values were significantly 
higher for isolate SI compared to S. aureus NCIMB 9518 for Cutan after 10 min, 
plus for Cutan compared to Soft Care Med H5 and Guest Medical for isolate SI after 
10 min (P <0.05). Cutan was therefore significantly more efficacious against isolate 
SI after 10 min compared to Soft Care Med H5 and Guest Medical and also that 
isolate SI was more susceptible to Cutan after a contact time of 10 min than isolate 
9518. Apart from these observations there was no significant difference between the 
efficacies of the AHRs using the ex-vivo carrier test.
4.3.3.2 Determining the Effect o f Mechanical Rubbing Using the Ex-Vivo Test 
Percentage recovery of S. aureus isolate NCIMB 9518 using the ex-vivo carrier test 
with rubbing was 24.46±8.98 and the differences in recovery were not found to be 
significant (P >0.05). Results of the ex-vivo test with mechanical rubbing are shown 
in Table 4.5. There was no significant difference between logio reduction values 
obtained after 10 s exposure to the AHRs (P >0.05).
4.3.3.3 Determining the Residual Activity o f AHR Using the Ex-Vivo Test
Results of the ex-vivo residual activity test are shown in Table 4.6. There was no 
significant difference between logio recovery values of S. aureus NCIMB 9518 after 
20 min exposure to skin with or without residual levels of Soft Care Med H5, Cutan 
or Guest Medical (P >0.05), indicating AHR does not have a residual effect.
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Figure 4.14: Logio Reduction of Isolate 44 Using the Ex-Vivo Carrier Test 
Mean logio reduction ± SD of isolate 44 after exposure to Soft Care Med H5, Cutan 
and Guest Medical isolates using the ex-vivo carrier test. Experiment was not 
performed for 5 min exposure to Guest Medical or 20 min exposure to Cutan AHR
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Figure 4.15: Logio Reduction of Isolate S. aureus NCIMB 9518 Using the Ex- 
Vivo Carrier Test
Mean logio reduction ± SD of isolate S. aureus NCIMB 9518 after exposure to Soft 
Care Med H5, Cutan and Guest Medical isolates using the ex-vivo carrier test
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Figure 4.16: Logio Reduction of Isolate SI Using the Ex-Vivo Carrier Test
Mean logio reduction ± SD of isolate SI after exposure to Soft Care Med H5, Cutan 
and Guest Medical isolates using the ex-vivo carrier test. Experiment was not 
performed for 5 min exposure to Soft Care Med H5 or Guest Medical, or 20 min 
exposure to Cutan
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Table 4.4: Bactericidal Contact Times of AHRs Using the Ex-Vivo Carrier
Test
Time point (min) by which a bactericidal effect was observed for Soft Care Med H5, 
Cutan and Guest Medical AHRs against isolates 44, S. aureus NCIMB 9518 and SI 
using the ex-vivo carrier test.
Isolate Time Point (min) by which a bactericidal effect was 
observed (mean >4 logio reduction)
Soft Care Med H5 Cutan Guest Medical
44 20 10 20
NCIMB 9518 >20 20 >20
SI 20 10 20
Table 4.5: Logio Reduction of S. aureus NCIMB 9518 after 10 s Exposure to
AHR with Mechanical Rubbing
Mean logio reduction ± SD of S. aureus NCIMB 9518 after 10 s exposure to Soft 
Care Med H5, Cutan and Guest Medical AHRs with mechanical rubbing
Soft Care Med H5 Cutan Guest Medical
1.37 ±0.21 1.46 ±0.20 1.47 ±0.19
Table 4.6: Logio Recovery of S. aureus NCIMB 9518 after 20 min Exposure
to Residual AHR
Mean logio recovery ± SD of S. aureus NCIMB 9518 after 20 min exposure to 
residual Soft Care Med H5, Cutan and Guest Medical AHRs
Control Soft Care Med H5 Cutan Guest Medical
7.00 ±0.023 7.01 ±0.031 7.10 ±0.099 6.97 ±0.06
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4.3.3.4 Comparison of the Efficacy o f AHRs Using Stainless Steel and Ex-Vivo 
Carrier Tests and the Ex-Vivo Test with Mechanical Rubbing
Results of the ex-vivo carrier test after a 10 s contact time are shown in Figure 4.17. 
There was no significant difference between logio reduction values for the ex-vivo 
carrier test after a 10 s contact time for Soft Care Med H5, Cutan and Guest Medical 
AHRs (P >0.05).
The average logio number of cells per surface was 6.31±0.11 for the stainless steel 
carrier test, 6.07±0.07 for the ex-vivo carrier test and 6.45±0.19 for the ex-vivo test 
with mechanical rubbing and therefore the results of these tests are directly 
comparable.
A comparison of the logio reduction values of S. aureus NCIMB 9518 after 10 s 
exposure to AHRs using the stainless steel carrier test, the ex-vivo carrier test and the 
ex-vivo carrier test with mechanical rubbing is shown in Figure 4.17. Logio 
reductions were higher for the stainless steel carrier test and ex-vivo carrier test with 
rubbing compared to the ex-vivo carrier test for Soft Care Med H5, Cutan and Guest 
Medical AHRs (P <0.05). Logio reductions were higher for the stainless steel carrier 
test compared to the ex-vivo test with rubbing for Soft Care (P <0.05), but higher for 
the ex-vivo test with rubbing compared to the stainless steel carrier test for Cutan (P 
<0.05).
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Figure 4.17: Logio Reduction of Isolate S. aureus NCIMB 9518 after 10 s 
Contact Time for Stainless Steel Carrier, Ex-Vivo Carrier and Ex-Vivo Carrier 
with Mechanical Rubbing Tests
Mean logio reduction ± SD of isolate S. aureus NCIMB 9518 after 10 s contact time 
with Soft Care Med H5, Cutan and Guest Medical AHRs using the stainless steel 
carrier test, the ex-vivo carrier test and the ex-vivo carrier test with mechanical 
rubbing. Mean logio reduction value labels are provided.
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4.4 DISCUSSION
4.4.1 Observation of Hand Sanitizing Practices in ITU
Observations of hand sanitizing procedures in UHW and MH ITUs are summarized 
in Table 4.1. Observing HCWs in UHW ITU had limitations because staff may have 
sanitized or washed their hands before arriving at the patient’s bedside. This was not 
as likely in MH ITU because staff did not move around the ward as much as at 
UHW; there were fewer doctors and no general thoroughfare through the ward. 
Another limitation associated with observing HCWs in UHW ITU was that not all 
healthcare procedures could be observed. This was partly due to obstruction of view 
by the HCW themselves and partly due to HCWs carrying out a large proportion of 
procedures on patients behind curtains. The procedures performed behind closed 
curtains were often invasive and presented a large risk of patient contamination, 
making it crucial that HCWs sanitized their hands or wore fresh gloves for such 
procedures. These procedures could not be observed and since it was unclear 
whether or not HCWs applied the appropriate hand hygiene practice during these 
times the time spent unobserved was not documented. Obstruction of view was not 
much of an issue at MH ITU. Potential object-to-patient and patient-to-object cross­
contamination may therefore be more frequent.
The observed low incidence of use of AHR may have been due to the large 
proportion of staff wearing gloves. It has been documented that poor adherence to 
hand hygiene practices is partly due to the belief that wearing gloves removes the 
need for hand sanitizing (Boyce & Pittet, 2002). However, gloves used in the ITUs 
of UHW and MH were not sterile, meaning that even if no other surface is touched 
by a HCW in between wearing gloves and touching the patient, there is still a 
possibility of introducing microorganisms originating from the gloves onto patients 
and surfaces. There was still a large percentage of staff (particularly from UHW) 
that did not use any sanitization or gloves, although this rarely occurred prior to 
touching patients at UHW and never at MH, only prior to touching objects. A much 
higher percentage of ITU HCWs were found to wear gloves in the study by Girou et 
al. (2002), compared to HCWs in this study (see Table 4.7). Karabay et al. (2005),
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however, found a much lower percentage (29% among HCWs using hand wash and 
41% among HCWs using AHR) of HCWs both from ITU and non-ITU wards using 
gloves, which is similar to results found by this study.
The volume of AHR used was also low. The Hand Decontamination Policy at UHW 
(Hosein, 2004) states that the amount of AHR used should be that specified by the 
manufacturer, which is 2-3 pumps in the case of Soft Care Med H5 AHR (used at 
UHW). The number of pumps required is not stated by the manufacturers of Cutan 
or Guest Medical AHR (used at MH), although Guest Medical AHR states to use a 
thumbnail amount. The actual number of pumps observed at UHW was less than is 
specified for Soft Care Med H5, which may be partly due to the fact that the required 
number of pumps is not written on the Soft Care Med H5 bottle. Kampf (2008) 
studied the difference in efficacy of varying volumes of four different AHRs when 
applied to hands contaminated with Serratia marcescens and rubbed in until hands 
were completely dry. He found that a volume of AHR found to sufficiently cover 
both hands (2.4 ml) was only able to provide logio reductions of 1.90-2.79 whereas a 
volume of 3.6 ml provided significantly higher logio reductions (2.53-3.04). These 
findings indicate that use of smaller volumes of AHR may have a major impact on its 
efficacy.
No minimum time is specified in the Hand Decontamination Policy for UHW staff or 
in the manufacturer’s use instructions for massaging the gel into the hands for Soft 
Care Med H5 or Guest Medical AHRs. However, it states on the Cutan bottle to 
massage AHR into hands for >30 s, which is twice as long as staff at MH took to rub 
AHR into their hands. It states on the Guest Medical bottle that AHR should be 
rubbed into hands until dry, which takes around 25 s of continual massaging until 
hands are completely dry after using one pump. The average length of time observed 
by MH staff was much less than this, although there were on occasions a length of 
time after sanitization before the HCW began a procedure or touched a surface. The 
Hand Decontamination Policy advises that the process is complete when hands are 
completely dry, but does not specify that hands should be continually massaged 
during this time period. A previous study that included observation of AHR contact 
times in ITUs showed similar contact times to this study (Larson et al., 2001),
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whereas another study showed much longer contact times (Girou et al., 2002), as 
shown in Table 4.7.
Table 4.7 also shows that a similar high percentage of ITU staff in this study rubbed 
the AHR into their hands correctly, compared to those in the study by Larson et al.
(2001).
Hand washing was infrequently observed, but this may meet the instructions laid 
down in the hand decontamination policy that if hands are physically clean then 
AHR can be used instead of soap. AHR cannot be used on gloves; therefore object- 
to-object cross-contamination is unavoidable. However, object-to-patient and 
patient-to-object cross-contamination can easily be avoided by a change of gloves 
immediately prior to touching a patient. The Hand Decontamination Policy also 
states that hand decontamination should occur before and after each patient contact, 
which was not observed in some situations.
Hand sanitization in the form of hand washing, especially use of AHR, was lower at 
MH compared to UHW. A similar percentage of staff massaged the AHR into all 
areas of their hands at both hospitals, although staff at MH did this for, on average, a 
slightly longer period of time. However, it must be remembered that these 
percentages were taken from only 5 observations where AHR was used, compared to 
30 at UHW, making a true comparison difficult. A similar percentage of staff wore 
gloves at both hospitals, although a much larger percentage used no form of 
sanitization or protection during procedures at MH. This therefore led to a higher 
percentage of potential staff-to-object and object-to-object cross-contamination at 
MH compared to UHW, although the lower percentage of potential staff to patient, 
object to patient and patient to object cross-contamination observed at MH was likely 
due to staff there touching the patients less than at UHW.
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Table 4.7: Comparison of Hand Sanitizing Observations from this Study and
Previous Studies
A comparison of hand sanitizing observations found in this study and studies by 
Larson et al. (2001) and Girou et al. (2002). N/A = not applicable, UHW = 
University Hospital of Wales, MH = Morriston Hospital
Observation This Study Larson et al. Girou et al.
UHW MH (2001) (2002)
Number of healthcare 54 56 26 114
observations
% activities where gloves 40 34 n/a 85
were worn
Mean AHR contact 11 15 13 30
time (s) (median)
% users applied AHR 75 80 92 N/A
correctly to hands
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The Epic Project guidelines (Pratt et al., 2001) state that ‘hands must be 
decontaminated immediately before each and every episode of direct patient 
contact/care and after any activity or contact that potentially results in hands 
becoming contaminated’. Since infection-causing bacteria are found in the hospital 
environment then touching a surface could, according to the guidelines, result in 
hands becoming contaminated and therefore hands should be decontaminated after 
touching anything. If these guidelines were implemented in UHW and MH ITUs the 
percentage of patient-to-object, object-to-patient and object-object potential cross- 
contamination would be dramatically reduced.
4.4.2 Stainless Steel Carrier Testing
Results of the carrier test plate count and Bioscreen methods for S. aureus NCIMB 
9518 are compared in Figure 4.6. An explanation for why Soft Care Med H5 AHR 
logio reductions using the plate count method were significantly higher than the 
Bioscreen results is not clear. The discrepancy between carrier test Bioscreen and 
plate count logio reductions can be explained by Lambert and van der Ouderaa’s 
(1999) theory that cells are reversibly damaged, but this means that Bioscreen results 
for Guest Medical against the hospital isolates must be interpreted with caution 
because they too are likely to be overestimated. This also means that in addition to 
cells killed during exposure, Guest Medical is sub-lethally damaging a number of 
those surviving; therefore although these may not be able to replicate on the surface 
of HCWs hands, they may still be able to cause infection if they are able to enter the 
body of a patient. The Bioscreen method is a high-throughput method and therefore 
extremely beneficial for the testing of a large number of samples. It is necessary, 
however, to validate the method using the plate count method to pre-determine 
whether the biocide in question is capable of causing reversible damage.
Plate count and Bioscreen results for isolate 44 and SI are compared in Figures 4.12 
and 4.13. Isolate 44 (the most-susceptible isolate) and SI (the least-susceptible 
isolate) were also found to be reversibly damaged by Guest Medical AHR and this is 
most likely the case for all isolates.
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The results of carrier testing of isolates using the Bioscreen method are summarized 
in Table 4.3. Bioscreen data for screening of isolates were not adjusted to 
compensate for the limit of detection because test samples where there was 0 CFU in 
5 wells may have actually contained 0 CFU/ml. Compensating for limit of detection 
for Bioscreen results seriously affected the results, where a 4 logio control, and 
therefore a bactericidal effect, was not always achieved. The contact times taken to 
achieve a bactericidal effect shown in Table 4.3 are therefore not adjusted to 
compensate for the limit of detection.
Differences in efficacy observed between the AHRs are apparent in Table 4.3 and are 
further highlighted in Figures 4.10 and 4.11. True Guest Medical logio reductions 
are those provided by the plate count methods and are shown in Figures 4.3, 4.12 and 
4.13 for isolates S. aureus NCIMB 9518, 44 and SI, respectively. The differences in 
efficacy observed between Soft Care Med H5, Cutan and Guest Medical AHRs 
observed may be partially due to the type of alcohol used in the products. Propyl 
alcohol is the most efficacious, followed by isopropyl alcohol and finally ethanol 
(Rotter, 2001) and this has also been demonstrated to be the case on pig skin (Bush et 
al., 1986). This explains why Soft Care Med H5 (a combination of propyl and 
isopropyl alcohols) was more efficacious than Cutan (a combination of ethanol and 
propyl alcohol) and why Guest Medical (consisting of ethanol) was the least 
efficacious when considering the true bactericidal effects achieved by the plate count 
carrier test. The reduced efficacy observed for Guest Medical may also be partially 
due to the lower concentration of alcohol in Guest Medical compared to Soft Care 
Med H5 and Cutan. This is because although alcohol was present at 70% for all the 
AHRs, Guest Medical AHR was 70% v/v, which is equivalent to only 62.6% w/w 
(Ali et al., 2001). Since alcohol has a high concentration exponent, this slightly 
lower concentration may have a large impact on efficacy. The difference in efficacy 
of the AHRs may also be explained by differences in the concentration exponent of 
their alcoholic constituents. Concentration exponents of aliphatic alcohols (which, 
among others, include propanol, isopropanol and ethanol) range between 6.0 and 
12.7 (Denyer et al., 1987), therefore even at the same concentration they may have 
different efficacies. The fact that Cutan AHR performed less well than Soft Care 
Med H5 could also be explained by the very high viscosity of Cutan, which may
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reduce its antimicrobial activity due to its restricted ability to access indentations on 
a surface and its potentially reduced access to the surface.
Variability was observed between the isolates and this is shown in Table 4.3 and also 
highlighted in Figures 4.7-4.9. It is unclear yet why AHRs would show variability in 
efficacy between hospital isolates and why some AHRs resulted in more variability 
than others. It is likely to be due to some isolates possessing some factor that enables 
them to endure longer periods of exposure to AHRs without being killed, or in the 
case of Guest Medical AHR without being irreversibly damaged. Isolate 44 is most 
susceptible and isolate SI is least susceptible to the AHRs. These organisms must 
therefore possess some differences in genotype or phenotype that result in the AHRs 
exerting a bactericidal effect in such different time frames. This will be investigated 
further.
Carrier test results in Table 4.3 show that Soft Care Med H5 AHR met the criteria of 
EN13697 (European Standard EN13697, 2001; >4 log reduction within 5 min) for all 
isolates, whereas Cutan and Guest Medical AHRs met the criteria for all but one 
isolate. However, the contact time EN13697 allows to reach a > 4 log reduction is 
not achieved in practice, due to the rapid evaporation time of the AHR. The criteria 
should therefore be met within the in-use time (11-15 s, Table 4.1) in order to 
achieve this reduction in practice.
Carrier test results obtained for the hospital isolates plus reference isolate shown in 
Table 4.3 do not reflect those obtained by Kampf and Hollingsworth (2008). They 
tested S', aureus NCIMB 9518, plus a vancomycin-intermediate and a methicillin- 
resistant S. aureus hospital strain against an 85% w/w ethanol AHR using a 
suspension test for a contact time of 15 s. They found that all three S. aureus strains 
showed a >5 logio reduction (bactericidal). However, since bacteria are easier to kill 
in a suspension than when dried on a surface these results cannot be directly 
compared and these logio reductions are therefore unlikely to occur on the hands of 
healthcare workers after 15 s. They also did not add organic material and therefore 
the conditions did not reflect those found on a HCWs hand and may have led to a 
higher logio reduction than would have been found under dirty conditions. Finally
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the AHR used was at a much higher concentration than those used in practice against 
the isolates in this study.
4.43 Ex- Vivo Carrier Testing
Ex-vivo carrier testing was carried out using thawed skin samples. Ears were frozen, 
then thawed to excise skin and re-frozen until the day of use. Ears were frozen upon 
arrival due to the sporadic and unpredictable supply of skin, making it impossible to 
excise and use fresh skin on the same day. Skin was re-frozen after excision, rather 
than used on the day of excision due to the fact that excision of skin took a long 
period of time and that some samples would have been wasted. A study by Messager 
et al. (2003) found that fresh and freshly-thawed excised human skin was 
morphologically similar, with no apparent damage except that some parts of the 
stratum comeum of the freshly-thawed skin showed slight fragmentation. Messager 
and colleagues (2003) also found significant levels of lactate dehydrogenase, a 
marker for skin viability, in both fresh and freshly-thawed skin, although levels in 
thawed skin were higher. They found that freshly-thawed skin contained a lower 
concentration of oxygen, a marker for metabolic activity, than fresh skin samples, 
although there was no significant difference in their pH. Most importantly, Messager
(2002) found there was no significant difference in the antibacterial activity of a 
range of antiseptics to S. aureus applied on either fresh or freshly-thawed skin.
Results of ex-vivo carrier testing are shown in Figures 4.14-4.16 and summarised in 
Table 4.4. The reason Cutan was the most efficacious AHR using the ex-vivo test 
and not Soft Care Med H5 is unclear, since Soft Care Med H5 was the most 
efficacious AHR using the stainless steel carrier test and the combination of alcohols 
it contains are the most effective. The most likely explanation is due to the high 
viscosity of Cutan AHR when compared to Soft Care and Guest Medical, which is 
likely to have reduced the evaporation time of the alcohol and since the ex-vivo 
carrier test involved long contact times, differences in evaporation rate of alcohol 
between AHRs is likely to have a large effect on bactericidal contact times. The 
reason isolate SI was more susceptible to Cutan is also not clear, since Table 4.3
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demonstrates that isolate SI was as susceptible to Cutan as isolate NCIMB 9518 
during stainless steel carrier testing.
Comparison of stainless steel carrier testing results in Table 4.3 and ex-vivo carrier 
testing in Table 4.4 also revealed that a much longer contact time was required to 
achieve a bactericidal effect using the ex-vivo carrier test compared to the stainless 
steel carrier test for isolates 44, NCIMB 9518 and SI. This is likely to be a 
combination of the fact that bacteria are able to ‘hide’ in crevices in the skin, where 
they would not be as exposed to the AHR, and the fact that skin acts as a partitioning 
phase so that some alcohol is lost into the skin layers. Biochemical properties of the 
skin may also affect the AHR or bacteria in some way. This theory is supported by 
the observation that the ex-vivo carrier test with rubbing was more effective than the 
ex-vivo carrier test without rubbing, since rubbing facilitates penetration of AHR into 
the crevices. Variation between AHRs and isolates found in Table 4.3 are not 
reflected in carrier test ex-vivo results in Figures 4.14-4.16. The reason there were 
not larger differences in variation could be due to the long time required to achieve a 
bactericidal effect using the ex-vivo test, making differences in the efficacy of AHRs 
and susceptibility to isolates less pronounced.
Results of the ex-vivo residual activity test are shown in Table 4.6. HCWs took 
between on average 11-15 s to rub AHR into their hands and during the residual 
activity test 15 sec of rubbing caused all AHR to be absorbed by the pig skin, with no 
residual effect observed. This indicates that the logio reduction values obtained for 
stainless steel (Table 4.3) and ex-vivo testing (Figures 4.14-4.16) by contact times 
longer than 10 s are unlikely to be achieved in practice. Wade & Casewell (1991) 
also found that alcohol, in the form of 60% v/v isopropanol, had no residual activity 
against species of Enterobacter in-vivo. Similarly, Lowbury et al. (1974) found 70% 
v/v ethanol had no residual activity against skin inoculated with S. aureus in-vivo, 
although they found that wearing gloves for 3 h after application of the alcohol 
resulted in a further reduction in bacterial numbers. Lilly et al. (1979), however, 
were able to demonstrate the residual activity of 70% w/v ethanol after 3 h against S. 
aureus in-vitro, although the additional decrease in bacterial numbers observed 
during the 3 h period may have been attributed to the temperature at which the dried
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suspensions were held. The alcohol used in these studies, however, was not in gel 
form.
4.4.4 Comparison of the Efficacy of AHRs Using Stainless Steel and Ex-Vivo 
Carrier Tests and the Ex-Vivo Test with Mechanical Rubbing
Results of the ex-vivo carrier test for S. aureus NCIMB 9518 at a 10 s contact time 
are shown in Figure 4.17. The fact that no difference was observed between logio 
reduction values after 10 s using Soft Care Med H5, Cutan and Guest Medical 
supports similar findings in Figure 4.15 for longer contact times.
The ex-vivo carrier test method showed the best recovery rate of cells (data shown in 
section 4.3.3.1). Recovery of cells from the ex-vivo carrier test with mechanical 
rubbing was very low in comparison (data shown in section 4.3.3.2) and this 
difference is most likely to be due to the bacteria being more deeply embedded in the 
skin crevices and therefore harder to recover with flushing.
The stainless steel carrier test also showed less recovery than the ex-vivo carrier test 
(data shown in section 4.3.2.2), although the recovery rate was much higher than 
achieved for the ex-vivo carrier test with mechanical rubbing. The reason for this is 
likely due to the drying step of the bacteria onto the stainless steel disk, which was 
achieved by incubation of the bacteria at 37°C, compared to air-drying at room 
temperature for the ex-vivo carrier test. It may also be due to the increased length of 
time of the drying process for the stainless steel disks, which was approximately 1 
hour, compared to approximately 20 min for the ex-vivo carrier test. Reduced 
recovery cannot be explained by the action of the glass beads killing some cells 
during the recovery step because recovery of NCIMB 9518 from stainless steel disks 
was performed using the flushing technique (in section 4.2.2.2) and similar recovery 
rates were achieved as those using glass beads (46.25±20.10 for carrier testing with 
flushing, compared to 52.83±13.91 for carrier test with glass beads).
Messager et al. (2004) found that mechanical rubbing resulted in a logio reduction of 
between 0.73 and 2.49 higher than without rubbing for the ex-vivo test. Although 
they used a slightly different contact time and different antiseptics, their results were
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comparable to those figures obtained by comparison of logio reduction values of ex- 
vivo carrier testing and ex-vivo testing with mechanical rubbing from Figure 4.17, 
which were of between 0.95 and 1.18 logio reduction higher. The reason the AHRs 
were more efficacious in the presence of mechanical rubbing is most likely due to the 
mechanical action, which caused cells to be removed from the surface of the skin 
into the AHR as a suspension, making them easier to kill. Some cells may also have 
been removed from skin crevices and therefore become more exposed to AHR. 
However, the reason a larger difference was not seen in logio reduction with 
mechanical rubbing compared to no mechanical rubbing is likely due to the 
mechanical action causing some bacteria to be forced into the crevices and therefore 
not exposed to the AHR, plus also the fact that the contact time allowed only a 
maximum of 10 s for the re-suspended bacteria to be killed and since there was only 
a small volume of AHR, the increased efficacy of the AHRs due to being in a 
suspension would not be as great.
4.4.5 Summary
HCWs in two local ITUs were found to apply AHR for a contact time of between 11 
and 15 s. Stainless steel carrier testing of clinical isolates of S. aureus from these 
ITUs was performed and revealed that by a contact time of 10 s Soft Care Med H5 
and Guest Medical AHRs were only able to achieve a bactericidal effect on 1 isolate 
and Cutan was unable to achieve a bactericidal effect on any isolates. None of the 
AHRs were able to achieve a mean logio reduction of >4 against the sixty isolates as 
a whole after 10 s; only Soft Care Med H5 was able to after a contact time of 30 s.
Comparison of plate count and Bioscreen methods of enumeration of the stainless 
steel carrier test revealed that Guest Medical logio reductions are overestimated for 
the Bioscreen method due to sub-lethal damage to the isolates. This means firstly 
that bacterial cells which have not been killed upon exposure to Guest Medical may 
be damaged, but they may still be able to cause infection if they enter a patient’s 
body, and secondly that Bioscreen logio reductions may not be true logio reductions. 
Bioscreen logio reductions for the most- and least-susceptible isolates were 
confirmed to be overestimated by comparison with the plate count method of
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enumeration, which found Soft Care to be the most-efficacious, followed by Cutan, 
then finally Guest Medical. Differences in efficacy between the AHRs are likely to 
be due to differences in formulation. It is recommended that if the Bioscreen is used 
to enumerate efficacy testing it should first be compared with the plate count method 
to determine whether the biocide being tested causes sub-lethal damage. If this is the 
case it may be beneficial to perform the plate count method alongside the Bioscreen 
so that accurate bactericidal data are obtained from the plate count results, while sub- 
lethal damage data can be collected from the Bioscreen.
Ex-vivo testing revealed that a bactericidal effect took much longer to be achieved on 
a skin surface than a stainless steel surface, with bactericidal times of between 10 and 
>20 min seen among the AHRs. A larger bactericidal effect was seen for the AHRs 
when mechanical rubbing was used. The AHRs were found to have no residual 
activity and therefore data from this section indicates that application of AHR by an 
ITU HCW is unlikely to result in a bactericidal effect. It is therefore likely that 
although hand sanitizers meet the criteria of standard methods such as the hygienic 
hand disinfection test EN1500 and suspension test EN1276, these performances may 
not be indicative of their efficacy in practice.
Since this study showed that AHRs are unable to achieve a bactericidal effect under 
conditions found in practice it is important to either increase the efficacy of the AHR 
or to change the conditions in which the AHR is used in practice. Firstly, the type of 
alcohol could be changed to a more efficacious combination. The concentration of 
alcohol could also be increased to find the optimal ratio with water. The most 
important change to the conditions in practice is by the application of a larger 
volume of AHR (as found by Kampf, 2008) and also by increasing the contact time 
on the hands of HCWs. Increasing the volume of AHR used will most likely 
increase the time taken by HCWs to rub it into their hands, since they are unlikely to 
leave their hands sticky.
HCWs did not always apply hand hygiene prior to, and during healthcare procedures, 
which could potentially result in cross-contamination between the HCW, the patient 
and the immediate surroundings. Hand washing and/or use of AHR is sufficient for
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activities not involving the patient and re-application of AHR is not necessary in 
between touching different objects, so the observed object-to-object potential cross­
contamination is unavoidable. However, patient-to-object and object-to-patient 
potential cross contamination can be easily avoided by application/removal of gloves 
immediately prior/post touching the patient. Staff-to-patient and staff-to-object 
cross-contamination can also be easily avoided by ensuring that hand washing or 
AHR application is performed at regular intervals and immediately after staff touch 
their hair, forearms or clothing.
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CHAPTER 5 THE EFFECT OF ALCOHOL HAND RUB 
ON STAPHYLOCOCCUS AUREUS
5.1 INTRODUCTION
5.1.1 The Cytoplasmic Membrane as a Target for Alcohol Hand Rub
The bacterial cytoplasmic membrane is a very important structure composed of lipid 
and protein and its integrity can therefore be compromised by any agent that is 
known to react with these components. The cytoplasmic membrane is also very 
accessible, since the only barrier between the cytoplasmic membrane and the 
environment is the cell wall and outer layers such as the capsule and slime layer. 
This makes it relatively easy for biocides to gain access to the membrane and is 
therefore a common site of action of biocides (Denyer & Stewart, 1998). Alcohol 
has a direct effect on the lipids and enzymes of the cytoplasmic membrane and 
indirectly impairs membrane biosynthesis (Denyer & Stewart, 1998; Kalathenos & 
Russell, 2003). The components and functions of the cytoplasmic membrane that are 
targets for disruption/damage by alcohol are summarised in Table 5.1.
Damage to the cytoplasmic membrane includes changes in permeability, leakage of 
intracellular material, osmotic lysis and inhibition of metabolic activity associated 
with the membrane (Denyer & Hugo, 1991). When a membrane is damaged rapid 
release of potassium ions (K+) occurs first and is therefore a marker for membrane 
damage. Release of larger cell constituents follows, including purines, pyrimidines, 
pentoses, inorganic phosphates and amino acids (Denyer & Hugo, 1991), which is 
initially rapid, followed by a slower, gradual release that is thought to be the result of 
autolysis. Autolysis is brought about when damage to the membrane causes 
disruption of intracellular homeostasis and involves activation of latent ribonucleases 
that break down RNA and cause leakage of nucleotides and nucleosides (Lambert & 
Smith, 1976; Denyer & Hugo, 1991; Denyer & Stewart, 1998). Autolytic enzymes 
such as murein hydrolase may also be activated, which damage the cell wall and 
eventually lead to cell death (Rice & Bayles, 2003).
129
Table 5.1: Components and Functions of the Bacterial Cytoplasmic Membrane That May Be Targeted by Alcohol
Description of the main components of the bacterial cytoplasmic membrane damaged by alcohols and the main functions of the bacterial 
cytoplasmic membrane that alcohols are able to disrupt. References: (Stanier et al., 1986; Kalathenos & Russell, 2003; Winn et al., 2005).
Component Function
Phospholipid Structural
Permease Active transport of nutrients and essential ions into the cell
Biosynthetic enzymes Mediate synthesis of membrane lipids and cell wall constituents such as peptidoglycan, teichoic acid,
polysaccharide and lipopolysaccharide
Electron transport enzymes Form the electron transport chain, which carries out redox reactions that release energy in the form of ATP as
part of oxidative phosphorylation
Membrane potential Creates energy
Barrier structure Retains useful compounds such as metabolites and excludes harmful external compounds
Membrane damage can be detected by a number of assays. These are mainly assays 
that can detect leakage of intracellular materials including K+, 260 nm-absorbing 
materials (purines and pyrimidines), pentose, inorganic phosphate, amino acids, 
proteins and the enzyme p-galactosidase (Denyer & Hugo, 1991; O’Neill et al.,
2004). Membrane damage can also be detected by loss of membrane 
impermeability. This can be demonstrated by a change in ion gradients across the 
membrane, lysis of protoplasts as a result of influx of previously impermeable ions 
and water, loss of salt tolerance, penetration of dye into the cytoplasm as measured 
by fluorescence spectrophotometry (for example using the BacLight assay; O’Neill 
et al., 2004) and lysis of whole bacterial cells in a hypotonic solution as a 
measurement of severe membrane damage (Denyer & Hugo, 1991). Structural 
damage to the cytoplasmic membrane can also be detected by electron microscopy 
(Kim et al., 2007), although this is a qualitative rather than quantitative approach.
The effect of membrane-active biocides on the leakage of K+ ions has been 
previously studied by a number of researchers, using flame photometry with an 
atomic absorption spectrophotometer (Heipieper et al., 1991; Codling et al., 2003; 
Walsh et al., 2003), inductively coupled plasma spectrometry (Johnston et al., 2003) 
and a K+ selective electrode (Inoue et al., 2004).
5.1.2 The Cell Wall as a Target for AHRs or Barrier to Prevent Their 
Penetration
In Chapter 4 the time taken for AHRs to have a bactericidal effect on S. aureus cells 
was determined. Since protoplasts are bacterial cells without a cell wall, comparison 
of the rate of lysis of bacterial cells and protoplast cells will determine whether the 
cell wall is the primary target of AHR (Xiong et al., 2005). It will also determine 
whether the cell wall and/or outer layers act as a barrier to AHR penetration. If the 
rate of protoplast lysis is the same, or similar, as the bactericidal rate found in 
Chapter 4 then the membrane is the primary target. If lysis of protoplasts is much 
slower than lysis of bacterial cells, or non-existent, the membrane is not the primary 
target, but the cell wall or outer layers, since they are the components that are 
missing from protoplasts (Xiong et al., 2005). However, if lysis of protoplasts is
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much quicker than lysis of bacterial cells, then the cell wall or outer layers must act 
as a barrier to prevent penetration of AHR.
Lysis of protoplasts by biocides has been measured quantitatively by a decrease in 
OD4 20 (Koo et al., 1997) and culturing on agar containing 20% sucrose (Xiong et al.,
2005). Lysis can also be quantified using phase contrast microscopy.
5 .U  The Effect of AHR on Cel! Structural Appearance
Transmission electron microscopy (TEM) enables the physical appearance of the 
intracellular structure of bacterial cells to be observed (Holt & Beveridge, 1982). 
TEM results can provide physical evidence of cellular damage, such as cell wall and 
membrane damage (deQueiroz & Day, 2007). Intracellular damage, or lack thereof, 
seen during TEM studies may therefore provide suggestions as to the mode of 
activity of a biocide and point to an area for further study. TEM may also be able to 
show the variation in the extent and nature of bacterial cell damage resulting from 
differences in AHR susceptibility among isolates by comparison of their intracellular 
damage at a range of contact times.
Alcohol is known to damage proteins and lipids and cause cell lysis (McDonnell & 
Russell, 1999; Ali et al., 2001). Alcohol is therefore likely to cause damage to the 
cytoplasmic membrane, cell wall, cytoplasm and capsule. Alcohol is known to be 
active against the cytoplasmic membrane (Franklin & Snow, 1989); therefore 
cytoplasmic membrane damage should be observed.
The effect of alcohol on the structural appearance of bacterial cells has not 
previously been studied, although the effect of a range of other biocides has been 
well studied (Kim et al., 2007; Huang et al., 2008; Oule et al., 2008). Structural 
damage to S. aureus cells after exposure to antibiotics has been demonstrated using 
TEM (Thomas et al., 1999).
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5.1.4 The Effect of AHR Protein Denaturation
Alcohol is known for its ability to denature proteins (McDonnell & Russell, 1999). 
Protein denaturation is the loss of a protein’s function as a result of structural damage 
and can be irreversible. Denaturation affects the weak bonds that determine the 3-D 
structure of the protein (the secondary and tertiary structures), which include 
hydrogen bonds, salt bridges, disulfide bonds and hydrophobic interactions (Tanford, 
1968). Peptide bonds are much stronger and denaturation reactions are therefore 
unable to break them, resulting in the protein’s primary structure remaining intact. 
Alcohol denatures proteins by breaking side chain intramolecular hydrogen bonds, 
which are involved in maintaining the tertiary structure of proteins. Hydrogen bonds 
are then formed between the new alcohol molecule and the protein side chains 
(Ophardt, 2003), as shown in Figure 5.1.
The carboxyl and amino groups of proteins have different charges, which mean that 
proteins containing different groups will have different net surface charges (Xia, 
2007). The charge of these groups is pH-dependent and they will therefore have 
different charges at different pH values. Protein solubility is dependent on net 
surface charge because proteins with a net positive or negative surface charge are 
more likely to interact with water than other proteins, making them soluble 
(Rabilloud, 2002). However, at a pH where the net charge is zero (known as the 
isoelectic point, or pi) proteins are more likely to interact with other proteins and 
therefore are at their most insoluble, due to the potential of aggregation. The pi of 
proteins is between pH 3 and pH 12, but for most proteins it is between 4 and 7 
(Eidhammer et al., 2008).
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Figure 5.1: Protein Denaturation by Alcohol
Shows disruption of the tertiary structure of proteins by alcohol and the subsequent 
formation of a new alcohol molecule with the protein side chains. Taken from 
Ophardt (2003).
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Denaturation results in the inner hydrophobic core of the protein being exposed to 
the hydrophilic environment, which often results in protein aggregating and 
becoming insoluble (Vojdani, 1996); therefore at the pi a protein in denatured form 
will be less soluble than in its native form. Protein denaturation can therefore be 
measured by filtering the solution to remove the aggregated denatured protein and 
measuring the change in total protein content (Suzuki & Suzuki, 1962) or measuring 
the change in OD2 8 0 . These methods would not be appropriate for this study for two 
reasons. Firstly, changes in OD2 8 0 could not be determined without washing the 
bacteria in water to remove AHR, since AHR has a high OD2 8 0 , meaning that if 
denaturation is not permanent then the protein may become soluble once again. 
Secondly, since this study is looking at total cell protein, treatment with AHR would 
be required on whole cells and after AHR exposure the cell would have to be broken 
up by sonication, which would break up the protein and it could not be quantified.
Protein denaturation has been previously measured indirectly by comparing the 
nitrogen content of denatured protein and native protein (Krueger & Nichols, 1935; 
Hendrix & Dennis, 1938). Nitrogen content is slightly lower among denatured 
protein, compared to native protein, which is due to the loss of nitrogen-rich 
compounds and the addition of water during denaturation (Hendrix & Dennis, 1938). 
Hendrix & Dennis performed this test on individual protein species and the 
denatured and native protein was separated by precipitation of denatured protein at 
the isoelectric point. This test would not be appropriate for the purposes of this 
study, since the aim was to determine the quantity of total cellular protein that is 
denatured after bacterial cells are exposed to AHR. Bacterial proteins are composed 
of a number of different species, which would not all have the same isoelectric point 
and therefore not all denatured protein would be precipitated.
5.1.5 The Effect of AHR on Expression of Virulence Genes
The presence/absence of virulence genes determined in Chapter 3 is not a true 
indication of the virulence genes used by the isolates under normal growth conditions 
or upon exposure to AHR, since few genes are consistently expressed and most are 
only switched on when required (Brown, 2006).
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Expression of specific genes can be determined by quantification of RNA, since 
RNA is transcribed from DNA as part of the process of generating the gene product. 
RT-PCR involves reverse-transcribing cellular RNA into DNA using reverse 
transcriptase, followed by amplification of the DNA product using PCR (Brown,
2006). It can be used to measure gene expression comparatively, where the 
concentration of DNA can be given as a ratio of that of a co-amplified internal 
consistently expressed housekeeping gene. Quantitative real-time PCR (qPCR) 
involves quantification of DNA product after each amplification cycle, using 
fluorescent dyes or probes and comparing results to those of known concentrations of 
DNA (VanGuilder et al., 2008). Expression of genes can also be performed using 
microarrays, which detect up- or down-regulation of all genes within the genome 
(Schena et al., 1995).
Alcohol has previously been shown to alter expression of bacterial genes. The 
bacterium Acinetobacter baumannii is able to metabolise low concentrations of 
ethanol and the presence of <1% AHR has been found to stimulate the secretion of 
extracellular protein that is possibly involved in increased pathogenicity (Edwards et 
al., 2007). The presence of low concentrations of ethanol, isopropanol and n- 
propanol (<6%) was found to increase production of biofilm in a number of clinical 
isolates of Staphylococcus epidermidis (Knobloch et al., 2002).
5.1.6 Aims and Objectives
The aim of this chapter was to determine the effect of AHR on S. aureus by 
investigating the effect of AHR on the cytoplasmic membrane, the cell wall, cell 
structural appearance, proteins and gene expression.
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5.1.7 Hypotheses
5./. 7.1 The Cell Wall as a Target for AHR or Barrier to Prevent Its Penetration
In Chapter 4 it was determined that isolate 44 was the most susceptible and isolate SI 
was the least susceptible to AHRs. A likely explanation as to why these isolates 
have varying susceptibilities is that there are differences in the composition and 
structure of the cell wall or outer layers between the isolates, which differentially 
slow the penetration of AHR into the cell. It can be determined whether the variation 
in susceptibility of these isolates is due to differences in cell wall or outer layer 
penetration by subjecting isolate 44 and SI protoplasts to AHR. If they are lysed as 
rapidly as each other there must be differences in the cell wall or outer layer of these 
isolates that caused the variation in susceptibility observed in Chapter 4. However, if 
they are lysed in the same order as they were found to be killed in Chapter 4 it may 
be that there must be differences in the cytoplasmic membrane or intracellular 
contents.
5.1.7.2 The Effect of AHR on Expression of Virulence Genes
One hypothesis is that some or all of the virulence genes are up-regulated (more 
greatly expressed) upon exposure to AHR, meaning that any bacterial cells that 
survive on the surface of HCWs hands may be more virulent. Another hypothesis is 
that some or all of the virulence genes will be down-regulated (less expressed) upon 
exposure to AHR due to the bacteria requiring up-regulation of genes to repair 
cellular damage.
5.2 MATERIALS AND METHODS
5.2.1 Determining the Effect of AHR on Leakage of Potassium Ions
The method used was based on that used by Walsh et al. (2003) and was performed 
in triplicate for S. aureus isolates 44, NCIMB 9518 and SI with Soft Care Med H5, 
Cutan and Guest Medical AHRs. The isolates were streaked onto 3 TSA plates and 
incubated at 37 °C for 18-24 h. Cells were harvested with a sterile cotton swab into 5
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ml ultra-high purity (UHP) water and centrifuged at 2,600 g  for 15 min. Cells were 
washed twice in UHP water and re-suspended in UHP water to a concentration of 
9.90 ± 0.26 logio CFU/ml according to section 2.5.3.
Positive controls were performed to determine the total K+ within the cells, where 3 
ml of the bacterial suspension was transferred to a fresh vessel and placed in a water 
bath for 20 min at 80 °C to allow complete breakdown of the bacterial cells. The 
sample was diluted 1 in 10 in UHP water and passed through a 0.2 pm syringe filter 
into a plastic universal.
For the test samples 10 ml of the bacterial suspension was transferred to a fresh 
vessel and centrifuged at 2,600 g for 15 min. The supernatant was discarded and the 
pellet was re-suspended in 10 ml AHR. After time points of 10s, 30s, 1 min, 2 min, 
5 min and 10 min 1 ml of suspension was transferred to 9 ml UHP water and passed 
through a 0.45 pm syringe filter, followed by a 0.2 pm syringe filter into a plastic 
universal. When this procedure was performed for Cutan AHR the suspension was 
transferred to 9 ml UHP water containing 3% w/v NaCl to reduce the viscosity of the 
AHR sufficiently to enable passage through the filters.
Negative controls were performed to determine the leakage of K+ from cells under 
the testing conditions. This was performed according to the method for the test 
samples, except the pellet was re-suspended in UHP water instead of AHR.
The K+ content of each AHR was also determined. A 1 ml volume of each AHR was 
added to 9 ml UHP water (UHP water containing 3 % w/v NaCl for Cutan AHR) and 
passed through a 0.45 syringe filter followed by a 0.2 pm syringe filter into a plastic 
universal.
The K+ content of each sample was determined by a technician using an atomic 
absorption spectrophotometer (Instrumentation Laboratory, Barcelona, Spain). All 
K+ samples were provided in ppm and the mean K+ value in each AHR plus in the 
positive control were combined to give the maximum (100%) K+ possible in the
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sample. K+ leakage was calculated as a percentage of the maximum K+ for the test 
and negative control samples.
5.2.2 Determining the Role of the Cell Wall as a Barrier to AHR Penetration
5.2.2.1 Materials
Hypertonic buffer consisted of 20% w/v sucrose, 0.05 M Tris-HCl and 0.15 M NaCl, 
pH 7.6. This was prepared in deionised water and filter sterilized when needed. 
Lysostaphin was prepared as a 1 mg/ml stock in hypertonic buffer and stored at -20 
°C until needed. DNase I was prepared as a 0.5 mg/ml stock in hypertonic buffer and 
stored at -20 °C until needed.
5.2.2.2 Generation of Protoplasts
This method was based on that by Xiong et al. (2005) and was performed for S. 
aureus 44, NCIMB 9518 and SI. Cultures were prepared according to section 2.4.3. 
The cells were washed from the surface with PBS and pooled together for 
centrifugation at 2,600 g for 15 min. The pellet was re-suspended in hypertonic 
buffer. A 340 pi volume of lysostaphin stock (final concentration of 68 pg/ml) and 
320 pi of DNase I stock (final concentration of 32 pg/ml) was added to the 
suspension, which was incubated at 37 °C for approximately 4.5 h to allow digestion 
of the cell wall. Protoplasts were collected by centrifugation at 6,000 g for 15 min 
and re-suspended in fresh digestion buffer. A 10 pi volume was observed under a 
light microscope at 100 x magnification to confirm the presence of undamaged 
protoplasts.
5.2.2.3 Determining the Rapidity of Protoplast damage by AHR
A qualitative test was performed with isolate NCIMB 9518 and Soft Care, Cutan and 
Guest Medical AHRs to determine the effect of AHR over time. This preliminary 
test was necessary to determine after which contact time to perform quantitative 
analysis. A 10 pi volume of protoplast suspension prepared according to 5.2.2.2 was 
added to 990 pi of neat AHR. After gentle mixing with a pipette a 10 pi volume was 
observed under an Olympus BX50 light microscope (Olympus, Southend-on-Sea,
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UK) at 100 x magnification. The entire slide was observed to determine the density 
of protoplast cells and their integrity, plus presence of debris, for a total of 20 min. 
This was also performed with a positive control and water control, where 10 pi of 
protoplast suspension was added to 990 pi of hypertonic buffer and SDW, 
respectively.
5.2.2.4 Determining the Effect o f  AHRs on Protoplasts
This method was performed with isolate NCIMB 9518 and Soft Care, Cutan and 
Guest Medical AHRs to determine whether there is any difference between the effect 
of each AHR on S. aureus protoplasts. Protoplast suspensions prepared according to
5.2.2.2 were adjusted to a concentration so that a 1 in 100 dilution resulted in 
between approximately 10 and 30 protoplasts per field of vision under a light 
microscope at 100 x magnification. A 10 pi volume of protoplast suspension was 
added to 990 pi of either AHR or neat digestion buffer (control). After 20 min a 10 
pi volume was observed under a microscope at 100 x magnification and the number 
of protoplasts in 10 fields of vision was counted. A water control was also 
performed, where 10 pi of protoplast suspension was added to 990 pi of SDW, to 
show the effect of a hypotonic solution on protoplasts. Each test was performed in 
triplicate. Statistical analysis was performed according to 2.8.1 to determine whether 
there was a significant difference between the total number of protoplasts in 10 fields 
of vision in the control solution and the AHR and water solutions.
5.2.2.5 Determining the susceptibility o f  5. aureus Protoplasts to AHR
This method was performed according to 5.2.2.4 with isolates 44 and SI, using Guest 
Medical AHR only, to determine whether the protoplasts of S. aureus isolates shown 
to be more susceptible to the bactericidal effects of AHR are also more susceptible to 
AHR. Statistical analysis was performed according to 2.8.1 to determine whether 
there was a significant difference between the total number of protoplasts in 10 fields 
of vision in the control solution and the AHR for each isolate.
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5.2.3 Determining the Effect of AHR on Bacterial Cell Structural Appearance
5.23.1 Materials
All TEM chemicals were prepared with double distilled water. Glutaraldehyde, 
araldite, dodecyl succinic anhydride and /7-benzyldimethylamine (BDMA) were 
purchased from Agar Scientific Ltd (Stansted, UK). Solutions of 1% osmium 
tetroxide and 2% glutaraldehyde were prepared in 0.1 M Sorensen buffer. Sorensen 
buffer consisted of 0.2 M monobasic sodium phosphate and 0.2 M dibasic sodium 
phosphate.
5.23.2 Exposure of Isolates to AHR
This procedure was performed for Guest Medical AHR only. Bacterial suspensions 
of S. aureus isolates 44, NCIMB 9518 and SI were prepared to concentrations of 
8.32, 8.32 and 8.31 logioCFU/ml, respectively, according to section 2.5.1. Four 5 ml 
volumes of each suspension were transferred to separate centrifuge tubes and 
centrifuged at 2,600 g  for 15 min. For pre-exposure testing a pellet was re­
suspended in 9 ml TSC buffer. For post-exposure testing three pellets were re­
suspended in 1 ml Guest Medical AHR for either 10 s, 1 min or 5 min. After the 
appropriate contact time 9 ml TSC buffer was added to the post-exposure tubes and 
left for 5 min neutralization time. All suspensions were washed in TSC buffer, re- 
suspended in 750 pi TSC buffer and transferred to a microcentrifuge tube.
5.23.3 Preparation o f Sample
Suspensions prepared according to 5.2.3.2 were washed in 2% glutaraldehyde and 
left for 1 h in 2% glutaraldehyde to fix. The samples were washed twice in 0.1 M 
Sorensen buffer and left for 1 h in 1% osmium tetroxide. The pellets were washed 
three times in Sorensen buffer and the pellet was embedded in 6% agar. The pellets 
were left for 10 min in progressively increasing concentrations of ethanol to 
dehydrate the agar for 10 min. The ethanol concentrations used were 50%, 70%, 
80%, 90% and 4 steps at 100%. The pellet was then washed in propylene oxide for 
10 min and left in resin (15 g araldite CY212, 15 g Dodecyl succinic anhydride and 
0.45 g BDMA) overnight at room temperature on a rotating platform. Pellets were 
removed from the resin, transferred to plastic moulds containing fresh resin and
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incubated for 48 h at 60 °C to solidify. Sections were cut from three separate areas 
of each sample using a Reichert-Jung Ultracut microtome (Wien, Austria) and placed 
onto separate copper grids. Samples were stained with 2% uranyl acetate for 10 min 
and Reynolds lead citrate for 5 min, rinsing twice in double distilled water after each 
step.
5.2.3.4 Analysis of Samples Using Transmission Electron Microscopy
Samples were analysed using an EM 280 transmission electron microscope (Philips, 
Croydon, UK) at 10,000, 40,000, 50,000 and 63,000 x magnification. At least 10 
random fields of vision were observed for each of the three grids for each sample and 
representative images were taken at 10,000 x magnification from one of the grids. 
Images taken at 40,000, 50,000 and 63,000 x magnification were taken to highlight 
particular cellular morphologies and were not necessarily representative.
5.2.4 Determining the Effect of AHR on Expression of Virulence Genes
5.2.4.1 Materials
All RT-PCR reagents were purchased from Promega (Southampton, UK), with the 
exception of dNTPs, which were purchased from Qiagen Ltd.
5.2.4.2 Reverse Transcription-PCR
This procedure was performed in duplicate for S. aureus isolates 44, NCIMB 9518 
and SI. RNA was extracted pre-exposure and post-exposure to Soft Care Med H5, 
Cutan and Guest Medical AHRs according to section 2.10.3. An RNA/primer mix 
was prepared for each RNA sample on ice in a pre-chilled 0.5 ml PCR tube, as 
described in Table 5.2. The tubes were placed in a Techgene Thermal Cycler PCR 
machine for the following cycle: 70 °C for 5 min, 4 °C for 5 min and transferred 
immediately to ice.
Reverse transcription (RT) was performed for each RNA/primer sample, including a 
mixture with reverse transcriptase mix (+RT), a mixture without reverse transcriptase 
(noRT, to ensure the absence of DNA) and a mixture with all the RT components but
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no RNA (water control, to ensure the components of the mixture contain no 
contaminants). The RT, noRT and water controls were prepared in pre-chilled 0.5 
ml PCR tubes in volumes sufficient for three RNA samples (Table 5.3). Tubes were 
kept on ice. A 6.5 pi volume of each of the three RNA samples was transferred to 
pre-chilled 0.5 ml PCR tubes containing 19.5 pi of the +RT mix and to pre-chilled 
PCR tubes containing 19.5 pi of the noRT mix. One further pre-chilled PCR tube 
was set up containing 19.5 pi of the water control mix with 6.5 pi of nuclease-free 
water. Tubes were placed in a Techgene Thermal Cycler PCR machine and run on 
the following cycle: 25 °C for 5 min, 42 °C for 60 min, 70 °C for 15 min and stored at 
-20 °C until needed.
PCR was performed on the RT samples to amplify the DNA products. PCR mixture 
(in 23pi volumes; prepared according to Table 3.6, Chapter 3) was added to 0.5 ml 
PCR tubes containing 2 pi of each RT sample. A negative control was performed 
with 23 pi of PCR mixture only. PCR was performed for each RT sample with the 
primers for each virulence gene that was determined to be present in each isolate in 
section 3.2.4, plus a housekeeping gene (see Table 5.4). The GlyA gene is a 
housekeeping gene that encodes serine/glycine hydroxymethlyl transferase A, which 
is involved in amino acid catabolism (Theis et al., 2007). This gene is likely to be 
expressed at a consistent level pre- and post-exposure to AHR and was therefore 
used in this study as a control gene. Samples were transferred to a Techgene 
Thermal Cycler PCR machine and run on the following cycle: 94 °C for 3 min; 35 
cycles of: 94 °C for 1 min, the optimum annealing temperature (Ta) specific for the 
primer pair (see Table 5.4) for 1 min, 72 °C for 2 min; 72 °C for 3 min. The Ta of 
each forward and reverse primer was calculated as follows:
Ta = Tm-5 Tm = 2 °C x (A+T) + 4 °C x (C+G)
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Table 5.2: RNA/Primer Mix
Volume of RNA/primer mix required for RT-PCR of one RNA sample
Component Volume
Random primer 1.5 pi
RNA 3 gg
Nuclease-free water To a final volume of 15 pi
T able 53: Reverse T ranscription Mix
Volume of each mixture required to perform RT on three RNA samples. RT 
mixtures included a mixture with reverse transcriptase (+RT), a mixture with no 
reverse transcriptase (noRT) and a mixture with no RNA (water control)
Component +RT (pi) noRT (pi) Water Control (pi)
Nuclease-free water 28.6 33.3 22.9
5 x reaction buffer 18.8 18.8 15
25 mM MgCl2 11.3 11.3 9
lOmMdNTP 4.69 4.69 3.75
RNasin 2.35 2.35 1.88
Reverse transcriptase 4.69 0 3.75
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Tm = melting temperature of the primer, which was provided by Invitrogen. Adenine 
(A), Thymine (T), Cytosine (C) and Guanine (G) are the nucleotides in the primer 
sequences. The Ta of each primer pair was determined, which was the same as for 
each forward and reverse primer if the Ta values were the same. Where the Ta was 
different for the forward and reverse primers the temperature belonging to the 
shortest primer was chosen and if the primers were the same length the highest 
temperature was chosen. The Ta must be between 50-68 °C; therefore if the 
calculated Ta fell out of this range it was adjusted to fall within it. Primer sequences 
for virulence genes are provided in Tables 3.4 and 3.5 (Chapter 3) and those for the 
housekeeping gene are provided in Table 5.5.
Electrophoresis was performed according to section 2.11. Where banding was found 
to be inconsistent between the two replicates then the procedure was carried out a 
third time, with a fresh RNA extraction. If the third replicate result matched that of 
either of the two previous replicates then that result was taken to be the true result.
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Table 5.4: Genes Amplified for PCR
Genes found to be present (+) in S. aureus isolates 44, NCIMB 9518 and SI during 
screening in section 3.2.4 (Chapter 3) plus a housekeeping gene. The optimum 
annealing temperature (Ta) is provided for each forward (F) and reverse (R) primer 
pair. * = housekeeping gene
Gene Isolate 44 Isolate 
NCIMB 9518
Isolate SI Optimum Ta of F and R 
Primers (°C)
hysA + + + 67
fnbA + + + 55
fiibB + + - 65
MgA + + + 59
hlgCB + + + 55
cap5 - + + 67
cap8 + + + 57
icaA + + + 57
icaD + + + 57
clfA + + + 51
glyA* + + + 50
Table 5.5: Housekeeping Gene Primers
Details of forward (F) and reverse (R) primer sequences for the housekeeping gene 
glyA, their product’s length and their origin.
Gene 5* to 3’ Primer Sequence Product Length Reference
(*>P)
glyA F-CTACAAACTCACAGCCAC
R-GTATCGGAAGCGGTTATG
98 Theis et al. 
(2007)
146
5.3 RESULTS
5.3.1 Determining the Effect of AHR on Leakage of Potassium Ions
Data showing the mean % K+ leakage for S. aureus isolates 44, NCIMB 9518 and S1 
after exposure to Soft Care Med H5, Cutan and Guest Medical AHRs are provided in 
Table 5.6 and are summarised in Figure 5.2. Leakage of K+ was highest from cells 
of isolate 44, followed by NCIMB 9518 and was lowest from isolate SI after 
exposure to Cutan. However, leakage of K+ was highest from cells of isolate 
NCIMB 9518 and of a similarly lower percentage from isolates 44 and SI after 
exposure to Soft Care Med H5 and Guest Medical. Overall, leakage of K+ from the 
isolates was highest after exposure to Cutan, and of a similarly lower percentage 
after exposure to Soft Care Med H5 and Guest Medical.
It is difficult to compare K+ leakage from the different isolates using the different 
AHRs due to the large SD that occurred under most conditions (Table 5.6). The 
mean K+ leakage had a tendency to increase sharply by a contact time of 10 s, reach a 
peak by either 30 s or 1 min and decrease. By a contact time of 10 min the 
percentage of K+ leakage had levelled off, with the exception of isolate 44 after 
exposure to Cutan and isolates NCIMB 9418 and SI after exposure to Soft Care Med 
H5, which was still increasing, plus isolate NCIMB 9518 after exposure to Guest 
Medical, which was still decreasing.
The effect of each AHR on K+ leakage was compared with its bactericidal effect to 
determine whether change in membrane permeability provides a major contribution 
to cell death. Table 5.7 compares K+ leakage with bactericidal activity and shows 
that K+ leakage had reached a peak prior to a bactericidal effect being achieved for 
all isolates under all conditions (> 4 log reduction), with the exception of isolate 44 
after exposure to Soft Care Med H5. Table 5.7 also shows that K+ leakage was 
below 50% under most conditions by the time a bactericidal effect was achieved. 
This indicates that membrane damage was not a major contributor to the bactericidal 
activity of AHR.
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Table 5.6: Percentage of K+ Leakage from S. aureus Isolates After Exposure to AHR
Mean percentage leakage ± SD of K+ from S. aureus isolates 44, NCIMB 9518 and SI after exposure to Soft Care Med H5, Cutan and Guest 
Medical AHRs.
Contact
Time Soft Care 
Med H5
Isolate 44 
Cutan Guest
Medical
Isolate NCIMB 9518
Soft Care Cutan Guest 
Med H5 Medical
Soft Care 
Med H5
Isolate SI 
Cutan Guest
Medical
10s 19.65 ±2.48 58.99±8.46 19.26±2.28 23.58±16.70 33.18±12.67 31.08±5.87 20.08±4.97 4.5lrbl .80 18.93±9.62
30 s 21.15±2.19 64.81±=19.07 19.78±3.10 26.82±19.08 62.72rbl4.91 37.61±9.94 20.62±4.48 4.61±0.82 18.88=b7.39
1 min 22.94±1.35 69.51±24.30 20.85±1.45 30.10±19.82 51.53±9.78 33.48±6.94 23.30±7.66 5.55±0.50 23.16rbl0.33
2 min 25.48±2.66 71.58±35.09 19.99±2.51 27.13±15.93 55.92±7.00 32.78±6.73 21.69±3.08 4.29±1.51 19.68drl3.01
5 min 27.15±1.24 72.13±30.63 25.70±5.21 28.23±19.91 54.39±7.03 56.03±20.45 15.87±8.35 5.79±2.37 24.59±13.03
10 min 26.17±1.83 75.48±36.06 23.38±2.43 34.88±28.99 53.63±7.93 32.25±2.97 33.08d=19.91 5.76±1.73 23.50±9.86
— ♦—  Isolate 44 Soft Care 
Med H5
-  - * — Isolate 9518 Soft 
Care Med H5
— a* • • Isolate S1 Soft Care 
Med H5
— ♦—  Isolate 44 Cutan
-  * - Isolate 9518 Cutan
a Isolate S1 Cutan
— ♦—  Isolate 44 Guest 
Medical
Isolate 9518 Guest 
Medical
a Isolate S1 Guest 
Medical
— ♦—  Control
0 100 200 300 400 500 600
Contact Time/s
Figure 5.2: Percentage K+ Leakage from S. aureus Isolates After Exposure to AHR
£  Mean percentage K+ leakage from S. aureus isolates 44, NCIMB 9518 and SI after exposure to Soft Care Med H5, Cutan and Guest Medical
Table 5.7: Comparison Between K+ Leakage and Cell Death
Mean K+ leakage from S. aureus isolates 44, NCIMB 9518 and SI after exposure to 
Soft Care Med H5, Cutan and Guest Medical AHRs by the contact times required to 
achieve a bactericidal effect ( T b e ; 4 log reduction), as determined in Chapter 4. Also 
shown is whether K+ leakage had peaked before (<), during (=) or after (>) the 
contact time by which a bactericidal effect was observed.
AHR Isolate Tbe % K+ Leakage 
Achieved by Tbe
Peak % K* Leakage 
Achieved <, = or > Tbe
Soft Care 44 10 s 19.7 >
Med H5 9518 30 s 26.8 <
SI 1 min 23.3 <
Cutan 44 5 min 72.1 <
9518 5 min 54.34 <
SI 5 min 5.8 <
Guest 44 5 min 23.4 <
Medical 9518 5 min 56.0 <
SI > 5 min 23.5 <
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5.3.2 Determining the Role of the Cell Wall as a Barrier to AHR Penetration
5.3.2.1 Determining the Rapidity of Protoplast damage by AHR
Figure 5.3 A shows an image of protoplasts prior to treatment with AHR. During the 
first 5 min of exposure of protoplast cells to Soft Care Med H5, Cutan and Guest 
Medical AHR there was no observable difference in the density of the suspension or 
the appearance of cells. After a contact time of 5 min a very small number of 
protoplasts (only a few on the entire slide) had a change in appearance, where the 
edge (Figure 5.3C) and/or surface (Figure 5.3D) had become damaged. At a contact 
time of 10 min a larger number of protoplasts had the damaged appearance of those 
in Figure 5.3C and 5.3D, plus a small number of cells had lost their integrity and the 
intracellular contents had leaked out (Figure 5.3E). The number of damaged and 
broken cells had increased by a contact time of 20 min and 25 min, but still the vast 
majority of cells appeared healthy and undamaged, like those in Figure 5.3A. 
Protoplasts in the water control lysed very quickly, whereby the number of cells 
present reduced at a fast rate and there was a large volume of debris present. By a 
contact time of only 5 min a large portion of cells present appeared damaged or lysed 
and a large proportion of the remaining cells had swollen to a very large size (Figure 
5.3B), due to the hypotonicity of the water. By 10 min most of the cells had lysed 
and by 20 min a very small number were left intact.
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Figure 5.3: Protoplast Appearance pre- and post- Exposure to AHR
Light microscope images of S. aureus NCIMB 9518 protoplasts. Scale bar = 120 
pm. A = pre-treatment, B = water control, C & D = following 5 min exposure to 
Guest Medical AHR, E = following 10 min exposure to Guest Medical AHR.
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5.3.2.2 Determining the Effect of AHRs on Protoplasts
The total number of NCIMB 9518 healthy protoplasts present after exposure to 
hypertonic buffer (control), Soft Care Med H5, Cutan, Guest Medical and water over 
ten fields of vision are shown in Table 5.8, along with the number of which appeared 
damaged. The mean of three replicates is given. There was no significant difference 
between the total number of protoplasts in 10 fields of vision in the control sample 
and Soft Care Med H5, Cutan or Guest Medical samples for isolate NCIMB 9518 (P 
>0.05). There was also no significant difference between the number of healthy 
protoplasts in the control sample and number of healthy protoplasts in the Soft Care 
Med H5, Cutan and Guest Medical samples (P >0.05). The total number of 
protoplasts in 10 fields of vision in the control sample was, however, significantly 
higher than in the water sample at 5 min and 20 min (P <0.05). This means that none 
of the AHRs caused a significant amount of damage to isolate NCIMB 9518 
protoplasts after 20 min contact time.
5.3.2.3 Determining the Susceptibility o f S. aureus Protoplasts to AHR
The total number of isolate 44 and SI healthy protoplasts present after exposure to 
hypertonic buffer (control) and Guest Medical AHR over ten fields of vision are 
shown in Table 5.9, along with the number of those which appeared damaged. The 
mean of three replicates is given. There was no significant difference between the 
total number of protoplasts in 10 fields of vision in the control sample and Guest 
Medical samples for either isolate 44 or isolate SI (P >0.05). There was also no 
significant difference between the number of protoplasts in the control sample and 
number of healthy protoplasts in the Guest Medical samples for either isolate 44 or 
isolate SI (P >0.05). This means that Guest Medical AHR did not cause significant 
damage to either of the isolates after 20 min contact time.
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Table 5.8: Number of S. aureus NCIMB 9518 Protoplasts Pre- and Post-
Exposure to AHRs
The mean of three replicates is shown of the total number of healthy and damaged 
protoplasts of S. aureus NCIMB 9518 over ten fields of vision at 100 x magnification 
± SD for the control (in hypertonic buffer) and after exposure to AHR and water. * 
Presence of cell debris.
Condition Mean Number of Healthy 
Protoplasts
Mean Number of Damaged 
Protoplasts
Control 204.33 ± 12.42 0
Soft Care Med H5 196.33 ±34.93 2.67 ± 1.53
Cutan 190.00 ±19.00 3.00 ± 1.00
Guest Medical 185.67 ±39.27 1.33 ± 1.53
Water 5 min 21.33 ±5.03 0*
Water 20 min 9.33 ±2.52 0*
Table 5.9: Number of Protoplasts Pre- and Post- Exposure to AHR
The mean of three replicates is shown of the total number of healthy and damaged 
protoplasts of S. aureus isolates 44 and SI over ten fields of vision at 100 x 
magnification ± SD after exposure to a hypertonic buffer (control) and Guest 
Medical AHR.
Condition Mean Number of Mean Number of
Protoplasts Damaged Protoplasts
Isolate 44 Control 184.67 ±34.53 0
Isolate SI Control 216.67 ±13.05 0
Isolate 44 Guest Medical 185.00 ± 16.37 4.00 ±2.65
Isolate SI Guest Medical 242.00 ± 32.23 2.33 ± 1.53
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5.33 Determining the Effect of AHR on Bacterial Cell Structure
Transmission Electron micrographs of S. aureus isolate 44, NCIMB 9518 and SI are 
shown pre- and post-treatment with Guest Medical AHR in Figures 5.4 to 5.12. An 
unidentifiable extracellular material (UEM) was observed in all organisms pre- and 
post-exposure to AHR. This was in relatively small quantities pre-exposure and for 
isolate SI post-exposure to AHR. Slightly larger quantities were observed for isolate 
NCIMB 9518 after 1 min and 5 min exposure to AHR, whereas quantities were 
greatly increased for isolate 44 after 1 min and 5 min exposure. This UEM is likely 
to be material from the bacterial surface that has come away from the bacterial cell 
wall, possibly during EM preparation, which may come away more easily when 
damaged.
There was no observable difference in the appearance of cells after 10 s exposure of 
isolate 44 to Guest Medical AHR (pictures not shown), compared to those pre- 
treatment (Figure 5.4). However, after 1 min exposure (Figure 5.5) areas of the cell 
wall of a large proportion of cells had become thicker and fuzzy. This may have 
been due to the cell wall being damaged, possibly by protein denaturation. The 
membrane of a large proportion of cells had also been damaged, which was indicated 
by a lack of integrity. Figure 5.5b also shows that after 1 min exposure the 
intracellular contents had leaked from one cell, but this was not a common 
occurrence. After 5 min exposure (Figure 5.6) a larger proportion of cells 
demonstrated the same cell wall and membrane damage seen in Figure 5.5, plus a 
small number of cells showed a change in the appearance of their cytoplasm, 
probably the result of coagulation of the cytoplasm by alcohol.
S. aureus NCIMB 9518 cells appeared to be less healthy pre-treatment (Figure 5.7) 
than isolate 44, due to the appearance of some membrane damage that may be the 
result of TEM preparation. There was no observable difference in the appearance of 
bacterial cells after 10 s exposure of isolate NCIMB 9518 to Guest Medical AHR 
(pictures not shown). However, by 1 min exposure (Figure 5.8) a number of cells 
had a large quantity of UEM that was either attached to the cell or forming a circle 
around the cell. It was different in appearance to, and in addition to, the UEM that 
was found in all the samples. Figure 5.8 also shows cell wall and cytoplasmic
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membrane damage had occurred by 1 min exposure, although this was not as 
extensive as in isolate 44. By 5 min (Figure 5.9) cell wall and cell membrane 
damage occurred in a large proportion of cells, although not as commonly as in 
isolate 44. After 5 min leakage of extracellular material was also observed, although 
this was not common.
Isolate SI pre-treatment cells appeared healthy (Figure 5.10). Unlike isolates 44 and 
NCIMB 9518, isolate SI showed membrane and cell wall damage in a number of 
cells after 10 s exposure to Guest Medical AHR (Figure 5.11). This was observed in 
a larger proportion of cells after a 1 min contact time (images not shown) and after 5 
min contact time damage was more extensive, including the presence of ghost cells 
(Figure 5.12).
Guest Medical therefore had the greatest effect on the physical appearance of cells of 
isolate 44 followed by isolate SI, with the least effect on cells from isolate NCIMB 
9518.
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Figure 5.4: TEM image of S. aureus isolate 44 pre-treatment
A = 10,000 x magnification, scale bar = 950 nm, B = 50,000 x magnification, scale 
bar =187 nm. CM = cytoplasmic membrane, CW = cell wall; UEM = unidentifiable 
extracellular material
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Figure 5.5: TEM image of S. aureus isolate 44 after 1 min exposure to Guest
Medical AHR
A = 10,000 x magnification, scale bar = 950 nm, B = 63,000 x magnification, scale 
bar =157  nm. L = leakage of intracellular material, MD = cytoplasmic membrane 
damage, WD = cell wall damage, UEM = unidentifiable extracellular material
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Figure 5.6: TEM image of S. aureus isolate 44 after 5 min exposure to Guest
Medical AHR
A = 10,000 x magnification, scale bar = 950 nm, B = 50,000 x magnification, scale 
bar =187 nm. CD = cytoplasm damage, WD = cell wall damage, MD = cytoplasmic 
membrane damage, UEM = unidentifiable extracellular material, WT = cell wall 
thinning.
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Figure 5.7: TEM image of S. aureus isolate NCIMB 9518 pre-treatment
A = 10,000 x magnification, scale bar = 950 nm, B = 63,000 x magnification, scale 
bar = 1 5 7  nm. MD = membrane damage. UEM = unidentifiable extracellular 
material.
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Figure 5.8: TEM image of S. aureus isolate NCIMB 9518 after 1 min
exposure to Guest Medical AHR
A = 10,000 x magnification, scale bar = 950 nm, B = 63,000 x magnification, scale 
bar = 157 nm. UEM = unidentifiable extracellular material.
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Figure 5.9: TEM image of S. aureus isolate NCIMB 9518 after 5 min
exposure to Guest Medical AHR
A = 10,000 x magnification, scale bar = 950 nm, B = 63,000 x magnification, scale 
bar =157 nm. WD = cell wall damage, L = leakage of intracellular material, UEM = 
unidentifiable extracellular material
WD UEM
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Figure 5.11: TEM image of S. aureus isolate SI after 10 s exposure to Guest 
Medical AHR
A = 10,000 x magnification, scale bar = 950 nm, B = 40,000 x magnification, scale 
bar =130 nm. MD = cytoplasmic membrane damage, WD = cell wall damage. UEM 
= unidentifiable extracellular material.
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Figure 5.10: TEM image of S. aureus isolate SI pre-treatment
A = 10,000 x magnification, scale bar = 950 nm, B = 50,000 x magnification, scale 
bar = 187 nm. UEM = unidentifiable extracellular material.
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Figure 5.12: TEM image of S. aureus isolate SI after 5 min exposure to Guest 
Medical AHR
A = 10,000 x magnification, scale bar = 950 nm, B = 50,000 x magnification, scale 
bar =187 nm. G = ghost cell, MD = membrane damage, WD = cell wall damage. 
UEM = unidentifiable extracellular material.
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53.4 Determining the Effect of AHR on Expression of Virulence Genes
Results of RT-PCR pre- and post-exposure to AHR for S. aureus isolates 44, NCIMB 
9518 and SI are summarised in Tables 5.10, 5.11 and 5.12, respectively. Examples 
of RT-PCR gels are shown in Figures 5.13 to 5.15, which also demonstrate the 
assignment of expression strength according to band intensity. As demonstrated in 
Chapter 3, isolate 44 possessed the virulence genes hysA, fnbA and fnbB, but these 
were not expressed. This was also the case for virulence genes hysA, cap5 and fnbA 
for isolates NCIMB 9518 and SI. The housekeeping gene glyA was, as expected, 
very highly expressed and its expression was constant pre- and post-exposure to 
AHR. The strength of expression was not the same for all genes pre-exposure to 
AHR in both replicates. This was the case even after a third replicate for genes cap8 
and hlgCB for isolate 44; capti, hlgA, hlgCB and icaA for isolate NCIMB 9518; hlgA 
and clfA for isolate S I. The strength of gene expression was often not the same post­
exposure to AHR for both replicates. This often led to replicates showing 
inconsistent change in gene expression (up-regulation, down-regulation or no 
change). This was the case for genes cap8, hlgA, hlgCB, icaA and clfA for isolate 44; 
cap8,fhbB, hlgA, icaA, icaD and clfA for isolate NCIMB 9518; clfA for isolate SI. 
Little difference was observed in gene expression pre-exposure to AHR between the 
isolates. More virulence genes were down-regulated post-exposure to AHR for 
isolates 44, NCIMB 9518 and SI than were up-regulated. Isolate SI showed down- 
regulation of the greatest number of virulence genes, followed by isolate 44, with 
isolate NCIMB 9518 showing down-regulation of the least number of genes. Isolate 
44 showed up-regulation of the greatest number of genes, followed by NCIMB 9518, 
with isolate SI showing up-regulation of the least number of genes.
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Table 5.10: RT-PCR Results for S. aureus Isolate 44
Results of expression of a range of virulence genes plus a housekeeping gene in S. 
aureus isolate 44 pre- and post-exposure to Soft Care Med H5, Cutan and Guest 
Medical AHRs, using RT-PCR. Genes are documented as being very highly 
expressed (++++), highly expressed (+++), moderately expressed (++), slightly 
expressed (+), or not expressed (-). Post-exposure results shown in red are more 
greatly expressed, those in black are expressed equally and those shown in blue are 
less expressed than pre-exposure. * Performed in triplicate. ** Housekeeping gene.
glyA
1 -H - f
++++
+
++
+-H-+
I I I  I
+ +
++++
++++
++++
++++
+++
++++
++
++
+
++++
++ +
+ +
+ + +
+++
Gene Pre- Post-Soft Care Post-Cutan Post-Guest
____________Exposure______ Med H5____________________ Medical
capS*
fnbA 
fiibB 
hlgA*
hlgCB*
icaA*
icaD 
clfA*
i—h 
++ 
+
+
-f i l l
+ + + +
++++
-H-H-
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Table 5.11: RT-PCR Results for 5. aureus Isolate NCIMB 9518
Results of expression of a range of virulence genes plus a housekeeping gene in S. 
aureus isolate NCIMB 9518 pre- and post-exposure to Soft Care Med H5, Cutan and 
Guest Medical AHRs, using RT-PCR. Genes are documented as being very highly 
expressed (++++), highly expressed (+++), moderately expressed (++), slightly 
expressed (+), or not expressed (-). Post-exposure results shown in red are more 
greatly expressed, those in black are expressed equally and those shown in blue are 
less expressed than pre-exposure. * Performed in triplicate. ** Housekeeping gene.
Gene Pre-
Exposure
Post-Soft Care 
Med H5
Post-Cutan Post-Guest
Medical
hysA — — — —
— — — —
cap5 — — — —
— — — —
cap8* +++ ~ r — —
++ ++ ++ ++
+ + + + +
fnbA — — — —
— — — —
fhbB* — — — —
+ + + — —
— — — —
hlgA* ++ ++ —
+++ + + ++ + +
— — — —
hlgCB* + + — — —
— — — —
+ + + +
icaA* + + +
+ + +
+ + + +
icaD* + + + +++ + + + + + +
+ +
c l f A * + + + +
+ + + + + + + +
+ + +
+ + + +
+ + + +
+ + +
+ + + +
— — - r + + - f -
g l y A * * + 4 - 4- +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +  |
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Table 5.12: RT-PCR Results for S. aureus Isolate SI
Results of expression of a range of virulence genes plus a housekeeping gene in S. 
aureus isolate SI pre- and post-exposure to Soft Care Med H5, Cutan and Guest 
Medical AHRs, using RT-PCR. Genes are documented as being very highly 
expressed (++++), highly expressed (+++), moderately expressed (++), slightly 
expressed (+), or not expressed (-). Post-exposure results shown in red are more 
greatly expressed, those in black are expressed equally and those shown in blue are 
less expressed than pre-exposure. * Performed in triplicate. ** Housekeeping gene.
Gene Pre-
Exposure
Post-Soft Care 
Med H5
Post-Cutan Post-Guest
Medical
hysA — — — —
— — — —
cap5 — — — —
— — — —
cap8* +++ +++ +++ +++
+ + ++
+ + + +
+++
+
+++
+++
+++
+++
fribA — — — —
— — — —
hlgA* ++ + + +
+++ — + +
hlgCB* +++ + ++ +
+ + + +
+ + + +
+ + +
+
+++
+ + + +
+++
++ +
icaA + + - -r -
++ - -
icaD* + + + — ---
++ __ --- +
+ + + +-H- +++ ~l—
clfA*
+ + + + +-H-+ -H-++ +-H-+
glyA**
+++
++++
+++
-H-H-
-HH-
-H-++ +"(■■+ +
++++ ++++ ++++ ++++
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Figure 5.13: Example of Gene Expression in S. aureus Isolate 44
The intensity of bands in lanes 2, 4, 6 and 8 were interpreted as greatly expressed (++++). All other 
lanes showed no expression (-). BP = length in base pairs.
o
Well Contents
1 1Kb Plus ladder
2 clfA pre (+RT)
3 clfA pre (noRT)
4 clfA Soft Care (+RT)
5 clfA Soft Care (noRT)
6 clfA Cutan (+RT)
7 clfA Cutan (noRT)
8 clfA Guest Med (+RT)
9 clfA Guest Med (noRT)
10 fhbB pre (+RT)
11 fnbB pre (noRT)
12 fiibB Soft Care (+RT)
13 fhbB Soft Care (noRT)
14 fhbB Cutan (+RT)
15 fhbB Cutan (noRT)
16 fhbB Guest Med (+RT)
17 fhbB Guest Med (noRT)
18 clfA negative control
19 fnbB negative control
20 1 Kb Plus Ladder
10 11 12 13 14 15 16 17 18 19 20
Figure 5.14: Example of Gene Expression in S. aureus Isolate NCIMB 9518
The intensity of the bands in lanes 10 and 14 were interpreted as greatly expressed (++++), 
whereas bands in lanes 12 and 16 were interpreted as highly expressed (+++). All other 
lanes showed no gene expression (-). BP = length in base pairs
Well Contents
Bp 1 1Kb Plus ladder
12,000 2 fribB pre (+RT)
2,000 3 fhbB pre (noRT)
1,650 4 fhbB Soft Care (+RT)
1,000 5 fnbB Soft Care (noRT)
850 6 fhbB Cutan (+RT)
650 7 fhbB Cutan (noRT)
500
400
8 fhbB Guest Med (+RT)
9 fhbB Guest Med (noRT)
300 10 clfA pre (+RT)
200
11 clfA pre (noRT)
12 clfA Soft Care (+RT)
13 clfA Soft Care (noRT)
100 14 clfA Cutan (+RT)
15 clfA Cutan (noRT)
16 clfA Guest Med (+RT)
17 fhbB Guest Med (noRT)
18 fhbB water control
19 clfA negative control
20 1 Kb Plus Ladder
Well Contents
3 4 5 6 10 11 12 13 14 15 16 17 18 19 20 Bp
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Figure 5.15: Example of Gene Expression in S. aureus Isolate SI
The intensity of the bands in lanes 11, 13, 15 and 17 were interpreted as highly expressed (+++), 
slightly expressed (+), moderately expressed (++) and slightly expressed, respectively. All other 
lanes showed no gene expression (-). BP = length in base pairs.
1 1Kb Plus ladder
2 fnbA pre (+RT)
3 fnbA pre (noRT)
4 fnbA Soft Care (+RT)
5 fnbA Soft Care (noRT)
6 fnbA Cutan (+RT)
7 fnbA Cutan (noRT)
8 fnbA Guest Med (+RT)
9 fnbA Guest Med (noRT)
10 hlgCB pre (+RT)
11 hlgCB pre (noRT)
12 hlgCB Soft Care (+RT)
13 hlgCB Soft Care (noRT)
14 hlgCB Cutan (+RT)
15 hlgCB Cutan (noRT)
16 hlgCB Guest Med (+RT)
17 hlgCB Guest Med (noRT)
18 hlgCB negative control
19 No sample
20 1 Kb Plus Ladder
5.4 DISCUSSION
5.4.1 The Cytoplasmic Membrane as a Target for Alcohol Hand Rub
All AHRs were too viscous to pass undiluted through the 0.45 and 0.2 pm filters, 
therefore diluting 1 in 10 in UHP water was sufficient to allow passage of Soft Care 
Med H5 and Guest Medical through the filters. However, Cutan was extremely 
viscous, which is due to the ingredient C l0-30 alkyl acrylate crosspolymer, which is 
a thickener commonly used in clear gels that makes the product easier to pump and 
handle. The crosspolymer was broken up by diluting Cutan in 3% w/v NaCl. S. 
aureus has been proven to have an osmotolerance to NaCl, with no apparent effect 
on the integrity of the cytoplasmic membrane below concentrations of 5% (Hajmeer 
et al., 2006); therefore the presence of NaCl should not have affected the test.
Figure 5.2 shows the K+ leakage curve for most isolates under most conditions 
featured an early peak in % leakage, followed by a reduction in leakage and in some 
cases a later, more gradual increase. Similar shaped curves have been found for 
release of 260 nm material from S. aureus after exposure to biocide (Denyer & 
Hugo, 1991).
The order of leakage of K+amongst isolates 44, NCIMB 9518 and SI after exposure 
to Cutan AHR fits in with results of stainless steel carrier testing from Chapter 4, 
which found that a bactericidal effect was achieved quicker for isolate 44, followed 
by isolate NCIMB 9518, and slowest for isolate SI. This was not, however, the case 
for Soft Care Med H5 and Guest Medical AHR. It is unclear why Cutan caused the 
greatest membrane damage when Cutan was found to take longest to achieve a 
bactericidal effect in Chapter 4.
K+ leakage was studied for longer contact times than those used to achieve a 
bactericidal effect in Chapter 4. If membrane damage was the primary mechanism of 
activity more K+ leakage would be expected by the bactericidal contact times than 
those seen for most samples. Furthermore the bacteria used to test K+ leakage were 
in a suspension, rather than on a surface and therefore AHR would be expected to
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cause damage to the bacteria quicker than was found in Chapter 4. The inoculum 
size for the stainless steel carrier test, however, was much smaller than that used for 
the K+ leakage test, a bactericidal effect (> 4 log reduction) would mean a much 
lower number of cells killed than for the K+ leakage test.
With the exception of isolate 44 after exposure to Soft Care Med H5, all isolates had 
leaked out as much K+ from their cells as they would do in the entire 10 min period 
prior to the contact time by which a bactericidal effect was achieved in Chapter 4. 
This suggests that the damage caused to the cytoplasmic membrane that caused K+ 
leakage may eventually have led to cell death. However, since a large portion of 
cells were able to survive for some period of time after this leakage occurs, the 
damage that led to leakage of K+ may not have been sufficient to cause cell death; 
therefore other factors are likely to have caused cell death.
K+ leakage was virtually non-existent from isolate SI after exposure to Cutan and 
was relatively low for Guest Medical and Soft Care Med H5 for all isolates within 
the bactericidal contact times, and even up to 10 min, indicating that membrane 
damage may not be severe enough to cause a bactericidal effect under these 
conditions.
The fact that not all AHRs were able to cause >50% of cellular K+ to leak from one 
or more of the isolates either within the contact time required to achieve a 
bactericidal effect (as shown in Table 5.7) or within the full 10 min contact time 
tested (as shown in Table 5.6) indicates that the major cause of bactericidal activity 
of AHR is not membrane damage. This theory is supported by findings by Johnston 
et al. (2003) that a membrane-active biocide was able to cause leakage of the total 
cellular K+ pool within 1 min. Inoue et al. (2004) tested three terpene alcohols 
(compounds derived from plants that are composed of alcohol with a terpene 
hydrocarbon) at various concentrations for membrane activity against S. aureus. 
Two of the alcohols caused very rapid leakage of K+, where the maximum K+ loss 
was achieved almost immediately. The third alcohol caused much slower leakage, 
where maximum K+ loss was achieved by between 1 and >15 min contact time. It is 
worth noting that a bactericidal effect (>4 logio reduction) was achieved for the
174
terpene alcohols, which were used at double the maximum concentration used for K+ 
leakage testing, by between 1-6 h. K+ leakage was therefore relatively rapid for all 
terpene alcohols. The study by Inoue et al. (2004) further supports the theory that 
the mode of action of Soft Care, Cutan and Guest Medical is not primarily the 
cytoplasmic membrane because the membrane-active agents tested caused maximum 
K+ loss at a much earlier time point than a bactericidal effect was achieved, whereas 
the AHRs tested in this study did not.
5.4.2 The Cell Wall as a Target for AHR or Barrier to Prevent Its Penetration
Since section 5.3.1 revealed the cytoplasmic membrane may not be the main cause of 
bactericidal effect, the cell wall was the most likely alternative. Differences in the 
susceptibility of isolates to AHR observed in Chapter 4 may therefore be due to 
differences in either AHR activity against the cell wall or differences in penetration 
of AHR into the cell. This was investigated by subjecting cells without a cell-wall 
(protoplasts) to AHR, which has not previously been performed. None of the AHRs 
caused significant damage to protoplasts after even a contact time much longer than 
that necessary to achieve a bactericidal effect on whole cells. This firstly confirmed 
results from section 5.3.1, that damage to the cytoplasmic membrane and 
intracellular contents is not the main mode of activity of AHR. This secondly 
indicated that the differences in efficacy observed between the AHRs against whole 
cells in Chapter 4 is likely to be due to differences in the cell wall or outer layers, 
such as the capsule or slime layer (Xiong et al., 2005). There was no significant 
damage to protoplasts of either the most- or least-susceptible strains following 
exposure to AHR, indicating that differences in susceptibility observed among the 
isolates in Chapter 4 was not due to differences in the cytoplasmic membrane or 
intracellular contents, rather differences in the cell wall or outer layers (Xiong et al., 
2005), since these are the components missing. Gilby & Few (1960) found that 
varying concentrations of ethanol were able to lyse large numbers of Micrococcus 
lysodeikticus protoplasts by a contact time of 20 min. It is unclear why similar 
outcomes were not observed in this study.
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5.4.3 The Effect of AHR on Cell Structural Appearance
As explained in Table 5.1 alcohols are known to damage lipid and proteins. 
However, it is not known what parts of the cell AHR damages and the effect on the 
physical appearance of the cell. This was determined using electron microscopy. A 
bactericidal effect (>4 logio reduction) was observed for isolates 44 and NCIMB 
9518 within 30 s exposure to Guest Medical AHR. Physical damage was seen after 1 
min exposure (30 s exposure was not performed), although not in as many cells as 
those that had been shown to be killed in Chapter 4. This indicates that damage 
sufficient to achieve a bactericidal effect must occur at earlier contact times and in a 
larger number of cells and this damage may not overtly alter the physical appearance 
of cells. In contrary to this observation, damage to isolate SI was physically 
apparent at a contact time as early as 10 s and extensive at 5 min, despite a >5min 
contact time being required to achieve a bactericidal effect using Guest Medical 
AHR in Chapter 4. This suggests that isolate SI may survive at least some of the 
damage that results in a change of physical appearance. The fact that damage to the 
appearance of bacterial cells of isolate SI was so rapid when it was the least- 
susceptible to being killed indicates that the damage seen at the earlier contact times 
is sub-lethal. Bacterial cells of isolate 44 were the most severely damaged, which 
supports the fact that isolate 44 was the most easily killed. This also indicates that 
some bacterial cell damage observed contributed to the bactericidal effect.
Damage to the bacterial cytoplasm observed in S. aureus cells (Figure 5.6) is likely 
to be due to coagulation of protein (McDonnell & Russell, 1999). The identity of the 
material surrounding isolate 44 after 1 min (Figure 5.5) and 5 min (Figure 5.6) 
exposure to Guest Medical AHR and to a lesser extent isolate NCIMB 9518 after 1 
min (Figure 5.8) and 5 min (Figure 5.9) exposure to Guest Medical AHR is not clear. 
It is present in all samples, although not in such great quantity. It is most likely to be 
material that has come away from the bacterial surface during preparation and the 
greater quantities may be the result of increased damage to the cell surface, which 
has caused the material to come away easier. This theory is likely, since a large 
quantity of the material was present post-exposure for isolate 44, the most 
susceptible isolate to Guest Medical AHR, whereas only a small increase in the 
amount of material was found post-exposure for isolate NCIMB 9518 and no
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increase for isolate SI, the least-susceptible isolate. Cuputy & Costerton (1982) 
found that preparation of thin sections for EM caused glycocalyx from the surface of 
S. aureus cells to be tom away. Jones et al. (1969) found material in their EM 
samples identical in appearance to the UEM found in this study coming away from 
the cell surface of bacterial cells and present throughout the sample. They identified 
it as polysaccharide-like. Jones et al. (1969) also found that the polysaccharide 
material was separated from the cell surface in some samples by a clear area of no 
polysaccharide, which was also found in EM samples of this study. They are unsure 
as to the reason for the clear area immediately surrounding the cell surface, but 
hypothesize it may be an artefact of dehydration or due to polysaccharide production 
ceasing or formation of a protective microenvironment around the cell. As 
mentioned in section 5.1.5 small concentrations of AHR has been found to stimulate 
the secretion of extracellular protein in Acinetobacter baumannii (Edwards et al.,
2007). Another theory as to the identity of the UEM is that since S. aureus is also 
able to metabolise ethanol (Artzatbanov & Petrov, 1990) it may stimulate secretion 
of extracellular protein, which may form whole, or part of, the UEM found in this 
study. The denser UEM found in Figure 5.8 was not similar in appearance to that 
found by Jones et al. (1969), but it is likely that the material has maintained its 
position during preparation. The polysaccharide found in Figure 5.8 may be a form 
of glycocalyx, such as a slime layer. The role of slime layers in biocide tolerance is 
not well known, but they at least provide a physical barrier to penetration or absorb 
the biocide (McDonnell, 2007). It is not clear why this material was surrounding 
cells following 1 min exposure to AHR but not following 5 min exposure. It could 
be that the material has been broken down by the alcohol, which is possible if this 
material consists of protein or lipid.
5.4.4 The Effect of AHR on Protein Denaturation
It was shown in section 5.3.2 that the cell wall or outer layers are likely to be the 
main target for AHR and are likely to be responsible for the difference in 
susceptibility seen among the isolates. Differences in susceptibility may be due to 
reduced penetration or increased repair of cell wall. If this is the case the main mode 
of action of AHR on the cell wall is most likely due to denaturation of proteins, since
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alcohol is known to denature proteins (McDonnell & Russell, 1999). Quantification 
of protein was unachievable, however, as outlined in section 5.1.4. It was therefore 
unknown whether differences between the susceptibility of isolates was due to
differences in penetration of the AHR into the cell or whether is was due to
differences in susceptibility of the cell wall to damage, most likely due to protein 
denaturation. Uptake studies are possible for biocides, which may rule out/implicate 
differences in penetration. However, such studies involve mixing bacterial cells with 
a known volume of biocide and after separation by either centrifugation or filtration 
either the quantity of biocide remaining in solution or the quantity taken into the cell 
are quantified (Salt & Wiseman, 1991). These methods are not possible to perform 
with AHRs, since their high viscosity does not permit separation without dilution, 
thus not allowing easy quantification of concentration.
5.4.5 The Effect of AHR on Expression of Virulence Genes
The reason some isolates are less susceptible to AHR than others may be due to
reduced penetration or due to increased expression of genes that may aid survival 
against AHR, such as those that encode biofilm production. If virulence genes are 
more expressed after exposure to AHR and AHR is not effective at killing S. aureus 
isolates in practice, then exposure to AHR in the healthcare environment may result 
in isolates becoming more virulent. There was a trend towards down-regulation of a 
number of the genes, indicating that these are not considered necessary for the cell 
during exposure to AHR and that more useful genes that aid survival are likely to be 
up-regulated. These results are supported by Bore et al. (2007), who found no up- 
regulation of virulence genes upon exposure to harmful conditions.
RT-PCR results were inconsistent and cannot therefore be relied upon to provide an 
accurate representation of gene expression. The use of qPCR is more accurate and 
would therefore provide a more accurate gene expression analysis (VanGuilder et ah,
2008). The virulence genes chosen, however, do not reflect genes that are likely to 
be used for repair or survival (with the exception of icaA and icaD, which encode 
production of biofilm); therefore microarray analysis would more useful, since it
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would identify all genes that are up- or down-regulated upon AHR exposure (Schena 
etal., 1995).
S. aureus has previously been found to respond to acidification to pH 4.5 by up- 
regulation of genes involved in acid defence, along with other stress response genes, 
down-regulation of genes involved with cellular growth, but no virulence gene up- 
regulation (Bore et al., 2007). Such genes may be similarly affected by exposure to 
AHR, along with currently unknown genes that may help S. aureus survive exposure.
5.4.6 Summary
This chapter demonstrated that although AHR had an effect on the cytoplasmic 
membrane (as demonstrated by the K+ leakage assay and TEM), it is most likely not 
the main target of AHR. It was demonstrated that the cell wall or outer layer of the 
cell are targeted by AHR and this was likely to be due to protein denaturation. It was 
also demonstrated that whilst damage to the cell affected its physical appearance this 
damage was not necessarily correlated to a bactericidal effect. Furthermore, 
bactericidal activity may occur prior to damage being observable. Not all virulence 
genes were expressed under pre- AHR exposure conditions. Although exposure to 
AHR caused a change in expression of some virulence genes, with a tendency 
towards down-regulation, these results were inconsistent due to variability in the test 
results.
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CHAPTER 6 PROPERITES OF STAPHYLOCOCCUS 
AUREUS LINKED TO ALCOHOL HAND RUB 
SUSCEPTIBILITY
6.1 INTRODUCTION
6.1.1 Bacterial Adhesion
Bacteria are able to adhere to living and inanimate surfaces. Adhesion to a surface 
protects bacteria from the environment and adhesion to skin assists entry into the 
host. Bacterial adhesion to surfaces is mediated by non-specific physical interactions 
and specific ligand-receptor interactions (Dalton & March, 1998). Non-motile 
bacteria such as S. aureus come into contact with a surface via gravity, convection or 
Brownian motion. The first phase of adhesion to a surface is the reversible, non­
specific adhesion of bacteria to the surface using weak bonds such as van der Waal’s 
forces, electrostatic interactions and hydrophobic interactions (Fletcher, 1996; Figure 
6.1). This attachment is reversible, since shear force will remove cells from the 
surface.
The second phase of adhesion to a surface involves specific interactions (Figure 6.1), 
which consist of ligand-receptor interactions that enable S. aureus to selectively bind 
to host cells. These are described in detail in Table 1.1, Chapter 1.
6.1.2 Cell Surface Hydrophobicity
Cell surface hydrophobicity refers to the degree to which a cell is repelled from 
water, where hydrophobic cells would be repelled by water away from the aqueous 
phase onto a surface (Rosenberg & Doyle, 1990). Hydrophobic interactions are one 
of the mechanisms of bacterial cell adhesion (Gorman, 1991; Fletcher, 1996). The 
bacterial surface consists of a number of moieties that promote (hydrophobins) and 
reduce (hydrophilins) hydrophobicity. Differences between bacterial cell surface 
hydrophobicities are the result of differences in concentrations, distribution and 
configuration of these moieties (Rosenberg & Doyle, 1990). One such hydrophobin 
is protein A. Jonsson & Wadstrom (1984) found that presence of protein A on the 
surface of S. aureus cells contributed to high levels of hydrophobicity among clinical 
isolates.
181
<2 d > 50 nm
Ltfshitz-van der Waals 
interactions
10-20nm
repulsive electrostatic 
interactions
( •  2 ‘ 10 nm
repulsive and attractive 
electrostatic interactions
0.5 - 2 nm
mterfactal water (<)is a barrier for specific 
interactions and may be removed by hydrophobic 
groups (HB)
< 1.0 nm
specific interactions
Figure 6.1: Forces Involved in Bacterial Adhesion to Surfaces
Diagram illustrating the forces involved in the interaction of a bacterium with a 
surface at various distances. Reproduced from Fletcher (1996).
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Bacteria that have more hydrophobic surfaces are able to auto-aggregate (Jonsson & 
Wadstrom, 1984) and adhere more easily to human skin (Rosenberg et ah, 1981) and 
invasive devices (Pascual et ah, 1986; Boujaafar et al., 1990). Bacteria that are more 
hydrophobic than phagocytes are able to resist phagocytosis (Cunningham et ah, 
1975). Absolom (1988) found that S. aureus was the most hydrophobic species of a 
number of microorganisms tested and therefore was not phagocytosed by neutrophils 
as readily as other species. Hydrophobic bacteria are therefore more virulent 
(Ljungh et al., 1985).
No single test adequately describes hydrophobicity because experimental conditions 
used in these tests influence/interfere with the observed outcome to some degree 
(Rosenberg et ah, 1980). More than one test is therefore necessary to increase 
confidence in results and the results of one single test should not be relied upon 
(Dillon et ah, 1986). Hydrophobicity can be measured directly by water contact 
angle measurements or indirectly by hydrophobic interaction chromatography, salt 
aggregation test (SAT), binding of individual hydrophobic molecules such as anionic 
surfactants, two-phase aqueous partitioning, microbial adhesion to hydrocarbons 
(MATH) and adhesion to polystyrene (Rosenberg, 2006).
The SAT measures the precipitation of cells by salts and is based on the principle 
that the more hydrophobic the surface of bacterial cells, the lower the concentration 
of salt required to aggregate them (Lindahl et ah, 1981). The hexadecane adherence 
assay (HAA) is a MATH test that measures the adherence of bacterial cells to the 
hydrocarbon ^-hexadecane, whereby more adherent cells are more hydrophobic. 
However, hexadecane is highly negatively charged due to ion adsorption and 
therefore HAA test results are also likely to reflect the electrical surface charge of 
cells to a small degree (Geertsema-Doombusch et ah, 1993). The xylene adherence 
assay (XAA) measures the adherence of bacterial cells to the hydrocarbon xylene in 
the same manner as for the HAA (Galliani et ah, 1994).
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6.13 Surface Charge
The surface of a bacterial cell has a net negative charge due to the phosphate groups 
of teichoic acid, carboxylates of peptidoglycan, acidic polypeptides and 
polysaccharides, plus polysaccharides of the glycocalyx (Somasundaran, 2006). This 
charge at the cell surface creates an electrostatic field surrounding the cell and is 
therefore balanced by positively charged ions in the immediate vicinity of the cell 
surface, which form an electrical double layer (Figure 6.2). The potential arising 
from the negatively charged surface decreases exponentially with distance from its 
surface, meaning that as a bacterium moves through a suspension medium it will 
carry a thin layer of the medium with it, including some positively charged ions 
(Finean et al., 1978). The potential at the surface of shear, or slipping plane (where 
the layer moves past the bulk solution) is called the zeta potential and is therefore a 
few mV lower than the true surface potential. The zeta potential of particles is 
measured by applying an electric field to the particle dispersion. Particles within the 
dispersion with a zeta potential will migrate toward the electrode with an opposite 
charge to themselves. The velocity at which this occurs depends on the magnitude of 
their zeta potential.
Surface charge is a critical property that influences bacterial adhesion to surfaces 
because it determines the electrostatic interaction between bacterial cells and 
surfaces (Luo et al., 2005). The more negatively charged a bacterium, the more 
effective it is at attaching to surfaces (Dickson & Koohmaraie, 1989). The negative 
charge of bacterial cells also means that cationic antimicrobial peptides produced by 
epithelial cells and neutrophils can easily bind to the bacterial membrane and lyse the 
cell (Sahl et al., 2005). S. aureus is able to modify its surface charge by addition of 
positively charged groups to components of the cell wall and cytoplasmic membrane, 
thereby neutralizing the negative charge and leaving S. aureus resistant to these, and 
other, host defences (Kraus et al., 2008). Bacterial surface charge has also been 
found to be influenced by quorum sensing, which can lead to aggregation and 
production of biofilm (Eboigbodin et al., 2006).
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Figure 6.2: Schematic Representation of Zeta Potential
Representation of the electrostatic phenomena that occur in the immediate vicinity of 
a negatively charged particle such as a bacterial cell. Reproduced from Malvern 
Instruments Ltd., Malvern, UK.
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6.1.4 Cell Size and Arrangement
Isolates of the same species are known to vary in size. S. aureus has been shown to 
increase cell size in response to the presence of harmful agents in the environment, to 
reduce the relative area of the cell surface and therefore reduce the chance of damage 
(Raju et al., 2007). This may be the result of the presence of surface structures, such 
as a capsule or slime layer, or a thicker cell wall. Increased cell size may, therefore 
result in the cells being less susceptible to AHR exposure. Bacterial cell size is 
usually measured using an electronic particle size counter or scanning electron 
microscopy (SEM; Russell et al., 1973).
6.1.5 Presence of a Capsule
S. aureus isolates can be heavily encapsulated (serotype 1 and 2, which produce 
mucoid colonies and are rare among clinical isolates) or microencapsulated 
(serotypes 3-8; O’Riordan & Lee., 2004). Capules consist of hexosaminuronic acids 
(types of amino sugar) and protein and may act as a barrier to biocide penetration and 
increase virulence by avoiding phagocytosis (O’Riordan & Lee, 2004, McDonnell, 
2007). The presence of a capsule can be determined by negative staining with crystal 
violet or india ink (Brooks et al., 2007), electron microscopy (Arizono et ah, 1991), 
serotyping using antibodies and PCR (Verdier et ah, 2007).
6.1.6 Protein Content of S. aureus
Chapter 5 concluded that the major effect of AHR is likely to be protein 
denaturation. Protein is present in the cytoplasm, the cytoplasmic membrane and the 
cell wall of S. aureus, as well as in the outer S-layer, capsule and sometimes the 
slime layer (McDonnell, 2007). The total protein content is usually determined by 
the Bradford method (Bradford, 1976), Lowry method (Lowry et al., 1951) and 
bicinchoninic acid assay (BCA; Smith et al., 1985) methods, which are all 
colourimetric assays that measure a change in absorbance as a result of a colour 
change in the reagent. The BCA method is often the assay of choice since it is 
quicker to perform than the Lowry method and more accurate than the Bradford 
method (Berges et ah, 1992).
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6.1.7 Aims and Objectives
The aim of this chapter was to determine the properties of S. aureus, including 
possible changes in those properties following AHR exposure that are linked to its 
susceptibility to AHR. The properties investigated were those that may affect 
susceptibility to AHR, including surface properties such as hydrophobicity and 
surface charge, cell size, cell arrangement and total protein content of the most- and 
least-susceptible isolates to AHR.
6.2 MATERIAL AND METHODS
6.2.1 Determining the Sub-Lethal Concentration of AHRs
6.2./. 1 Validation of PBS as a Neutralizer for AHR at a 1 in 9 Dilution
A bacterial suspension of S. aureus NCIMB 9518 was prepared to a concentration of 
8.61 ± 0.11 logio CFU/ml according to section 2.5.1. One ml of AHR was added to 8 
ml phosphate buffered saline (PBS) and vortex mixed, then left for 5 min to allow 
neutralization. One ml of bacterial suspension was added and vortex mixed, then 
after 5 min a viable count was performed according to section 2.6.1.1. A control was 
also performed, where 1 ml bacterial suspension was added to 9 ml PBS. This 
procedure was performed 5 times for Soft Care Med H5, Cutan and Guest Medical 
AHRs, using a fresh bacterial culture for each replicate. Statistical analysis was 
performed on the logio duplicate counts according to section 2.8.1 to determine 
whether there was a significant difference between the test and control counts.
6.2.1.2 Validation o f TSB as a Neutralizer for AHR at a 1 in 9 Dilution
The test was performed five times for Soft Care Med H5, Cutan and Guest Medical 
AHRs according to the neutralizer validation of PBS in section 6.2.1.1, except the 
test and controls were performed with TSB instead of PBS. Suspensions used were 
prepared to a concentration of 8.57 ± 0.09 logio CFU/ml.
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6.2.1.3 Determining the Sub-Lethal Concentration of AHRs
A bacterial suspension of S. aureus NCIMB 9518 was prepared to a concentration of 
8.53 ± 0.11 logio CFU/ml according to section 2.5.1. AHR was mixed with TSB at 
concentrations of 1 in 10, 1 in 12 and 1 in 14 and left for 5 min. Ten wells of a 
Bioscreen honeycomb plate were filled with 350 pi of each AHR concentration. A 
50 pi volume of suspension was added to the first 5 wells for each AHR 
concentration. A fifty pi volume of TSC buffer was added to the remaining 5 wells 
of each AHR concentration, which acted as negative controls (blanks). A further ten 
wells were filled with 350 pi TSB. Fifty pi of suspension was added to the first five 
wells, which acted as positive controls. Fifty pi TSC buffer was added to the 
remaining five wells to serve as negative controls (blanks). The honeycomb plate 
was incubated in a Bioscreen microbial growth analyser at 37 °C for 14 hours with an 
OD reading taken every 15 min using a wideband filter with a wavelength of 420- 
580 nm. The plate was set to shake for 10 s before each OD420-580 reading. The mean 
of each test and positive control OD42 0 -5 8 0  reading was calculated at each 15 min 
reading interval and the overall mean value of each blank was subtracted from the 
appropriate test and positive control mean values to provide a true OD420-580 value. 
The mean-blank results were used to create a graph and the resulting growth curves 
were analysed.
6.2.2 Determining the Cell Surface Hydrophobicity of S. aureus Isolates
6.2.2.1 Materials
Sodium phosphate (Acros Organics) was used to make sodium phosphate buffer to a 
concentration of 0.002 M in deionised water and was adjusted to pH 6.8 using 
ammonium hydroxide (Acros Organics). Ammonium sulphate was prepared to a 
concentration 4 M in 0.002 M sodium phosphate buffer.
6.2.2.2 Salt Aggregation Test
This test was originally described by Lindahl et al. (1981). An overnight broth 
culture was prepared according to 2.4.4, and centrifuged at 940 g  for 10 min. The 
pellet was washed twice with 0.002 M sodium phosphate buffer and re-suspended in
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0.002 M sodium phosphate buffer to a concentration of 9.70 logio CFU/ml according 
to section 2.5.3. A range of different concentrations of ammonium sulphate (‘salt’) 
were prepared in 0.002 M sodium phosphate buffer. These included dilutions of 4.0 
M to 0.2 M (differing by 0.2 M per dilution) and dilutions of 0.2 M to 0.02 M 
(differing by 0.02 M per dilution). Twenty five pi of each ‘salt’ dilution was added 
to a glass depression slide (Fisher Scientific) and 25 pi of bacterial suspension was 
added. A negative control was also performed with 25 pi 0.002 M sodium phosphate 
buffer and 25 pi suspension. The mixtures were placed on a Grant Bio POS 300 
rotating platform at 120 rpm for 2 min. Mixtures were observed manually for 
changes in visual appearance. A positive result was signified by optimal 
aggregation, which consisted of a clear solution with white aggregates approximately 
1-10 mm in diameter. This test was performed with S. aureus isolates 44, 27, 37, 
NCIMB 9518, 52, 34, S12, S5, 6 , 51, 28 and SI.
6,2,23 Hexadecane Adherence Assay
This test method was based on those described by Rosenberg et al. (1980) and 
Greene et al. (1992). A 24 h broth culture was prepared according to 2.4.4 and 
centrifuged at 940 g  for 10 min. The pellet was washed twice with PBS and re­
suspended in PBS to an OD540 of 0.54 ± 0.03. Eight hundred pi ^-hexadecane was 
added to a round-bottomed glass test tube (Fisher Scientific) containing 3 ml of the 
bacterial suspension. The test tube was incubated for 10 min at 30°C and following
1.5 min of vortex mixing, was left for 15 min for bacterial cells to adhere to the 
hexadecane. Finally, 1 ml of the aqueous (bottom) layer was extracted using a 
Pasteur pipette and the OD540 was measured. This test was performed in triplicate 
for S. aureus isolates 44, 27, 37, NCIMB 9518, 52, 34, SI2, S5, 6 , 51, 28 and SI. 
The % adherence for each replicate was calculated using the following equation:
% adherence = G D in itia l ~ OD+hexadecane 
GDjnjtial
x 1 0 0
The method used to detect adherence post-exposure to AHR was similar to that 
described above, except after washing twice in PBS cells were re-suspended in 5 ml 
of a 1 in 10 dilution of AHR in PBS and left for a contact time of 10 min. Cells were
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centrifuged at 2600 g  for 15 min, washed twice in PBS and re-suspended in PBS to 
an OD54 0 of 0.54 ± 0.03. This test was performed in triplicate for S. aureus isolates 
44, 27, 37, NCIMB 9518, 52, 34, S12, S5, 6 , 51, 28 and SI using Soft Care Med H5, 
Cutan and Guest Medical AHRs.
Statistical analysis was performed according to section 2.8.1 to determine whether % 
adherence values varied among the isolates. Statistical analysis was also performed 
according to section 2 .8 . 2  to determine whether % adherence values were different 
pre- and post-exposure.
6,2.2.4 Xylene Adherence Assay
This test method was based on those described by Rosenberg et al. (1980) and 
Galliani et al. (1994). A 24 h broth culture was prepared according to section 2.4.4 
and centrifuged at 940 g  for 10 min. The pellet was washed twice with PBS and re­
suspended in PBS to an OD540 of 1.05 ± 0.03. A volume of 250 pi p-xylene (Acros 
Organics) was added to a round-bottomed glass test tube containing 3 ml of the 
bacterial suspension. The tube was incubated for 10 min at 30°C and following 1.5 
min of vortex mixing, was left for 15 min for bacterial cells to adhere to the p- 
xylene. Finally, 1 ml of the aqueous (bottom) layer was extracted using a Pasteur 
pipette and the OD540 was measured. This test was performed in triplicate for S. 
aureus isolates 44, 27, 37, NCIMB 9518, 52, 34, S12, S5, 6 , 51,28 and SI and the % 
adherence for each replicate was calculated using the following equation:
% adherence = G D jnitia l “ OD+p-xylene
G D jnitial
x 1 0 0
The % adherence post-exposure to AHR was a modified form of the above method, 
where after washing twice in PBS cells were re-suspended in 5 ml of a 1 in 10 
dilution of AHR in PBS and left for a contact time of 10 min. Cells were centrifuged 
at 2600 g  for 15 min, washed twice in PBS and re-suspended in PBS to an OD540 of
1.05 ± 0.03. This test was performed in triplicate for S. aureus isolates 44, 27, 37, 
NCIMB 9518, 52, 34, SI2, S5, 6 , 51, 28 and SI using Soft Care Med H5, Cutan and 
Guest Medical AHRs. Statistical analysis was performed as in section 6.2.2.3.
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6.23 Determining the Surface Charge of S. aureus Isolates
This test was based on the method in Matz & Jurgens (2001). It was performed in 
triplicate for S. aureus isolates 44, 27, 37, NCIMB 9518, 52, 34, SI2, S5, 6, 51, 28 
and SI pre- and post-exposure to Soft Care Med H5, Cutan and Guest Medical 
AHRs. For pre-exposure testing a 24 h broth culture was prepared according to 
section 2.4.4. Suspensions were prepared in 0.0001 M KC1 buffer according to 
section 2.5.2, with two washing steps. Suspensions were adjusted to achieve a 
concentration of 6.21 ±0.14 logio cfu/ml and enumerated according to section 2.6.1. 
Two ml of each suspension was analysed using a Zetasizer 2000 (Malvern 
Instruments Ltd., Malvern, UK), which took five measurements of the zeta potential 
(mV). For post-exposure testing washed suspensions were centrifuged at 2600 g and 
the pellet was re-suspended in 5 ml AHR diluted 1 in 10 in 0.0001 M KC1 buffer for 
a contact time of 10 min. Suspensions were washed twice in 0.0001 M KC1 buffer 
and adjusted, enumerated and analysed as above.
Statistical analysis was performed according to section 2.8.1 to determine whether 
zeta potential values varied among the isolates. Statistical analysis was also 
performed according to section 2.8.2 to determine whether zeta potential values were 
different pre- and post-exposure.
6.2.4 Determining Cell Size, Arrangement and Surface Properties of S. aureus 
Using Microscopy
6.2.4.1 Materials
All SEM chemicals were prepared with double distilled water. Cacodylate buffer 
consisted of 300 mM Tris-HCl, 1 M sodium cacodylate and 10 mM cobalt chloride.
6.2.4.2 Preparation o f Sample
S. aureus isolates 44, NCIMB 9518 and SI were incubated in broth according to 
section 2.4.4 and 750 pi of culture was transferred to a microcentrifuge tube and 
centrifuged at 2,200 g for 5 min. The pellets were washed in 2% glutaraldehyde in 
0.1 M Sorensen buffer and left for 1 h in 2% glutaraldehyde to fix. The samples
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were washed twice in 0.1 M cacodylate buffer and left for 1 h in enough 1% osmium 
tetroxide in cacodylate buffer to cover the pellet. The pellets were washed three 
times in cacodylate buffer, re-suspended and placed in purpose-made plastic 
filtration capsules containing 13 mm 0.2 pm cellulose acetate filters (Sartorius, 
Epsom, UK). The filtration capsules were centrifuged at 2,200 g  for 5 min and the 
samples were progressively dried by adding increasing concentrations of ethanol to 
the filtration capsule for 5 min, which were 50%, 70%, 90% and three steps of 100%. 
Samples were dried in a critical point drier (Samdri 780, Maryland, USA), then 
removed from the filtration capsules and attached with double-sided tape to brass 
SEM specimen carriers. The specimens were coated with gold using a gold sputter 
coater (EMScope, UK).
6,2.43 Analysis o f Samples Using Scanning Electron Microscopy 
Samples prepared according to section 6.2.4.2 were examined at 1,000 x and 10,000 
x magnification using an XL20 scanning electron microscope (Philips, Croydon, 
UK). Each sample was examined at 10,000 x magnification to observe cell size. 
Ten fields of vision were observed at this magnification and five representative 
images were taken.
6.2.4.4 Measuring the Size o f S. aureus Cells Using SEM Images
The size of S. aureus cells was determined by measuring the diameter of 15 random 
bacterial cells per field of vision. The actual diameter was calculated using the 
following equation:
Actual diameter = scale bar size (um) x observed diameter of cell (mm) 
of cell (pm) length of scale bar (mm)
The mean diameter plus SD of bacterial cells for each of the five fields of vision for 
each isolate was calculated to determine the overall mean diameter of bacterial cells 
for each isolate. Statistical analysis was performed on the mean diameter of cells 
from each field of vision according to section 2.8.1 to determine whether there was a 
significant difference between bacterial cell diameter of the three isolates.
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6.2.4.5 Determining the Presence/Absence of Capsules Surrounding S. aureus 
Cells
This method was performed for S. aureus isolates 44, NCIMB 9518 and SI. 
Cultures were prepared according to section 2.4.3 and washed from the surface with 
SDW. Cells were air dried onto a microscope slide and stained with crystal violet 
(Pro-Lab Diagnostics, Neston, UK) for 8 min. The crystal violet was washed from 
the surface of the slide with 20% w/v copper sulphate. Cells were observed under a 
light microscope at 100 x magnification and capsules were observed as a light 
coloured halo surrounding the cell surface.
6.2.5 Determining the Total Protein Content of S, aureus Cells
6.2.5.1 The Bicinchoninic Acid Protein Assay
The BCA method was performed according to the method provided by Sigma- 
Aldrich. Overnight broth cultures were performed for S. aureus isolates 44, NCIMB 
9518 and SI according to section 2.4.4. Cultures were centrifuged at 2,600 g  for 15 
min, washed in SDW and finally re-suspended in SDW. The concentration of culture 
used during testing was determined by measuring the dry weight of an equal volume 
of the suspension used for the BCA assay. This was achieved by centrifuging a 1 ml 
volume of suspension and drying the pellet at 105 °C in a heating block (Techne) for 
6 hours. A further 1 ml volume of each suspension was diluted with 1.5 ml SDW 
and 100 pi 100 mM phenylmethanesulfonyl fluoride (PMSF) prepared in ethanol 
was added. Each suspension was sonicated on ice for three sets of 60 s, with 30 s 
intervals between each sonication. After this process samples were kept on ice. 
Each suspension was centrifuged at 4 °C at 2,500 g for 15 min and the supernatant 
was retained for further testing. One hundred pi volumes of each suspension were 
added to 2 ml working reagent (stock prepared as 100 ml BCA and 2 ml 4 % w/v 
copper sulphate pentahydrate). One hundred pi volumes of BSA at a range of known 
concentrations between 0 and 1000 pg/ml were also added to 2 ml working reagent 
and all reactions were incubated at 37 °C for 30 min. The OD562 of all reactions was 
measured. Tests were performed in triplicate.
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6.2.S.2 Calculating the Total Protein Content
A fitted line plot of BSA protein concentration (pg/ml) against OD562 was created, 
allowing the protein concentration of each sample in the reaction tubes to be 
determined using the linear equation (Figure 6.9). The concentration of protein in 
the original 1 ml suspension was determined by multiplying the concentration of 
protein in the reaction tube.
63  RESULTS
63.1 Determining the Sub-Lethal Concentration of AHRs
6.3.1.1 Validation o f PBS as a Neutralizer for AHR at a 1 in 9 Dilution
PBS was used to dilute AHR to a sub-lethal concentration during hydrophobicity 
testing in section 6.2.2; therefore its ability to quench the bactericidal effect of AHR 
was validated. Results are shown in Table 6.1. There was no significant difference 
between test and control counts for Soft Care Med H5, Cutan and Guest Medical (P 
>0.05), indicating that PBS was effective at neutralizing the bactericidal activity of 
the AHRs at a 1 in 9 dilution.
6,3. L2 Validation o f TSB as a Neutralizer for AHR at a 1 in 9 Dilution
TSB was used to dilute AHR to a sub-lethal concentration during the test to 
determine the sub-lethal activity of AHRs in section 6.2.1.3; therefore its ability to 
quench the bactericidal effect of AHR was validated. Results are shown in Table
6.2. There was no significant difference between test and control counts for Soft 
Care Med H5, Cutan and Guest Medical (P >0.05), indicating that TSB was effective 
at neutralizing the bactericidal activity of the AHRs at a 1 in 9 dilution.
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Table 6.1: PBS Neutralization Validation Results
Mean ± SD log 10 cfu/ml of S. aureus NCIMB 9518 after exposure to Soft Care Med 
H5, Cutan and Guest Medical AHRs for the validation of PBS neutralizer test.
AHR Logio Control CFU/ml Logio Test CFU/ml
Soft Care Med H5 7.86 ±0.05 7.89 ± 0.09
Cutan 7.80 ±0.11 7.82 ± 0.06
Guest Medical 7.65 ± 0.28 7.68 ± 0.35
Table 6.2: TSB Neutralization Validation Results
Mean ± SD log 10 cfu/ml of S. aureus NCIMB 9518 after exposure to Soft Care Med 
H5, Cutan and Guest Medical AHRs for the validation of TSB neutralizer test.
AHR Logio Control CFU/ml Logio Test CFU/ml
Soft Care Med H5 7.72 ±0.10 7.69 ±0.10
Cutan 7.70 ±0.10 7.66 ±0.10
Guest Medical 7.68 ± 0.07 7.77 ± 0.08
195
6.3,1.3 Determining the Sub-Lethal Concentration of AHRs
Growth curves of S. aureus NCIMB 9518 in the presence of sub-lethal 
concentrations of AHR are shown in Figure 6.3. The 1 in 10 dilution grew slower 
than the 1 in 12, which grew slower than the 1 in 14 dilution, for all AHRs. Soft 
Care Med H5 reduced bacterial growth the most, followed by Guest Medical, and 
Cutan reduced bacterial growth the least. Cutan and Guest Medical AHRs showed a 
clear increase in bacterial number over time at dilutions 1 in 10, 1 in 12 and 1 in 14, 
whereas Soft Care Med H5 AHR did not. No dilutions of any AHR showed growth 
of S. aureus as rapid as that of the control. A 1 in 10 dilution of AHR produced the 
strongest sub-lethal activity against S. aureus NCIMB 9518 and therefore this 
dilution of AHR will be used during subsequent testing in this chapter to achieve a 
sub-lethal effect on S. aureus isolates.
63.2 Determining the Cell Surface Hydrophobicity of S. aureus Isolates
6.3.2.1 Salt Aggregation Test
Results of the SAT are shown in Table 6.3. No optimal aggregation was observed 
for any of the isolates at any concentration. A few small aggregates were observed 
for isolates 28, 34 and 51 at a concentration of 4.0 M, but this did not comply with 
the definition of ‘true aggregation’ according to Lindahl et al. (1981) and was 
therefore regarded as a negative result. Since no end point was observed for this test 
it was aborted after 1 run of pre-exposure to AHR.
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Figure 6.3: Sub-Lethal of lin 10,1 in 12 and 1 in 14 Diluted AHRs
Jo Growth of S. aureus NCIMB 9518 in the presence of Soft Care, Cutan and Guest Medical AHRs diluted 1 in 10, 1 in 12 and 1 in 14
Table 63: Results of Salt Aggregation Test
Presence or absence of aggregation for S. aureus NCIMB 9518 plus 11 hospital 
isolates in the presence of varying concentrations of ‘salt’. +/- = few or no 
aggregates, classed as a negative result, - = no aggregation.
Salt Isolate
Cone. 44 27 37 NCIMB 52 34 S12 S5 6 51 28 SI
(M)___________________9518_____________________________________
4.0 - - +/. +/. -
3. 8 ...........................................................................................................
3. 6 ...........................................................................................................
3. 4 ...........................................................................................................
3. 2 ...........................................................................................................
3. 0 ...........................................................................................................
2 .  8 ..........................................................................................................................................................
2. 6 ............................................................................................
2. 4 ............................................................................................................
2. 2 ............................................................
2 .  0 .........................................................................................................................................................................................
1 . 8 .........................................................................................................................................
1 . 6 ............................................................................................................
1. 4 ............................................................................................................
1 . 2 .................................................................................................................
1 . 0 ............................................................................................................
0 . 8 .....................................................................................................................
0 . 6 ............................................................................................................
0.4 - - ...............................................................
0 . 2 ............................................................................................................
0 . 1 8 ............................................................................................................
0 . 1 6 ............................................................................................................
0 . 1 4 ............................................................................................................
0 . 1 2 .................................................................................................................
0 . 1 0 ...........................................................................................................
0 . 0 8 ............................................................................................................
0 . 0 6 ...........................................................................................................
0 . 0 4 ...........................................................................................................
0 . 0 2 ............................................................................................................
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63.2.2 Hexadecane Adherence Assay
The mean % adherence values for isolates pre- and post-AHR exposure are shown in 
Figure 6.4. Adherence was considered to be positive if % adherence was >75%, 
intermediate if % adherence was 25-75% and negative if % adherence was <25%. 
Isolates with a positive adherence were hydrophobic, those showing intermediate 
adherence were of intermediate hydrophilicity/hydrophobicity and those isolates with 
a negative adherence were hydrophilic. A total of 67% of the isolates were 
hydrophobic and 33% were of intermediate hydrophobicity/hydrophilicity pre­
exposure to AHR.
The % adherence values of the 12 isolates were not significantly different from each 
other under either pre- or post-AHR exposure conditions (P >0.05), except after 
exposure to Cutan (P <0.05). There was also no significant difference between the 
% adherence values pre-and post-exposure to AHR for most isolates (P >0.05). 
However, the % adherence values were significantly higher after exposure to Soft 
Care Med H5 for isolates 27, 37, S5 and 28, after exposure to Cutan for isolates S5 
and 28 and after exposure to Guest Medical for isolate S5 (P <0.05). The % 
adherence values were significantly lower after exposure to Cutan for isolates 
NCIMB 9518 and 34 (P <0.05). This means that exposure to Soft Care Med H5 
caused cells to become significantly more hydrophobic for isolates 27, 37, S5 and 28; 
exposure to Cutan caused cells to become significantly more hydrophobic for isolates 
S5 and 28, but caused cells to become significantly less hydrophobic for isolates 
NCIMB 9518 and 34; exposure to Guest Medical caused cells to become 
significantly more hydrophobic for isolate S5.
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Figure 6.4: Results of the Hexadecane Adherence Assay
Mean percentage adherence +/- SD of S. aureus NCIMB 9518 plus 11 hospital isolates pre- and post- exposure to Soft Care Med H5, Cutan 
and Guest Medical AHRs for the Hexadecane Adherence Assay. * indicates where a value was significantly different.
63.23 Xylene Adherence Assay
The mean % adherence values for isolates pre- and post-AHR exposure are shown in 
Figure 6.5. Adherence was considered to be positive if % adherence was >75%, 
intermediate if % adheience was 25-75% and negative if % adherence was <25%. 
Isolates showing positive adherence were hydrophobic, those showing intermediate 
adherence were of intermediate hydrophilicity/hydrophobicity and those isolates 
showing negative adheience were hydrophilic. A total of 33% of the isolates were 
hydrophobic and 67% were of intermediate hydrophobicity/hydrophilicity pre­
exposure to AHR.
There was no significant difference between the % adherence of the twelve isolates 
under any of the conditions (pre- or post-exposure to AHR; P >0.05), except after 
exposure to Cutan (P <0.05). There was also no significant difference between the 
% adherence values pre-and post-exposure to AHR for most isolates (P >0.05). 
However, % adherence values were significantly higher after exposure to Soft Care 
Med H5 for isolate SI, after exposure to Cutan for isolates 6 and SI and after 
exposure to Guest Medical for isolate 6 (P <0.05). This means that exposure to Soft 
Care Med H5 caused cells to become significantly more hydrophobic for isolate SI, 
exposure to Cutan caused cells to become significantly more hydrophobic for isolates 
6 and SI and exposure to Guest Medical caused cells to become significantly more 
hydrophobic for isolate 6.
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Figure 6.5: Results of the Xylene Adherence Assay
Mean percentage adherence +/- SD of S. aureus NCIMB 9518 plus 11 hospital isolates pre- and post- exposure to Soft Care Med H5, Cutan 
and Guest Medical AHRs for the Xylene Adherence Assay. * indicates where a value was significantly different.
6.3.2.4 Comparison o f HAA and XAA
The HAA and XAA hydrophobicity tests produced different % adherences for S. 
aureus isolates 44, 27, 37, NCIMB 9518, 52, 34, S12, S5, 6, 51, 28, SI (Figures 6.4 
and 6.5, respectively), which resulted in some of the isolates being categorised as 
being of different hydrophobicities. This was partly due to the % adherence values 
being near the boundary of hydrophobic and intermediate categories, partly due to 
the large variability between replicates and partly due to actual differences between 
the tests. A comparison of the hydrophobicity of the isolates using the HAA and 
XAA is shown in Table 6.4.
Statistical comparison of HAA and XAA % adherence results pre- and post-exposure 
to AHR was also performed, according to section 2.8.1. There was no significant 
difference between the two assays (P >0.05), except isolate S5 had a significantly 
higher % adherence after exposure to Cutan using the HAA compared to using the 
XAA (P <0.05). This is in spite of the fact that less isolates were categorised as 
hydrophobic and % adherence appeared lower for some isolates for the XAA 
compared to the HAA.
The isolates were ranked from 1-12 according to the highest (1) to the lowest (12) 
mean % adherence values for the HAA and the XAA hydrophobicity tests pre- and 
post-exposure to each AHR (see Table 6.5). The isolates were found to not be 
ranked in the same order for the HAA and XAA for pre- or post-exposure conditions.
The correlation co-efficient was determined for HAA and XAA to determine whether 
they were positively correlated. Scatterplots were created of the mean % adherence 
values for each of the isolates for the HAA and XAA, one plot for each condition 
(pre- and post- exposure to AHR). Distribution of data for each scatterplot was 
confirmed as satisfactory for using the Spearman’s rank correlation coefficient. The 
Spearman’s rank correlation coefficients (rs) are shown in Table 6.6. The rs values 
were lower than the critical value (minimum value required for a significant result, 
which was determined from a standard table of values according to the number of 
pairs of data points) for each condition; therefore there was no correlation between 
the HAA and XAA pre- or post-exposure to AHR (P <0.05).
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Table 6.4: Comparison of Hydrophobicity of S. aureus Isolates Using the
HAA and XAA
Hydrophobicity of S. aureus isolates pre- and post-exposure to Soft Care Med H5, 
Cutan and Guest Medical using the HAA and XAA hydrophobicity tests. + = 
hydrophobic (adherence of >75%), +/- = intermediate hydrophobicity/hydrophilicity 
(adherence of 25-75%). Isolates are listed from the most-susceptible to AHR (isolate 
44) to the least-susceptible (isolate SI). HAA = hexadecane adherence assay, XAA 
= xylene adherence assay.
Isolate Pre- Post-Soft Care Post-Cutan Post-Guest
exposure Med H5 Medical
HAA XAA HAA XAA HAA XAA HAA XAA
44 + + + +/- + + + +
27 +/- +/- + + +/- +/- +/- +
37 + +/- + + +/- +/- + +
NCIMB 9518 + +/- + + + +/- + +/-
52 + + + + + + + +
34 + + + + + + + +
S12 +/- + + + + + + +/-
S5 + +/- + + + + +/- +
6 + +/- + + + + + +/-
51 +/- +/- + + + + +/- +/-
28 +/- +/- + + + + + +
SI + +/- + + + + + +
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Table 6.5: Rank of S. aureus Isolates According to % Adherence Using HAA
and XAA
Isolates are listed from the most-susceptible to AHR (isolate 44) to the least- 
susceptible (isolate SI). Isolates were ranked from 1-12 according to the highest (1) 
to the lowest (12) mean % adherence values for the HAA and the XAA pre- and 
post-exposure to Soft Care Med H5, Cutan and Guest Medical AHR. HAA = 
Hexadecane Adherence Assay, XAA = Xylene Adherence Assay.
Isolate Ranked % Adherence Values for HAA versus XAA
Pre-Exposure Post-Soft Care Post-Cutan Post-Guest
Med H5 Medical
HAA XAA HAA XAA HAA XAA HAA XAA
44 5 10 8 1 8 10 10 12
27 1 2 7 11 1 3 2 5
37 11 1 11 2 2 2 6 6
NCIMB
9518
6 6 3 3 1 1 7 4
52 7 9 10 7 6 9 9 7
34 12 12 12 12 12 8 11 10
S12 3 11 2 10 9 7 8 2
S5 8 3 6 4 3 6 1 8
6 9 5 9 9 5 4 4 3
51 4 4 1 5 4 5 3 1
28 2 7 4 6 10 11 5 9
SI 10 8 5 8 7 12 12 11
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Table 6.6: Correlation between HAA and XAA
Spearman’s rank correlation coefficients of the ranked % adherence values for the 
HAA versus XAA pre- and post- exposure to Soft Care Med H5, Cutan and Guest 
Medical. The critical value was based on the number pairs of data points used to 
calculate the correlation coefficient. HAA = Hexadecane Adherence Assay, XAA = 
Xylene Adherence Assay, rs = Spearman’s rank correlation coefficient, - = no 
correlation.
Ranked % Adherence Values for HAA versus XAA
Pre- Post-Soft Post-Cutan Post-Guest
Exposure Care Med H5 Medical
rs 0.08 0.12 0.39 0.53
Critical Value 0.59 0.59 0.59 0.59
Correlation - - - -
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6 3 3  Determining the Surface Charge of S. aureus Isolates
The results of surface charge analysis are shown in Figure 6.6. Data were interpreted 
according to manufacturer’s instructions (Malvern Instruments), where <-30 mV or 
>+30 mY is classed as a high zeta potential and >-30 to <+30 is classed as a low zeta 
potential; therefore out of a total of 48 samples (12 bacterial strains under 4 
conditions) 19 isolates had high zeta potentials and 29 isolates had low zeta 
potentials. There was a significant difference in the zeta potential values between the 
12 isolates pre-exposure and post-exposure to Soft Care Med H5 (P <0.05), but no 
significant difference in the zeta potential values between the isolates post-exposure 
to Cutan and Guest Medical (P >0.05). There was no significant difference between 
zeta potential values pre- and post-exposure to AHR for any isolates (P >0.05), 
except isolate 28 had a significantly lower (less negative) and isolate S5 had a 
significantly higher (more negative) zeta potential after exposure to Soft Care Med 
H5, isolate 37 had a significantly higher zeta potential after exposure to Cutan and 
isolate S5 had a significantly higher zeta potential after exposure to Guest Medical (P 
<0.05).
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Figure 6.6: Results of Surface Charge Analysis of S . aureus Pre- and Post- Exposure to AHR
Mean zeta potential ± SD of S. aureus NCIMB 9518 plus 11 hospital isolates pre- and post-exposure to Soft Care Med H5, Cutan and Guest 
Medical AHRs. * indicates where a value was significantly different and their colour indicates to which condition they refer.
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6.3.4 Determining the Correlation between Hydrophobicity and Surface 
Charge
S. aureus isolates 44, 27, 37, NCIMB 9518, 52, 34, S12, S5, 6, 51, 28 and SI were 
ranked from the highest % adherence to the lowest, according to the mean % 
adherence values for the HAA (Table 6.7) and the XAA (Table 6.8) hydrophobicity 
tests and from the highest zeta potential to the lowest, pre-exposure to AHR. The 
isolates were found to not be ranked in the same, or reverse, order for the surface 
charge and hydrophobicity test for pre- or post-exposure conditions.
Scatterplots were created of the mean % adherence values for the HAA test and 
mean zeta potential values for the surface charge, one for each condition (pre- and 
post-exposure to each AHR). Scatterplots were also created of the mean % 
adherence values for the XAA test and mean zeta potential values for the surface 
charge, one for each condition. Distribution of the data points for each scatterplot 
was satisfactory for using the Spearman’s rank correlation coefficient. The 
Spearman’s rank correlation coefficients (rs) for HAA versus zeta potential and XAA 
versus zeta potential are shown in Tables 6.9 and 6.10, respectively. The rs values 
were lower than the critical value for HAA versus zeta potential pre- and post- 
exposure and for XAA versus zeta potential pre- and post-exposure to Soft Care Med 
H5 and Guest Medical. This means there was no correlation (P <0.05) between 
HAA and surface charge. The rs value was higher than the critical value for XAA 
versus zeta potential post-exposure to Cutan, meaning that a correlation may exist 
where the higher the zeta potential (the more negative the mV) the higher the % 
adherence for the XAA (P >0.05). This indicates at a possible association between 
hydrophobicity using the XAA and surface charge, although no association was 
found under any condition except for after exposure to Cutan AHR.
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Table 6.7: Rank of SL aureus Isolates According to % Adherence Using HAA
and Zeta Potential
Isolates are listed from the most-susceptible to AHR (isolate 44) to the least- 
susceptible (isolate SI). Isolates were ranked from the highest % adherence to the 
lowest, according to the mean % adherence values for the HAA and from the highest 
zeta potential to the lowest, pre- and post- exposure to Soft Care Med H5, Cutan and 
Guest Medical.
Isolate Ranked % Adherence Values for HAA versus Zeta Potential
Pre-Exposure Post-Soft Care Post-Cutan Post-Guest
Med H5 Medical
HAA Zeta HAA Zeta HAA Zeta HAA Zeta
44 5 5 8 3 8 12 10 11
27 1 6 7 7 1 3 2 2
37 11 7 11 9 2 2 6 3
NCIMB
9518
6 3 3 1 11 4 7 9
52 7 9 10 12 6 9 9 12
34 12 8 12 6 12 8 11 1
S12 3 12 2 8 9 7 8 5
S5 8 10 6 11 3 10 1 10
6 9 2 9 5 5 5 4 6
51 4 1 1 2 4 1 3 7
28 2 4 4 10 10 11 5 4
SI 10 11 5 4 7 6 12 8
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Table 6.8: Rank of S, aureus Isolates According to % Adherence Using XAA
and Zeta Potential
Isolates are listed from the most-susceptible to AHR (isolate 44) to the least- 
susceptible (isolate SI). Isolates were ranked from the highest % adherence to the 
lowest according to the mean % adherence values for the XAA and from the highest 
zeta potential to the lowest, pre- and post- exposure to Soft Care Med H5, Cutan and 
Guest Medical.
Isolate Ranked % Adherence Values for XAA versus Zeta Potential
Pre-Exposure Post-Soft Care Post-Cutan Post-Guest
Med H5 Medical
XAA Zeta XAA Zeta XAA Zeta XAA Zeta
44 10 5 1 3 10 12 12 11
27 2 6 11 7 3 3 5 2
37 1 7 2 9 2 2 6 3
NCIMB
9518
6 3 3 1 1 4 4 9
52 9 9 7 12 9 9 7 12
34 12 8 12 6 8 8 10 1
S12 11 12 10 8 7 7 2 5
S5 3 10 4 11 6 10 8 10
6 5 2 9 5 4 5 3 6
51 4 1 5 2 5 1 1 7
28 7 4 6 10 11 11 9 4
SI 8 11 8 4 12 6 11 8
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Table 6.9: Correlation between HAA and Surface Charge
Spearman’s rank correlation coefficients of the ranked % adherence values for the 
HAA versus zeta potential values for surface charge pre- and post- exposure to Soft 
Care Med H5, Cutan and Guest Medical. The critical value was based on the number 
of pairs of data points used to calculate the correlation coefficient. HAA = 
Hexadecane Adherence Assay, rs = Spearman’s rank correlation coefficient, - = no 
correlation.
Ranked % Adherence Values for HAA versus Zeta Potential
Pre- Post-Soft Post-Cutan Post-Guest
Exposure Care Med H5 Medical
rs 0.24 0.34 0.45 0.13
Critical Value 0.59 0.59 0.59 0.59
Correlation - - - -
Table 6.10: Correlation between XAA and Surface Charge
Spearman’s rank correlation coefficients of the ranked % adherence values for the 
XAA versus zeta potential values for surface charge pre- and post- exposure to Soft 
Care Med H5, Cutan and Guest Medical. The critical value was based on the number 
of pairs of data points used to calculate the correlation coefficient. XAA = Xylene 
Adherence Assay, rs = Spearman’s rank correlation coefficient, + = correlation, - = 
no correlation.
Ranked % Adherence Values for HAA versus Zeta Potential
Pre- Post-Soft Post-Cutan Post-Guest
Exposure Care Med H5 Medical
rs 0.34 0.15 0.71 0.15
Critical Value 0.59 0.59 0.59 0.59
Correlation - - + -
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6.3.5 Determining the Correlation between Bacterial Adhesion and 
Susceptibility to AHR
S. aureus isolates 44, 27, 37, NCIMB 9518, 52, 34, SI2, S5, 6, 51, 28 and SI were 
ranked from the highest mean log reduction after 10 s exposure to AHR using the 
carrier test Bioscreen method to the lowest, using data from Figure 4.10 in Chapter 4 
(see Table 6.11).
Scatterplots were created of the mean log reductions of each isolate versus either the 
mean % adherence values for the HAA, the mean % adherence values for the XAA 
or the mean zeta potential values. Comparison was performed post- exposure to Soft 
Care Med H5, Cutan and Guest Medical. Distribution of the data points for each 
scatterplot was satisfactory for using the Spearman’s rank correlation coefficient. 
The Spearman’s rank correlation coefficients (rs) for log reduction versus HAA, 
XAA and zeta potential are shown in Table 6.12. The rs values were lower than the 
critical value and therefore there was no correlation between bacterial adhesion and 
exposure to AHR (P <0.05).
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Table 6.11: Rank of S. aureus Isolates According to % Log Reduction after 10
s Exposure to AHR
Isolates are listed from the overall most-susceptible to AHR (isolate 44) to the 
overall least-susceptible (isolate SI). Isolates were ranked from the lowest log 
reduction after 10 s to the highest, after exposure to Soft Care Med H5, Cutan and 
Guest Medical.
Isolate Ranked Mean log Reduction after 10 s exposure to AHR
Soft Care Med H5 Cutan Guest Medical
44 12 12 11
27 11 10 12
37 9 7 6.5
NCIMB 9518 2 3 3
52 8 8.5 10
34 6 4.5 4
S12 10 11 8
S5 7 8.5 5
6 5 6 6.5
51 3 4.5 9
28 4 2 4
SI 1 1 1
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Table 6.12: Correlation between Bacterial Susceptibility to AHR and Adhesion
Spearman’s rank correlation coefficients of the ranked mean % adherence values for the HAA and XAA and the ranked mean zeta potential 
values versus the ranked mean log reduction after 10 s exposure to AHR. AHRs included Soft Care Med H5, Cutan and Guest Medical. The 
critical value was based on the number of pairs of data points used to calculate the correlation coefficient. HAA = Hexadecane Adherence 
Assay, XAA = Xylene Adherence Assay, rs = Spearman’s rank correlation coefficient, - = no correlation.
Ranked Mean Log Reduction after 10 s Exposure to AHR Versus Post-Exposure to Adhesion Tests
Soft Care Med H5 Cutan Guest Medical
HAA XAA Zeta HAA XAA Zeta HAA XAA Zeta
h 0.38 -0.01 0.37 -0.35 -0.13 0.21 -0.25 -0.28 0.12
Critical Value 0.59 0.59 0.59 0.59 0.59 0.59 0.59 0.59 0.59
Correlation - - - - -
6.3.6 Determining Cell Size, Arrangement and Surface Properties of S. aureus 
Using Microscopy
6.3.6.1 Cell Size and Arrangement of S. aureus Cells
SEM images o f S. aureus cells at 10,000 x magnification are shown in Figure 6.7. 
Differences were observed between the arrangement of S. aureus cells among the 
isolates. Figure 6.7 shows that bacterial cells belonging to isolate SI (Figure 6.7c) 
are arranged in large groups, whereas bacterial cells belonging to isolate NCIMB 
9518 (Figure 6.7b) are arranged in smaller groups. Isolate 44 was arranged in 
smaller groups, but there were less bacteria in the specimen (Figure 6.7a).
The mean bacterial cell diameter was 0.76 ± 0.03 pm, 0.70 ± 0.01 pm and 0.74 ± 
0.02 pm for S. aureus isolates 44, NCIMB 9518 and SI, respectively. Statistical 
analysis revealed that isolates 44 and SI were significantly larger than isolate 
NCIMB 9518 (P <0.05), but there was no significant difference between the 
diameter of isolates 44 and SI (P >0.05).
6.3,6.3 Determining the Presence/Absence of Capsules Surrounding S. aureus 
Cells
Images of capsule staining are shown in Figure 6.8. Capsules were found to be 
present for isolates 44 (Figure 6.8a), isolate NCIMB 9518 (Figure 6.8b) and SI 
(Figure 6.8c).
63.7 Determining the Total Protein Content of S. aureus Cells
Figure 6.9 shows the fitted line plot of BSA concentrations against OD56 2. The 
calculated concentration of protein in each test suspension is shown in Table 6.13. 
There was no significant difference between the protein concentration of isolates 44, 
NCIMB 9518 and SI (P >0.05). There was no significant difference between the dry 
weight of the bacterial samples (P >0.05).
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Figure 6.7: Size of S. aureus Cells
Shows S. aureus cells at 10,000 x magnification using SEM imaging. A = isolate 44, 
B = NCIMB 9518, C = isolate SI.
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Figure 6.8: Capsule Staining of S. aureus Isolates
A = isolate 44, B = NCIMB 9518, C = SI. Arrows show presence of a capsule
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Figure 6.9: Fitted Line Plot of Protein Concentration vs Optical Density
The OD562 of known concentrations of BSA were plotted to provide a calculation for 
determining the protein concentration of test samples based on their OD562.
Table 6.13: Concentration of Protein in S. aureus Isolates
Shows the mean ± SD total protein concentration of S. aureus isolates 44, NCIMB 
9518 and SI per 1 ml test sample.
Isolate Mean Protein Concentration 
(mg/1 ml sample)
44 10.96 ±2.07
9518 10.74 ±2.24
SI 13.75 ± 1.08
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6.4 DISCUSSION
6.4.1 Sub-Lethal Activity of AHRs
To determine the effect AHRs have on bacterial cells (such as change in gene 
expression, hydrophobicity and surface charge), bacterial cells must remain viable 
throughout exposure to the AHR. A concentration of AHR must therefore be used 
that is strong enough to have an effect on bacterial cells but diluted enough for the 
bactericidal effect to be neutralized. Guest Medical AHR was demonstrated to have 
a sub-lethal effect on S. aureus isolates, as discussed in Section 4.4.2. Ethanol, 
isopropanol and w-propanol have been previously demonstrated to have a sub-lethal 
effect on strains of S. epidermidis at concentrations as low as 0.5-6% v/v (Knobloch 
et al., 2002).
Since the bactericidal effect of AHR was quenched at a dilution of 1 in 9 in PBS the 
assumption was that any other buffer would neutralize the AHR at a dilution of 1 in 
9, due to the high concentration exponent of alcohols. The efficacy of 0.0001 M KC1 
as a neutralize^ which was used during surface charge testing, was therefore not 
validated. However, it was felt necessary to check the ability of TSB to quench the 
bactericidal effect of AHR at a dilution of 1 in 9, due to the greater quantity of 
ingredients it contains.
6.4.2 Hydrophobicity Testing and Its Limitations
The SAT has several limitations. Firstly, the SAT is fairly lengthy and is therefore 
not ideal for testing a large number of samples. Secondly, the test is qualitative and 
therefore only able to rank isolates according to their hydrophobicity and compare 
the hydrophobicity pre- and post- exposure to various conditions, rather than provide 
an actual value. Thirdly, electrostatic interactions are more likely to influence the 
results than other hydrophobicity tests (Rosenberg & Doyle, 1990). The SAT did not 
work on S. aureus isolates tested in this study, which was also the case for Dillon et 
al. (1986) and Emanuel (2008, personal communication). The SAT has, however, 
been previously successful in determining the cell surface hydrophobicity of S. 
aureus (Ljungh et al., 1985; Rozgonyi et al., 1985).
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The HAA method had to be modified from that described in Greene et al. (1992) to 
include a washing step after exposure of cells to AHR. This is because the AHR 
precipitated upon exposure to hexadecane, resulting in a white appearance that 
caused the OD+hexadecane to be much higher than ODm itiai- Washing was also 
performed using the XAA, since it was assumed that the same precipitation would 
occur with any hydrocarbon. Standardizing the two methods also allowed for a more 
reliable comparison of results. Washing cells was not found to prevent a significant 
change in hydrophobicity after exposure of cells to a biocide, even after washing 
cells three times (Camacho et al., 2007).
Most isolates were hydrophobic and some were of intermediate 
hydrophobicity/hydrophilicity pre-exposure to AHR, which supports similar findings 
in a review of studies by Wadstrom, (1990), which revealed that most strains were 
hydrophobic.
Standard deviations for the % adherence obtained using the HAA and XAA were 
often very high; therefore interpretation of statistical data and forming conclusions 
derived from results should be done with caution. The lack of observed statistically 
significant increase in hydrophobicity post-AHR exposure for most isolates could be 
due to the fact that the hydrophobicity of some of the isolates was initially very high 
and also due to the large variation in replicate results. On the other hand, the 
statistical significance observed in some of the isolates under certain conditions may 
have proved non-significant if performed on other occasions, due to high variability. 
However, performing both tests and detecting a significant difference between the 
assays only for one isolate under one condition provides additional strength to an 
otherwise unreliable assay. High standard deviations may also be responsible for the 
fact that although there was a tendency towards lower % adherence values for the 
XAA compared to the HAA this was not statistically significant under most 
conditions.
The hydrophobicity of the isolates varied depending on whether the HAA or XAA 
was used; therefore the isolates were ranked differently according to their % 
adherence for these two tests. Dickson & Koohmaraie (1989) ranked a range of
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bacterial species according to their hydrophobicity, as determined by the HAA and 
XAA. They also found that while some bacteria were ranked the same, or similar, 
for both tests other isolates were ranked very differently. Dillon et al. (1986) tested 
two strains of S. aureus using HAA and XAA and found to be similar, especially for 
one of the isolates.
6.43 Link between Hydrophobicity and Surface Charge
Tables 6.7 and 6.8 show that very few isolates were ranked the same, or similar, 
according to their surface charge and hydrophobicity; therefore no association was 
seen between hydrophobicity and surface charge in this study. Dickson & 
Koohmaraie (1989) also ranked bacteria according to their hydrophobicity as 
determined by the HAA and XAA and their surface charge. They also found that 
very few isolates were ranked the same or similar according to hydrophobicity and 
surface charge and there was therefore no association between hydrophobicity and 
surface charge. Matz & Jurgens (2001) also found no association between cell 
surface hydrophobicity and surface charge. Theoretically an inverse correlation 
should exist between hydrophobicity and surface charge, where the higher the cell 
surface hydrophobicity, the lower the surface charge. This is because surface charge 
increases the likelihood of polar interactions with water molecules, which results in 
more charged surface groups and therefore a lower hydrophobicity (Rosenberg & 
Doyle, 1990). Rosenberg & Doyle (1990) review a number of studies that compared 
hydrophobicity and surface charge, which either found no correlation or an inverse 
correlation.
6.4.4 The Effect of AHR Exposure on Non-Specific Adhesion in S. aureus
The effect of exposure of S. aureus to AHR on non-specific adhesion was 
investigated with respect to hydrophobicity using the HAA and XAA and surface 
charge (zeta potential). The results are summarised in Table 6.14. Although there 
was mostly an increase in hydrophobicity and surface charge after exposure to AHR, 
this was not often significant and some isolates under some conditions showed a 
decrease that was sometimes significant. These results indicate there is no strong 
effect of AHR exposure on the non-specific adhesion of bacteria, especially since
2 2 2
there is no apparent pattern among the isolates or the AHRs. Differences in adhesion 
of bacteria as a result of hydrophobicity and surface charge reflect differences in cell 
surface molecular structure, composition and orientation (Rosenberg & Doyle, 1990; 
Somasundaran, 2006). Since there were no real differences in hydrophobicity using 
the HAA and XAA or surface charge testing the zeta potential it therefore appears 
that there may not be differences in bacterial cell surface properties between isolates 
44, NCIMB 9518 and SI or pre- and post exposure to AHR. Further testing could be 
performed, however, using tests that have less variability, since it is important to 
determine whether S. aureus isolates that are able to survive exposure are more or 
less virulent than before.
Gorman (1991) found that change in the hydrophobicity of isolates from a number of 
bacterial species was not the same after exposure to chlorhexidine, providone iodine 
and taurolidine. He found that the change in hydrophobicity was not even the same 
among different hydrophobicity tests, although isolates tended to show a decrease in 
hydrophobicity. Jones et al. (1996) found a significant reduction in the number of 
Pseudomonas aeruginosa cells able to attach to plastic surfaces with incorporated 
biocides than without and cell surface hydrophobicity was lower. Bruinsma et al. 
(2001) found that after damaging P. aeruginosa cells by either sonication or 
exposure to a lens care solution they were less hydrophobic, which was likely due to 
damage caused to the cell surface. Bruinsma et al. (2006) found that P. aeruginosa 
isolates resistant to a QAC-based lens care solution had a less negative surface 
charge than susceptible strains, although there was no difference between the 
hydrophobicity of sensitive and resistant strains. They conclude that electrostatic 
repulsion between cationic surface molecules and QAC obstructs entry of biocide 
into the cell. The fact that exposure to AHR did not increase surface charge 
remarkably in this study indicates that entry of alcohol into the bacterial cell may not 
be impeded by the bacteria itself.
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Table 6.14: The effect of Exposure of S . aureus to AHR on Non-Specific Adhesion
Indicates differences in hydrophobicity (% adherence using HAA and XAA) and surface charge (zeta potential) after exposure to Soft Care 
Med H5, Cutan and Guest Medical AHRs. * indicates a significant difference. HAA = Hexadecane Adherence Assay, XAA = Xylene 
Adherence Assay, |  = increase, j = decrease
Isolates Post-Exposure to Soft Care Med H5 Post-Exposure to Cutan Post-Exposure to Guest Medical
HAA XAA Zeta HAA XAA Zeta HAA XAA Zeta
44 r i t t  T 4 T t 1
27 t * T i 4 T T 4 T t
37 T* T 4 t  T T* t  T t
NCIMB 9518 T t 4 1 * T T 4 t t
52 T T t T T T t  t 4
34 T T 4 1 * t" T T t 4
S12 t T t 4 4 t 4 t T
S5 t * T T* t *  1 T t *  4 t *
6 T t t i  r t 4 t * r
51 T T 4 r  r t 4 4 4
28 t * t 4* 1* * T 4 t  t T
SI t T T T * t T t t
6.4.5 Cell Size and Arrangement
It has previously been observed that environmental and clinical isolates may be 
larger than reference strains of the same species (Martin, personal communication), 
which supports the findings of this study. Cell size (or rather the differences in 
structure between different cell sizes) is unlikely to have an impact on the 
susceptibility to AHR, especially since the most- and least-susceptible isolates were 
the same size.
6.4.6 Capsule Formation
Isolates 44, NCIMB 9518 and SI did not have mucoid colonies and therefore are not 
heavily encapsulated. They all possessed a capsule, as determined by microscopy 
and are therefore all microencapsulated.
6.4.7 Summary
The S. aureus isolates used in this study were either hydrophobic or of intermediate 
hydrophobicity and of both high and low zeta potential. No link was demonstrated 
between non-specific adhesion of S. aureus (by way of their hydrophobicity and 
surface charge) and their susceptibility to AHR. There was mostly no difference in 
the hydrophobicity or surface charge of the isolates post-exposure to AHR and 
certainly no trend in the direction of the exceptions. It therefore appears as though 
surface interactions do not change after exposure to AHR.
There was also no observable link between cell size and presence of capsule and 
their susceptibility to AHR, although cells of isolates less susceptible to AHR 
clumped together in larger clusters than those more-susceptible. It is likely, therefore 
that differences in susceptibility to AHR are related to the structure and composition 
of the bacterial cell wall and/or outer layers, since those were determined to be the 
main target for AHR in Chapter 5.
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CHAPTER 7 GENERAL DISCUSSION
7.1 THE POTENTIAL LINK BETWEEN GENOTYPIC AND
PHENOTYPIC TRAITS OF S. AUREUS ISOLATES
There were 10 different antibiotic resistance profiles for all hospital isolates (Table 
3.8, Chapter 3), compared to 38 different RAPD banding patterns (Table 3.7, Chapter 
3). This indicated that more than one genotypically identical group of isolates 
produced an identical antibiotic resistance (ABR) profile. However, some isolates 
that appeared to be of the same strain because they had identical banding profiles for 
all primers tested showed different ABR profiles. Genotypic and phenotypic profiles 
did not therefore match (Cheeseman et al., 2007). This was also found by Norazah 
et al. (2009) and Uma Karthika et al. (2009). Variability within a strain may be the 
result of the loss/gain of ABR genes, but the reason variability was observed was 
most likely due to the small portion of the genome sampled by RAPD, which is 
unlikely to coincide with an ABR gene. Phenotypic results may not match genotypic 
results even if the primers were for ABR genes. This is because ABR genes may not 
be switched on in some cases, despite the gene being present, or the genes may be 
expressed in varying degrees (Depardieu et al., 2007).
There were 12 antiseptic susceptibility (ASS) profiles for all hospital isolates (Table 
4.3, Chapter 4), compared to the 38 RAPD banding patterns. More than one 
genotypically identical group of isolates showed the same ASS profile. However, 
some isolates with the same RAPD profile showed different ASS profiles. It is 
unclear what mechanisms are responsible for differences in ASS profiles. However, 
if reduced susceptibility is due to genetic differences between isolates the genes 
encoding them are unlikely to be included in the small portion of the genome 
transcribed by the primer.
The relationship between genotypic RAPD profiles and ABR/ASS profile is shown 
in Table 7.1. It shows that there was only one incidence where 3 isolates shared the 
same RAPD and ABR profiles. It also shows that there were six incidences where 2 
isolates shared the same RAPD and ABR profiles, three incidences where 2 isolates 
shared the same RAPD and ASS profiles, plus only 1 incidence where 2 isolates 
shared the same RAPD, ABR and ASS profiles. Since there were 60 isolates used in 
this study some similarities would be expected to occur by chance. It is unlikely,
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therefore, that there is a link between their genotypic grouping using RAPD and the 
phenotypic traits determined in this study among the isolates. Isolates found to be 
the same strain according to RAPD testing should not therefore be assumed to share 
the same phenotypic characteristics.
Table 7.1: The Relationship between Genotypic and Phenotypic Profiles of
S. aureus Isolates
Previous chapters determined that there were 39, 10 and 12 RAPD, antibiotic 
resistance (ABR) and antiseptic susceptibility (ASS) profiles among the isolates, 
respectively. The isolates in this table are therefore assigned the numbers 1 to 39, 1 
to 10 and 1 to 12 according to their RAPD, ABR and ASS profiles, respectively. The 
numbers are assigned arbitrarily to all isolates with the same profile; therefore all 
isolates within the same column with the same number showed the same profile. The 
numbers assigned to isolates should not be compared between columns, since this 
does not demonstrate a relationship. Rather, isolates assigned the same number in 
one column and also assigned the same number in a second column (but not 
necessarily the same number as the first column) show a relationship. For example, 
isolates 10 and 13 have been assigned the same ABR profile number (1) and have 
also been assigned the same ASS profile number (4). This means that in the case of 
both ABR and ASS, isolates 10 and 13 have the same profiles. The numbers have 
been colour-coded to aid comparison. All ABR and ASS profiles have been colour- 
coded, plus all but one of the RAPD profiles assigned to multiple bacteria.
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Table 7.1:
Isolate Profile Number
RAPD ABR ASS
Isolate Profile Number
RAPD ABR ASS
14
15
16
17
18
19
20 
21
24
25
26
27
28
30
31
32 
34
37
38
39
41
42
19
32
5 1 4
6 31 1
9 13 5
10 13 1
n 5
13 8 1
27
8
34
1
1
36
26
35
2
1
10
NA
NA
4 5 2
19 1
3 5 4 S6
9 10 mm S7
2 5 3 S8
24 8 5 S10
33 10 4 Sll
1 9 3 S12
2 5 3 NCIMB
9518
■
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7.2 THE POTENTIAL LINK BETWEEN SUSCEPTIBILITY TO AHR AND 
OTHER PHENOTYPIC TRAITS OF S. AUREUS ISOLATES
MRSA and MSSA isolates appeared to be evenly distributed among the antiseptic 
susceptibility profiles (Table 4.3, Chapter 4). This means MRSA did not have 
reduced susceptibility to AHR compared to MSSA, unlike with other antiseptics 
(Suller & Russell, 1999). This may mean that reduced susceptibility to AHR and 
other antiseptics is not mediated by the same mechanisms. Table 7.1 shows that the 
same ABR and ASS profiles were shared between 2 isolates on 7 occasions, 3 
isolates on 4 occasions, 4 isolates on 2 occasions and 7 isolates on 1 occasion. 
Therefore although there were a number of situations where isolates shared both 
ABR and ASS profiles, this usually occurred between small numbers of isolates and 
does not necessarily indicate a relationship between ABR and ASS. This is because 
the similarities observed are likely due to there only being a small number of profiles 
to which the isolates could belong. It is therefore unlikely that a relationship exists 
between ABR and ASS, which may not be mediated by the same mechanisms.
This study found no link between non-specific adhesion of S, aureus (by way of their 
hydrophobicity and surface charge) and their susceptibility to AHR (section 6.3.5). 
The 12 isolates tested for non-specific adhesion were also tested for the 
presence/absence of the adhesion genes cna, fob A, fiibB and clfA in section 3.3.4. 
Table 7.2 shows the adhesion gene profile of the 12 isolates in relation to their ABS 
profile. Six of the 12 isolates possessed all of the adhesion genes, five of the 
remaining six isolates did not possess one adhesion gene and one isolate did not 
possess two adhesion genes. There was also no apparent difference between the 
adhesion gene profiles of isolate 44 (the most-susceptible isolate to AHR) and isolate 
SI (the least-susceptible isolate to AHR), except that isolate SI did not have the gene 
jhbB, which encodes adhesion to fibronectin on host tissue. There does not appear, 
therefore, to be an association between non-specific adhesion and susceptibility to 
AHR.
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Table 7.2: Adhesion Gene Profiles of S. aureus Isolates
Demonstrates presence (+) or absence (-) of adhesion genes in S', aureus reference 
strain NCIMB 9518 plus 11 hospital isolates. Isolates are listed from the most- 
susceptible to AHR (isolate 44) to the least-susceptible (isolate SI).
Isolates fnbA fnbB cna clfA
44 + + - +
27 + + + +
37 + + + +
NCIMB 9518 + + - +
52 + + + +
34 + + +
S12 + - + +
S5 + - + +
6 + + + +
51 + + - +
28 + + + +
SI + - - +
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The surface charge of bacteria was found to be associated with susceptibility to 
cationic compounds, where more negatively charged bacteria were more susceptible 
to cationic compounds (Bruinsma et al., 2006). This was due to electrostatic 
repulsion between the cationic compound and the less negatively charged bacterial 
surface reducing interaction with, and therefore gaining entry to, the bacterial cell. 
AHR is not a cationic compound and surface charge of the bacteria cannot reduce 
AHR interaction with bacterial cells. The differences observed in susceptibility of 
the isolates to AHR is therefore not likely to be linked to their ability to adhere to 
surfaces, or to each other and is likely due to some other factor.
73  HOW EFFECTIVE IS AHR AGAINST S. AUREUS?
Soft Care Med H5 was found to be the most efficacious AHR against S. aureus using 
the stainless steel carrier test (Table 4.3, Chapter 4). Cutan was found to be the most 
effective using the ex-vivo carrier test (Table 4.4, Chapter 4), which was likely due to 
its high viscosity decreasing evaporation time of the alcohol and increasing the 
efficacy over the 20 min contact time. In practice, however, the AHR is rubbed in 
and evaporates quickly, making Soft Care Med H5 the most efficacious AHR in 
practice. This is due to its formulation, since Soft Care Med H5 contains alcohols 
that are most efficacious (Rotter et al., 2001).
Soft Care Med H5 AHR met the criteria of EN13697 (European Standard EN13697, 
2001), since it was able to achieve a >4 logio reduction within 5 min. However, 
Cutan and Guest Medical did not, since a >4 logio reduction was not achieved for all 
isolates within 5 min (only 16% and 86% of isolates, respectively). This indicates 
that some AHRs are not of an acceptable standard according to the European 
Committee for Standardization. AHRs have also failed to meet the criteria of 
EN1500 (European Standard EN1500, 1997; Kramer et al., 2002). These standard 
methods do not, however, take into consideration the contact time of AHR on the 
hands of HCWs in practice, which is due to the rapid evaporation of AHR and the 
lack of residual activity (section 4.3.3.3). It was found that only Soft Care Med H5 
and Guest Medical were able to achieve a >4 log reduction for only one isolate 
(Table 4.3, Chapter 4) within the contact times used in practice (11-15 s, Table 4.1, 
Chapter 4) using the stainless steel carrier test. It was found that AHR was even less
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effective at reducing the number of viable S. aureus cells on the surface of skin, with 
no AHR able to meet the criteria of EN13697 (Table 4.4, Chapter 4). It does not 
therefore appear that AHRs are effective at achieving an acceptable reduction of S. 
aureus cells from the hands of HCW by contact times set by the European 
Committee for Standardization, or those used in practice.
The bactericidal efficacy of alcohol is caused by its ability to damage proteins and 
lipids within bacterial cells (Ali et al., 2001) and is membrane active (Franklin & 
Snow, 1989; Ali et al., 2001). The AHRs tested in this study disrupted the integrity 
of the cytoplasmic membrane of S. aureus cells (section 5.3.3), causing intracellular 
leakage of K+ (Figure 5.2, Chapter 5). Membrane damage was, however, unlikely to 
contribute to the bactericidal activity of the AHRs (section 5.3.2.3). AHR also 
damaged the intracellular contents of S. aureus cells of the most-susceptible isolate 
to AHR, resulting in a change in the appearance of the bacterial cytoplasm (section 
5.3.3) that is likely due to coagulation of protein (McDonnell & Russell, 1999). 
However, this damage to the bacterial cytoplasm was not observable until after a 
bactericidal effect was achieved and was not observed in >4 logio cells, indicating 
that intracellular damage may not be the cause of the bactericidal effect. Exposure to 
AHR caused an increase in the appearance of UEM (section 5.3.3), which is likely to 
be polysaccharide that has come away from the bacterial cell surface as a result of 
damage (Jones et al., 1969). It is therefore unclear, from this study and previous 
investigations, the exact cause(s) of the bactericidal activity of AHR against S. 
aureus.
1A HOW USEFUL IS AHR IN THE INTENSIVE THERAPY UNIT?
AHRs are the most efficacious instant hand sanitizers (Ayliffe et al., 1988) and the 
use of AHR versus hand washing is known to increase hand hygiene compliance in 
the ITU (Hugonnet et al., 2002; Creedon, 2005 and Eldridge et al., 2006). AHR has 
also been found to be as effective as, or more effective than, hand washing at 
reducing bacterial numbers on the hands of HCWs (Larson et al., 2001; Rotter, 2001; 
Girou et al., 2002; Karabay et al., 2005) and preventing HAI (Larson et al., 1995). 
This is why AHR is used in the ITU and throughout the healthcare setting.
233
AHR is not, however, appropriate for use over gloves and since direct patient contact 
by HCWs involves the use of gloves, AHR does not have a direct role in the 
prevention of potential object-to-patient cross-contamination (Table 4.1, Chapter 4). 
This may partially explain why AHR was so infrequently used, particularly in MH 
(Table 4.1, Chapter 4). Use of AHR may, however, reduce potential contamination 
of objects by the hands of HCWs that may subsequently be transferred from the 
object to the patient via gloved hands.
AHR is also not effective at killing all microorganisms that are found in the 
healthcare environment. Most notable is that AHR is unable to reduce numbers of 
Clostridium difficile on the hands of HCWs (Oughton et al., 2009). This is not 
limited to AHR, since alcohol, chlorhexidine, iodophors, parachlorometaxylenol 
(PCMX) and triclosan are not reliably sporicidal against Clostridium spp (Boyce & 
Pittet, 2002). AHR may not therefore be the most useful agent on a busy ward that is 
subject, or especially prone, to Clostridium difficile outbreak.
AHR is also not the ideal agent for use by HCWs whose religious beliefs do not 
permit them the consumption of alcohol, since their hand hygiene compliance may 
be low. Allegranzi et al. (2009) found that although a number of religions prohibit 
the consumption of alcohol, AHR is usually accepted in a medicinal capacity since it 
is used for optimal patient care delivery. Despite this they rationalize that some 
HCWs may avoid the use of AHR to prevent inhalation or absorption through the 
skin; therefore compliance may be reduced.
AHR also does not have any residual activity (section 4.3.3.3) and therefore cannot 
eliminate transient organisms that are picked up by the HCW in between 
applications. Hospital policy directs HCWs to sanitize their hands before wearing 
sterile gloves, before and after each patient contact, after any potential microbial 
contamination and after touching clinical equipment (Hosein, 2004). Hand hygiene 
should therefore be performed after very short intervals so that elimination of 
transient organisms will be achieved with repeat hygiene procedures, rather than 
through residual effect. Not all directions within the hospital hand decontamination 
policy were adhered to at all times, however, and as a result hand hygiene was not
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performed as frequently as desired, allowing transient organisms to potentially be 
transferred via HCWs hands (Table 4.1, Chapter 4). The use of a hand hygiene agent 
with an effective immediate and persistent antimicrobial activity may therefore be 
more effective for ITU HCWs, such as an AHR containing a low percentage of 
antiseptic with a persistent antimicrobial effect (Gaonkar et al., 2005; Shintre et al., 
2006).
7.5 CONCLUSION
Despite AHR comprising a large part of the hand hygiene regimens in the healthcare 
environment very little is known about its efficacy against conditions found in 
practice, such clinical strains attached to a surface. Very little is also known of their 
effect on bacterial cells and the causes of differences in susceptibility among isolates. 
This study aimed to discover how effective AHRs are in practice against S. aureus, 
the nature of their bactericidal effect on S. aureus cells and the cause of differences 
in susceptibility among S. aureus isolates. It was found that Soft Care Med H5, 
Cutan and Guest Medical AHRs were unable to achieve a bactericidal effect within 
the time HCWs took to rub AHR into their hands, which was particularly apparent 
when AHR was tested against bacterial cells on the surface of skin. AHR was found 
to have no residual effect and the mechanical action of hand rubbing was not found 
to increase bacterial cell death by very much. It is therefore unlikely that AHRs kill 
all microbial flora on HCWs hands in practice, although only S. aureus has been 
tested and such a large number of bacterial cells as used during carrier testing is not 
likely to be present in such a concentrated fashion.
As previously stated in the literature, AHR was found to damage the cytoplasmic 
membrane, which was demonstrated using K+ leakage and TEM testing. This was 
not, however, found be the cause of the bactericidal effect or the differences in 
susceptibility among strains, as demonstrated with S. aureus protoplasts. Protoplast 
testing found it was the cell wall or outer layers that were implicated in the 
bactericidal effect, which is most likely to be protein denaturation. Protein 
denaturation could not be confirmed as the primary cause of the bactericidal effect 
due to lack of a suitable protocol. Further work is therefore necessary to determine 
the main mode of action of AHR using a quantitative method.
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The presence/absence and expression of the selected virulence genes, hydrophobicity 
and surface charge appeared to provide no contribution to susceptibility of S. aureus 
to AHR. Further work is therefore necessary to find the cause of the difference in 
susceptibility to AHR.
S. aureus isolates in die hospital environment that have survived exposure to AHR 
did not appear to be more adherent to surfaces in terms of their hydrophobicity or 
surface charge and did not up-regulate expression of virulence genes that are not 
involved in increasing their survival, but down-regulated them in some instances. It 
is therefore not likely that S. aureus isolates that are exposed to AHR but not killed 
become more virulent.
AHRs have a number of disadvantages that make them less useful to HCWs in ITUs, 
and other hospital wards, than they could potentially be. Hand santitizing regimens 
currently used by ITU staff in local hospitals do not maximize prevention of 
transmission of microorganisms or HCAI. Improvements could be made to the AHR 
and hand sanitizing regimens to increase their usefulness and efficacy.
7.6 RECOMMENDATIONS
The author of this study proposes several recommendations:
It is recommended that future efficacy testing of instant hand sanitizing agents are 
performed using the stainless steel carrier test according to EN13697, but using 
clinical strains of organisms likely to be found in the hospital environment. It is also 
recommended that an ex-vivo test be performed where possible, since it reflects more 
accurately the conditions found in practice.
It is recommended that improvements are made to AHRs to increase their efficacy 
and usefulness and to correct their disadvantages. The advantages and disadvantages 
of AHRs are shown in Table 7.3, along with recommendations for improvement. It 
is recommended that the efficacy of AHR is increased by increasing the volume of 
AHR used per application. Since compliance is a problem amongst HCWs it is 
recommended that manufacturers alter the AHR dispensers so that one pump expels
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a larger volume of AHR, rather than asking HCWs to use another pump, which may 
be too large a volume. It is recommended that the efficacy of AHR is also increased 
by developing the most efficacious combination of alcohol type and concentration. 
Until this has been completed it is recommended that the most efficacious AHR from 
this study (Soft Care Med H5) replace Cutan and Guest Medical AHRs and be used 
in conjunction with hand washing. It is also recommended that a non-alcoholic 
instant hand sanitizer be made available that is also sporicidal, particularly against C. 
difficile. This hand sanitizer can be provided for HCWs whose religion prohibits use 
of AHR so they will feel more comfortable in the workplace and may show increased 
hand hygiene compliance. This sanitizer can also be used in wards during an 
outbreak of C. difficile.
It is recommended that improvements are made to the hand hygiene regimens used in 
ITUs to minimize the spread of S. aureus and other microorganisms and potentially 
reduce HCAI. The best practice for hand sanitizing in ITUs is shown in Table 7.4, 
including improvements that can be made to achieve this. Firstly, HCWs should be 
re-trained to ensure that they put on gloves immediately prior to touching the patient 
to avoid the possibility of contaminating the patient with microorganisms picked up 
on the gloves from the environment. Secondly, HCWs should be informed that hand 
washing and/or use of AHR is sufficient for activities not involving the patient and 
that re-application of AHR is not necessary in between touching different objects. 
Thirdly, HCWs should be re-trained to ensure they apply AHR at regular intervals 
and immediately after touching their hair, forearms or clothing. This should change 
the low frequency of AHR use observed in the ITUs, particularly in MH (Table 4.1, 
Chapter 4).
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Table 73: The Ideal Properties of Instant Hand Sanitizers
Shows the advantageous properties of an instant hand sanitizer and whether AHRs 
demonstrate these properties to excellent levels (++), acceptable levels (+) or 
unacceptable levels (x). Potential improvements are also shown, where realistically 
achievable.
Ideal Properties Level Alcohol Hand Rub
demonstrated Improvements
in AHR
Rapid activity X Increase volume dispensed with each pump 
and alter alcohol type/concentration
Broad activity + Add sporicidal agent
Residual activity X Add an active agent with residual activity
Sporicidal X Add a sporicidal agent
Gentle on skin + Provide alternative hand sanitizer for 
affected HCWs
Cost ++ Not applicable
Stain-resistance ++ Not applicable
Religious + Provide alternative hand sanitizer for
acceptance affected HCWs
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Table 7.4: Best Practice for Hand Sanitization in ITUs
Shows the best practice for hand sanitization in ITUs and whether HCWs observed in 
this study were observed to achieve this (Table 4.1, Chapter 4) to excellent levels 
(++), acceptable levels (+) or unacceptable levels (x). Potential improvements are 
also shown, where realistically achievable.
Best Practice for Hand Sanitization in ITUs Achieved? Improvements
Wash hands only if physically dirty/after patient ++ Not applicable
contact
Use AHR frequently X Retrain staff
Apply a generous amount of AHR to hands X Retrain staff
Apply AHR to all areas of the hand + Retrain staff
Rub into hands for at least 1 min X Retrain staff
Apply AHR before glove application X Retrain staff
Apply gloves immediately prior to patient contact X Retrain staff
Remove gloves immediately after patient contact + Retrain staff
Apply AHR if own hair, skin or clothing is touched X Retrain staff
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7.7 FUTURE WORK
Although Soft Care Med H5 was found to be the most efficacious AHR further work 
should be carried out to determine whether any other AHRs currently available are 
even more efficacious. Work should also be carried out to potentially develop the 
most efficacious combination of alcohol type and concentration to ensure AHRs used 
in the healthcare environment are as efficacious as they can be.
Further work should be performed to determine the effect of AHR on other major 
HCAIs such as Streptococcus pneumoniae, Klebsiella spp, Enterococcus spp, 
coagulase-negative staphylococci and Escherichia coli (HPA, 2008). Further work 
should also be performed to determine whether AHR is effective against rare but 
serious nosocomial pathogens such as Mycoplasma and Ureaplasma spp. 
Mycoplasma and Ureaplasma can be found in the urethra (Zenilman, 2007); 
therefore insertion of catheters and use of bed pans may facilitate the introduction of 
these organisms into the environment and thus their spread via the hands of HCWs.
This study was unable to determine the reason why S. aureus isolates showed 
differences in susceptibility to AHR. Further testing should therefore be performed 
to determine the genotypic/phenotypic differences in the isolates that cause 
differences in susceptibility. One hypothesis is that since protein denaturation is a 
mode of bactericidal activity (and likely the major mode of activity), differences in 
susceptibility of isolates to protein denaturation may be the reason for differences in 
bactericidal susceptibility. This hypothesis can be tested by comparison of the 
protein profiles of the most- and least-susceptible S. aureus isolates using two- 
dimensional gel electrophoresis, which separates proteins according to their 
isoelectric point and molecular weight (Gravel, 2002). If there are any differences in 
the presence/absence or proportion of particular protein species between these 
isolates this may be responsible for reduced (or increased) susceptibility to protein 
denaturation, decreased penetration through the cell wall or increased cell repair. 
Proteins of interest could be isolated from the gel and sequenced to discover their 
identity and function. This technique could not be performed post-exposure to AHR, 
since denatured proteins may be destroyed by the method used to break apart the 
cells to extract protein. This may, however, form a crude determination of the
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protein undamaged during alcohol exposure and pre- and post- AHR exposure 
protein profiles could be performed and compared between isolates.
Further work should be performed to determine the effect of AHR on gene 
expression and identify the gene(s) responsible for causing bacteria to be less 
susceptible to AHR. This would need to be performed using microarray, since this 
method allows expression of all genes within the bacterial genome to be analysed 
(Schena et al., 1995). The genome of isolates can be compared to determine the 
differences in gene expression between isolates with different susceptibility to AHR 
and compare an individual isolate pre- and post-exposure to AHR.
Currently manufactured alcohol-free instant hand sanitizers that are sporicidal should 
be searched for (or developed specifically) and tested according to conditions in 
practice, particularly with respect to their efficacy against C. difficile.
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